细胞株Cell Lines 10-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格：¥19200
- 货 号：Cell Line CV10
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID CHLA-20
AC CVCL_6602
SY CHLA20
DR Cosmic; 1890108
RX PubMed=9850071;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-20_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 15,19
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17
ST D3S1358: 16
ST D5S818: 12,15
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 23,24
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6594 ! CHLA-15
SX Female
CA Cancer cell line
//
ID CHLA-200
AC CVCL_M147
DR Cosmic; 1875114
RX PubMed=22120608;
WW http://www.cogcell.org/dl/BrainTumorDataSheets/CHLA-200_Cell_Line_Data_Sheet_COGcell_org_2015.pdf
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11
ST D16S539: 12
ST D18S51: 15,17
ST D19S433: 15
ST D21S11: 29,32.2
ST D2S1338: 18,22
ST D3S1358: 14,16
ST D5S818: 9,12
ST D7S820: 8,12
ST D8S1179: 10,15
ST FGA: 21,26
ST TH01: 6
ST TPOX: 8
ST vWA: 17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-215
AC CVCL_AQ36
SY CHLA215
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 14
ST D16S539: 12
ST D18S51: 18,19
ST D19S433: 13,13.2
ST D21S11: 29,31
ST D2S1338: 23
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 21,22
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-218
AC CVCL_0B48
DR Cosmic; 2228215
RX PubMed=25010205;
WW http://www.cogcell.org/cellreqs-eft.php
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12
ST D18S51: 11,13
ST D19S433: 13,16
ST D21S11: 29,31
ST D2S1338: 23
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 8,13
ST FGA: 21,24
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-222
AC CVCL_AQ37
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 9
ST D16S539: 12
ST D18S51: 16
ST D19S433: 12,15
ST D21S11: 28,31
ST D2S1338: 17,20
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 9,14
ST FGA: 23,25
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,19
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-223
AC CVCL_AQ38
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9,12
ST D16S539: 10,13
ST D18S51: 14,16
ST D19S433: 13,14
ST D21S11: 30,31.2
ST D2S1338: 20,24
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 12,15
ST FGA: 23,24
ST TH01: 7
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-224
AC CVCL_AQ39
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 12
ST D18S51: 12,17
ST D19S433: 13.2,14
ST D21S11: 31.2,32.2
ST D2S1338: 19,23
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 11,14
ST FGA: 22,26
ST TH01: 6,9
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-225
AC CVCL_A057
RX PubMed=11507071;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,13
ST D16S539: 11,13
ST D18S51: 12,16
ST D19S433: 13,16.2
ST D21S11: 28,31.2
ST D2S1338: 17,24
ST D3S1358: 14,15
ST D5S818: 9,11
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 22,26
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-246
AC CVCL_AQ40
RX CelloPub=CLPUB00315;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 14,16
ST D19S433: 14,15
ST D21S11: 30,32.2
ST D2S1338: 21,23
ST D3S1358: 15,17
ST D5S818: 7,12
ST D7S820: 8
ST D8S1179: 10,11
ST FGA: 20,26
ST TH01: 9
ST TPOX: 8,12
ST vWA: 14,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-247
AC CVCL_AQ14
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 10,15
ST D16S539: 11,12
ST D18S51: 10,12
ST D19S433: 14,14.2
ST D21S11: 28,33.2
ST D2S1338: 17,25
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 21,25
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-25
AC CVCL_M152
DR Cosmic; 2228216
DR GEO; GSM1676353
DR GEO; GSM1701683
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=26351324;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/CHLA-25_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Omics: Deep RNAseq analysis.
ST Source(s): COG; PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 14,17
ST D19S433: 14
ST D21S11: 29,32.2
ST D2S1338: 19,22
ST D3S1358: 17,18
ST D5S818: 10
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 24,25
ST TH01: 7
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A444 ! TTC-466
SX Female
CA Cancer cell line
//
ID CHLA-253
AC CVCL_AQ15
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 10,15
ST D16S539: 11,12
ST D18S51: 10,12
ST D19S433: 14,14.2
ST D21S11: 28,33.2
ST D2S1338: 17,25
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 21,26
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AX48 ! CHLA-253h
SX Male
CA Cancer cell line
//
ID CHLA-253h
AC CVCL_AX48
SY CHLA253h
DR Cosmic; 1890109
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 10,15
ST D16S539: 11,12
ST D18S51: 10,12
ST D19S433: 14,14.2
ST D21S11: 28,33.2
ST D2S1338: 17,25
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 21,26
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ15 ! CHLA-253
SX Male
CA Cancer cell line
//
ID CHLA-255
AC CVCL_AQ27
SY Childrens Hospital Los Angeles-255
RX PubMed=12810621;
CC Derived from metastatic site: Brain.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 15,19
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17
ST D3S1358: 16
ST D5S818: 12,15
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 23,24
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-258
AC CVCL_A058
SY CHLA258
DR Cosmic; 1112131
DR Cosmic; 2228217
DR Cosmic; 2294582
DR GEO; GSM1676354
DR GEO; GSM1701684
RX PubMed=15289350;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/CHLA-258_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 89 hours (COG).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): COG; PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 10,12
ST D18S51: 12,17
ST D19S433: 14
ST D21S11: 31.2
ST D2S1338: 17,23
ST D3S1358: 15
ST D5S818: 7,11
ST D7S820: 11,12
ST D8S1179: 14,15
ST FGA: 19,25
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-259
AC CVCL_M148
RX PubMed=22120608;
RX PubMed=24300787;
WW http://www.cogcell.org/dl/BrainTumorDataSheets/CHLA-259_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 11
ST D18S51: 13
ST D19S433: 16
ST D21S11: 29,30
ST D2S1338: 17,18
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 20,26
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-266
AC CVCL_M149
RX PubMed=22120608;
WW http://www.cogcell.org/dl/BrainTumorDataSheets/CHLA-266_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 45 hours (COG).
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,10
ST D16S539: 10,12
ST D18S51: 17,19
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 20
ST D3S1358: 15,18
ST D5S818: 10,12
ST D7S820: 10,12
ST D8S1179: 10,14
ST FGA: 23,24
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-32
AC CVCL_M151
DR Cosmic; 2228218
DR GEO; GSM1676355
DR GEO; GSM1701685
RX PubMed=15289350;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=26351324;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/CHLA-32_Cell_Line_Data_Sheet_COGcell_org.pdf
CC Omics: Deep RNAseq analysis.
ST Source(s): COG; PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 11 (COG)
ST CSF1PO: 10,11 (PubMed=24312454)
ST D13S317: 12
ST D16S539: 12
ST D18S51: 19 (COG)
ST D18S51: 18,19 (PubMed=24312454)
ST D19S433: 13,15
ST D21S11: 28,31
ST D2S1338: 24
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 13,15
ST FGA: 24
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-42
AC CVCL_6603
SY CHLA_42
DR Cosmic; 930039
DR Cosmic; 1890123
RX PubMed=9850071;
RX PubMed=11212268;
RX PubMed=23202128;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-42_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,13
ST D16S539: 11,13
ST D18S51: 13,14
ST D19S433: 13,14
ST D21S11: 29,31
ST D2S1338: 17,20
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 8,13
ST FGA: 23,25
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-51
AC CVCL_6604
DR Cosmic; 930040
DR Cosmic; 1161982
RX PubMed=9850071;
RX PubMed=11507071;
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 11,13
ST D18S51: 15,18
ST D19S433: 14,14.2
ST D21S11: 30
ST D2S1338: 21,23
ST D3S1358: 15
ST D5S818: 10,13
ST D7S820: 10,11
ST D8S1179: 12,14
ST FGA: 19,22
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-52
AC CVCL_6605
DR Cosmic; 930041
RX PubMed=11212268;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 15,16
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 20,23
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 13,14
ST FGA: 21,25
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-53
AC CVCL_AQ16
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 15,16
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 20,23
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 13,14
ST FGA: 21,25
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-54
AC CVCL_6606
DR Cosmic; 930042
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11
ST D18S51: 14
ST D19S433: 12,16
ST D21S11: 28,30
ST D2S1338: 18,20
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 13,16
ST FGA: 21,26
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-57
AC CVCL_0B49
WW http://www.cogcell.org/cellreqs-eft.php
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 10,11
ST D18S51: 17
ST D19S433: 15,17
ST D21S11: 28,29
ST D2S1338: 22,23
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 12,13
ST D8S1179: 11,12
ST FGA: 20,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-60
AC CVCL_6607
DR Cosmic; 930043
RX PubMed=11212268;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 11,13
ST D18S51: 15
ST D19S433: 15
ST D21S11: 28,30
ST D2S1338: 23
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 7,10
ST D8S1179: 13,14
ST FGA: 23,26
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-61
AC CVCL_AQ17
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 11,13
ST D18S51: 15
ST D19S433: 15
ST D21S11: 28,30
ST D2S1338: 23
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 7,10
ST D8S1179: 13
ST FGA: 23,26
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-79
AC CVCL_6608
SY CHLA_79
DR Cosmic; 930044
DR Cosmic; 1019943
DR Cosmic; 1161983
RX PubMed=9850071;
RX PubMed=11507071;
RX PubMed=11212268;
RX PubMed=23202128;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12
ST D16S539: 12
ST D18S51: 14
ST D19S433: 14,15
ST D21S11: 30,30.2
ST D2S1338: 17,23
ST D3S1358: 17,18
ST D5S818: 11,13
ST D7S820: 8,9
ST D8S1179: 12
ST FGA: 20,21
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-8
AC CVCL_6609
RX PubMed=9850071;
RX PubMed=11507071;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 17
ST D19S433: 13,15
ST D21S11: 30,30.2
ST D2S1338: 18,19
ST D3S1358: 17,18
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 21,24
ST TH01: 6
ST TPOX: 8,11
ST vWA: 19,20
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHLA-9
AC CVCL_M150
SY CHLA9
DR Cosmic; 2228220
DR GEO; GSM1676339
DR GEO; GSM1701626
RX PubMed=15289350;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/CHLA-9_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 51 hours (COG).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): COG; PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 12,14
ST D19S433: 12,13
ST D21S11: 28,29
ST D2S1338: 19,20
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 10,13
ST FGA: 23,24
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6583 ! CHLA-10
SX Female
CA Cancer cell line
//
ID CHLA-90
AC CVCL_6610
SY CH-LA-90
DR Cosmic; 930045
DR Cosmic; 1167412
RX PubMed=9850071;
RX PubMed=11507071;
RX PubMed=11212268;
RX PubMed=15150091;
RX PubMed=24792489;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-90_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 59 hours (COG).
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 12
ST D18S51: 17
ST D19S433: 14
ST D21S11: 28,30.2
ST D2S1338: 18,24
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 11
ST FGA: 20,22
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-95
AC CVCL_6611
DR Cosmic; 930046
RX PubMed=11212268;
WW http://www.cogcell.org/dl/NB_Data_Sheets/CHLA-95_Cell_Line_Data_Sheet_COGcell_org.pdf
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 9,14
ST D18S51: 13,14
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 17,23
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 12,13
ST FGA: 20,23
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHLA-98
AC CVCL_6612
DR Cosmic; 930047
RX PubMed=11212268;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 12
ST D18S51: 12,13
ST D19S433: 12,13
ST D21S11: 30
ST D2S1338: 20,23
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 19,24
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHLA-99
AC CVCL_0B50
WW http://www.cogcell.org/cellreqs-eft.php
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 14,16
ST D19S433: 12
ST D21S11: 30,31.2
ST D2S1338: 18,20
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 12,13
ST D8S1179: 10,14
ST FGA: 22
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHM 2100
AC CVCL_7179
SY CHM2100
DR Lonza; 1379
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34469; Choroideremia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID ChM114-1
AC CVCL_X917
RX PubMed=2579038;
RX PubMed=6093374;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9598; ! Pan troglodytes
OI CVCL_X918 ! ChM114-2
CA Transformed cell line
//
ID ChM114-2
AC CVCL_X918
RX PubMed=2579038;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9598; ! Pan troglodytes
OI CVCL_X917 ! ChM114-1
CA Transformed cell line
//
ID CHME-5
AC CVCL_5J53
SY CHME5
RX PubMed=7478261;
RX PubMed=8845742;
RX PubMed=10074188;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Miscellaneous: The cell line name was not assigned in the original paper (PubMed=7478261).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CHMm
AC CVCL_L146
RX PubMed=19754820;
CC Derived from metastatic site: Pleural effusion.
CC Breed/subspecies: Mixed breed.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L147 ! CHMp
SX Female
CA Cancer cell line
//
ID CHMp
AC CVCL_L147
RX PubMed=19754820;
CC Breed/subspecies: Mixed breed.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L146 ! CHMm
SX Female
CA Cancer cell line
//
ID CHMp-13a
AC CVCL_L144
RX PubMed=21714977;
CC Breed/subspecies: Maltese.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L147 ! CHMp
SX Female
CA Cancer cell line
//
ID CHMp-5b
AC CVCL_L145
RX PubMed=21714977;
CC Breed/subspecies: Maltese.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L147 ! CHMp
SX Female
CA Cancer cell line
//
ID CHO
AC CVCL_0213
SY Chinese Hamster Ovary; CHO-ori
DR BTO; BTO:0000246
DR CLO; CLO_0002421
DR MCCL; MCC:0000102
DR CLDB; cl721
DR CLDB; cl722
DR CLDB; cl724
DR CCRID; 3111C0001CCC000116
DR CCRID; 3131C0001000100003
DR CCRID; 3153C0001000000050
DR ChEMBL-Cells; CHEMBL3308072
DR ChEMBL-Targets; CHEMBL613853
DR CLS; 603479/p746_CHO
DR ECACC; 00102307
DR ECACC; 85050302
DR ICLC; ATL95003
DR KCB; KCB 82012YJ
DR KCB; KCB 83004YJ
DR Lonza; 755
DR MeSH; D016466
DR NCBI_Iran; C111
DR Wikidata; Q56646
RX DOI=10.3390/pr1030296;
RX PubMed=4120885;
RX PubMed=13598821;
WW https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
WW http://www.cells-talk.com/index.php/page/copelibrary?key=CHO
WW http://www.cho-cell-transfection.com/index.html
WW http://biotechhistory.org/magazine-article/vital-tools-brief-history-cho-cells/
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 1-15 500
AC CVCL_6339
SY CHO 1-15
DR CLO; CLO_0002422
DR ATCC; CRL-9606
DR BCRJ; 0067
DR NCBI_Iran; C527
RX Patent=US4766075;
CC Transfected with: HGNC; 9051; PLAT.
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C527.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 100DACT
AC CVCL_4V30
RX PubMed=2445701;
CC Selected for resistance to: ChEBI; CHEBI:27666; Actinomycin D (ActD).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V31 ! CHO 15DACT
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 13-5-1
AC CVCL_AZ68
SY CHO-13-5-1; 13-5-1
DR BTO; BTO:0005752
DR TOKU-E; 4000
RX PubMed=7790352;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 14-2-1
AC CVCL_AZ69
SY CHO-14-2-1; 14-2-1
RX PubMed=7790352;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 15DACT
AC CVCL_4V31
RX PubMed=2445701;
CC Selected for resistance to: ChEBI; CHEBI:27666; Actinomycin D (ActD).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 1beta9, 12.5, clone 36
AC CVCL_DC99
SY CHO 1beta9,12.5 Clone 36; CHO-1 beta 9, 12.5, CL 36
DR ATCC; CRL-9800
DR CCRID; 3142C0001000000431
RX Patent=US5221620;
CC Transfected with: HGNC; 11766; TGFB1.
CC Discontinued: ATCC; CRL-9800; probable.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 22H11
AC CVCL_GX98
SY CHO 22h11; 22H11
DR TOKU-E; 4001
RX PubMed=10699869;
CC Transfected with: Glutamine synthetase (GS) expression system carrying a gene for human-mouse chimeric antibody cB72.3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 25-RA
AC CVCL_U429
SY 25-RA; 25RA; Clone 25-RA; 25 RA CHO
RX PubMed=2404988;
RX PubMed=3335499;
RX PubMed=6105157;
RX PubMed=8898195;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 4364
AC CVCL_K254
SY CHO clone 4364; CHOK1 4364; 4364
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 51D1
AC CVCL_5A48
SY 51D1
RX PubMed=16522646;
RX PubMed=20434408;
RX PubMed=22923057;
CC Knockout cell: Method=Homologous recombination; Rad51d.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 51D1.3
AC CVCL_5A49
SY 51D1.3
RX PubMed=16522646;
RX PubMed=20434408;
CC Knockout cell: Method=Homologous recombination; Rad51d.
CC Transfected with: UniProtKB; G3GTU6; Cricetulus griseus Rad51d.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5A48 ! CHO 51D1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 7PA2
AC CVCL_HC66
SY CHO-7PA2; CHO7PA2; 7PA2
RX PubMed=7721886;
RX PubMed=23948918;
RX PubMed=24840308;
CC Transfected with: HGNC; 620; APP (isoform APP751 with F-717).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 7WD10
AC CVCL_HC65
SY CHO7WD10; 7WD10; 7W
RX PubMed=8021238;
WW http://www.tiandz.com/product/14124.html
CC Transfected with: HGNC; 620; APP (isoform APP751).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO 92UG21-9 gp120 (Clade D)
AC CVCL_1Y13
SY HIV-1 secreting 92UG21-9 gp120 CHO cells
DR NIH-ARP; 4699-378
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO AC29
AC CVCL_U430
SY AC29; AC29 CHO; CHO (AC29); AC-29
RX PubMed=3335499;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U429 ! CHO 25-RA
SX Female
CA Spontaneously immortalized cell line
//
ID CHO AL
AC CVCL_CX61
SY AL
RX PubMed=286318;
RX PubMed=1475708;
RX PubMed=8946021;
RX PubMed=9357544;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U406 ! CHO-glyA
CA Hybrid cell line
//
ID CHO AL-AND6
AC CVCL_CX63
SY AL-AND6; AND6; GM15827
DR CLO; CLO_0027760
DR Coriell; GM15827
RX PubMed=1475708;
RX PubMed=8946021;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_CX61 ! CHO AL
CA Hybrid cell line
//
ID CHO ALC
AC CVCL_CX62
SY ALC
RX PubMed=9357544;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_CX61 ! CHO AL
CA Hybrid cell line
//
ID CHO beta2(414)cl.32
AC CVCL_DD00
SY CHO-beta2(414) CL.32; beta2(414)cl.32; CHO-beta2(414) CL.32 pTGF-beta2(414)
DR ATCC; CRL-10300
DR CCRID; 3142C0001000000471
RX Patent=US5221620;
CC Transfected with: HGNC; 11768; TGFB2.
CC Discontinued: ATCC; CRL-10300; probable.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO CAT-S
AC CVCL_DR98
SY CAT-S
DR PRIDE; PXD003462
RX Patent=US9068198;
RX PubMed=27070921;
CC Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 10090201.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO CD28
AC CVCL_9V75
DR NCBI_Iran; C504
RX PubMed=2164219;
CC Transfected with: HGNC; 1653; CD28.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO CERT
AC CVCL_GP77
RX PubMed=27547109;
CC Transfected with: HGNC; 2205; COL4A3BP (with A-132).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO clone 13
AC CVCL_9244
DR CLO; CLO_0002423
DR CLDB; cl725
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_9243 ! CHO MT+
SX Female
CA Spontaneously immortalized cell line
//
ID CHO clone B
AC CVCL_9245
DR CLO; CLO_0002424
DR CLDB; cl726
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_9243 ! CHO MT+
SX Female
CA Spontaneously immortalized cell line
//
ID CHO CT43
AC CVCL_U431
SY CT43
RX PubMed=10660558;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U429 ! CHO 25-RA
SX Female
CA Spontaneously immortalized cell line
//
ID CHO CT52
AC CVCL_U432
SY CT52
RX PubMed=2404988;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U429 ! CHO 25-RA
SX Female
CA Spontaneously immortalized cell line
//
ID CHO CT60
AC CVCL_U433
SY CT60
RX PubMed=2404988;
RX PubMed=10660558;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-282.html
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U429 ! CHO 25-RA
SX Female
CA Spontaneously immortalized cell line
//
ID CHO DP-12
AC CVCL_8844
SY CHO-DP12
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO DP-12 clone#1933
AC CVCL_8846
SY CHO DP-12, clone#1993 alL8.92 NB 28605/12
DR CLO; CLO_0002426
DR ATCC; CRL-12444
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_8844 ! CHO DP-12
SX Female
CA Spontaneously immortalized cell line
//
ID CHO DP-12 clone#1934
AC CVCL_8845
SY CHO DP-12, clone#1934 aIL8.92 NB 28605/14
DR CLO; CLO_0002425
DR ATCC; CRL-12445
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_8844 ! CHO DP-12
SX Female
CA Spontaneously immortalized cell line
//
ID CHO HcD6
AC CVCL_9Y69
SY CHO HcD6-SF
RX PubMed=25548123;
RX PubMed=26803706;
CC Omics: Metabolome analysis.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO irs-20
AC CVCL_S167
SY CHO irs 20; irs-20; IRS-20; irs20
RX PubMed=7504309;
RX PubMed=7910196;
RX PubMed=8248482;
RX PubMed=9008208;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_S165 ! CHO-10B2
SX Female
CA Spontaneously immortalized cell line
//
ID CHO irs1SF
AC CVCL_K038
SY irs1SF
DR CLO; CLO_0050425
DR RCB; RCB2328
RX PubMed=3347204;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Spontaneously immortalized cell line
//
ID CHO IS1
AC CVCL_S166
RX PubMed=7528122;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_S165 ! CHO-10B2
SX Female
CA Spontaneously immortalized cell line
//
ID CHO JR-FL gp160 (Clone A19)
AC CVCL_1Y10
DR NIH-ARP; 4022-100
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO MT+
AC CVCL_9243
DR CLO; CLO_0002428
DR CLDB; cl727
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO MW959 gp140 (Clade A)
AC CVCL_1Y09
DR NIH-ARP; 4698-97
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO NL4-3 gp120
AC CVCL_1H27
SY HIV-1 NL4-3 gp120 secreting CHO Cells
DR NIH-ARP; 4125-456
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO NL4-3 gp160
AC CVCL_1G49
DR NIH-ARP; 3972-385
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO PBj gp130
AC CVCL_1Y08
SY 2-8-2
DR NIH-ARP; 4126-104
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO Q131-91A
AC CVCL_1N58
RX PubMed=2286371;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1N56 ! Urd-C
SX Female
CA Spontaneously immortalized cell line
//
ID CHO ST4.2
AC CVCL_W649
SY CHO-ST4.2
DR NIH-ARP; 501-15
CC Transfected with: HGNC; 1678; CD4.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO Tet-On 3G
AC CVCL_V348
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_3G_Cell_Lines
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO XBP1s
AC CVCL_GP78
RX PubMed=27547109;
CC Transfected with: HGNC; 12801; XBP1 (isoform XBP1s).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-10B2
AC CVCL_S165
SY CHO 10B2; CHO10B2; 10B2
RX PubMed=22923057;
CC Misspelling: Occasionally 'CHO 10B12'.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-13D-35D
AC CVCL_IR13
SY 13D-35D
RX PubMed=18078289;
RX PubMed=19134553;
CC Transfected with: HGNC; 775; SERPINC1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-1C6
AC CVCL_8847
DR CLO; CLO_0002435
DR ATCC; CRL-1793
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-22
AC CVCL_V326
DR BTO; BTO:0004810
RX PubMed=16895900;
CC Transfected with: HGNC; 2577; CYBA.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-43-3B
AC CVCL_5A47
SY CHO 43-3B; 43-3B
RX PubMed=2499773;
RX PubMed=2499774;
RX PubMed=3982442;
RX PubMed=6889678;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D898 ! CHO-9
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-6
AC CVCL_4700
SY CHO6; CHO 6
DR BTO; BTO:0003450
RX PubMed=12379725;
RX PubMed=16925789;
CC Characteristics: Resistant to infection by Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia trachomatis.
CC Characteristics: Has a defect in the processing of the signal sequence of P4HB/PDIA1 which lead to impaired chlamydial attachment and infectivity.
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-7
AC CVCL_D893
SY CHO7
DR BTO; BTO:0002988
RX PubMed=2570073;
RX PubMed=17038318;
CC Characteristics: Were derived from parent cell line by adaptation to continuous growth in lipoprotein-deficient serum.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-9
AC CVCL_D898
SY CHO9; GM16132
DR CLO; CLO_0018833
DR Coriell; GM16132
RX PubMed=1518409;
RX PubMed=2499774;
RX PubMed=6889678;
RX PubMed=8187089;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_V245 ! CHO-KK
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-91
AC CVCL_V327
DR BTO; BTO:0004809
RX PubMed=16895900;
CC Transfected with: HGNC; 2578; CYBB.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-91-22
AC CVCL_V328
DR BTO; BTO:0004808
RX PubMed=16895900;
CC Transfected with: HGNC; 2577; CYBA.
CC Transfected with: HGNC; 2578; CYBB.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-91-22-47-67
AC CVCL_V329
SY CHOphox
DR BTO; BTO:0004807
RX PubMed=16895900;
CC Transfected with: HGNC; 2577; CYBA.
CC Transfected with: HGNC; 2578; CYBB.
CC Transfected with: HGNC; 7660; NCF1.
CC Transfected with: HGNC; 7661; NCF2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-91-47-67
AC CVCL_V330
SY CHO-91/47/67
DR BTO; BTO:0004806
RX PubMed=16895900;
CC Transfected with: HGNC; 2578; CYBB.
CC Transfected with: HGNC; 7660; NCF1.
CC Transfected with: HGNC; 7661; NCF2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-A7
AC CVCL_H340
SY CHO A7; A7
DR BTO; BTO:0005753
RX PubMed=3924915;
RX PubMed=4033657;
RX PubMed=6727873;
RX PubMed=7159597;
RX PubMed=7198184;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AA8
AC CVCL_4386
SY CHO AA8; CHO (AA8); AA8
DR BTO; BTO:0002641
DR CLO; CLO_0001630
DR CLO; CLO_0050419
DR ATCC; CRL-1859
DR BCRC; 60162
DR ChEMBL-Cells; CHEMBL3307400
DR ChEMBL-Targets; CHEMBL614555
DR RCB; RCB2326
DR TOKU-E; 498
RX DOI=10.3390/pr1030296;
RX PubMed=2218721;
RX PubMed=2687628;
RX PubMed=3347204;
RX PubMed=7360155;
RX PubMed=7404270;
RX PubMed=8765433;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AA8 Tet-Off
AC CVCL_V347
SY CHO AA8 Tet-Off
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AR1
AC CVCL_5A24
SY AR1
RX PubMed=162911;
CC Selected for resistance to: ChEBI; CHEBI:16335; Adenosine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AR7
AC CVCL_5A25
SY AR7
RX PubMed=162911;
CC Selected for resistance to: ChEBI; CHEBI:16335; Adenosine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AS52
AC CVCL_Y504
SY AS52
RX PubMed=2432598;
RX PubMed=6095070;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-152.html
CC Transfected with: UniProtKB; P0A9M5; E.coli gpt.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_Y503 ! CHO-X3/5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AT3-2
AC CVCL_DE19
SY AT3-2
RX PubMed=3129654;
RX PubMed=6449663;
RX PubMed=7491132;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Selected for resistance to: ChEBI; CHEBI:77751; 8-azaadenine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AUXB1
AC CVCL_D264
SY CHO AUXB1; AuxB1; AUXB1; AUX B1; Aux-B1; AuX B1
DR TOKU-E; 4114
RX PubMed=583488;
RX PubMed=3365701;
RX PubMed=3839900;
RX PubMed=4547236;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AUXB3
AC CVCL_5A30
SY CHO AUXB3; AUXB3; AUX B3
RX PubMed=583488;
RX PubMed=4547236;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-AUXE29
AC CVCL_M722
SY AUXE29; AuxE29
RX PubMed=4585080;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-betaGal
AC CVCL_Y102
DR BCRC; 60377
RX PubMed=11776965;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Discontinued: BCRC; 60377; probable.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-betaGal-SF
AC CVCL_Y103
DR BCRC; 60378
RX PubMed=11776965;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_Y102 ! CHO-betaGal
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CD36
AC CVCL_8848
DR CLO; CLO_0002459
DR ATCC; CRL-2092
RX PubMed=7682381;
CC Transfected with: HGNC; 1663; CD36.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CHRB30
AC CVCL_4703
SY CHRB30; CHrB30
DR BTO; BTO:0000860
RX PubMed=2412130;
RX PubMed=2863759;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D266 ! CHO-CHRC5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CHRC4
AC CVCL_D265
SY CHRC4
RX PubMed=4855907;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D264 ! CHO-AUXB1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CHRC5
AC CVCL_D266
SY CHO/CHRC5; CHO CHRC5; CHRC/5; CHRC5
DR ChEMBL-Cells; CHEMBL3307930
DR ChEMBL-Targets; CHEMBL614457
RX PubMed=2158805;
RX PubMed=2412130;
RX PubMed=3365701;
RX PubMed=3567908;
RX PubMed=4855907;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D264 ! CHO-AUXB1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CHRM1
AC CVCL_U002
DR ECACC; 10110203
RX PubMed=21335600;
CC Transfected with: HGNC; 1950; CHRM1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CHRM2
AC CVCL_U003
DR ECACC; 10110204
RX PubMed=21335600;
CC Transfected with: HGNC; 1951; CHRM2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CHRM5
AC CVCL_U004
DR ECACC; 11041302
RX PubMed=21335600;
CC Transfected with: HGNC; 1954; CHRM5.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Cho-CK
AC CVCL_M268
RX CelloPub=CLPUB00275;
RX PubMed=1312890;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHO-CNR1
AC CVCL_U000
DR ECACC; 12110601
RX PubMed=21335600;
CC Transfected with: HGNC; 2159; CNR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CUR2
AC CVCL_5A37
SY CUR2
RX PubMed=8589689;
RX PubMed=9762903;
CC Selected for resistance to: ChEBI; CHEBI:29036; Copper(2+).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-CUR3
AC CVCL_D583
SY CUR3
DR BTO; BTO:0005225
RX PubMed=8589689;
RX PubMed=9762903;
CC Selected for resistance to: ChEBI; CHEBI:29036; Copper(2+).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-DG44
AC CVCL_7180
SY CHO DG44; CHO-DG44 (DHFR-); DG44; CHO DG-44
DR Lonza; 468
DR NCBI_Iran; C576
DR TOKU-E; 3678
RX DOI=10.1007/978-1-4020-5476-1_59;
RX DOI=10.3390/pr1030296;
RX PubMed=6305508;
RX PubMed=16403443;
RX PubMed=23873082;
WW https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
WW http://www.thermofisher.com/order/catalog/product/A1100001
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-404.html
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7182 ! CHO-pro3-
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-DXB11
AC CVCL_1977
AS CVCL_9246
SY CHO DXB11; CHO-DUX-B11; CHO-DUK-XB11; DUK-XB11; CHO-DUKX B11; DUKX-B11; DUX B11; DXB-11; DXB11; CHO-DUKX; DUKX-CHO; DUKX; CHO-DHFR -; CHO/dhFr-; CHO duk
DR CLO; CLO_0002429
DR CLO; CLO_0002460
DR CLO; CLO_0002849
DR CLDB; cl728
DR CLDB; cl729
DR CLDB; cl1114
DR ATCC; CRL-9096
DR BCRC; 60133
DR BCRJ; 0068
DR CCRID; 3111C0001CCC000003
DR CCRID; 3131C0001000100004
DR CCRID; 3142C0001000000092
DR DSMZ; ACC-126
DR ECACC; 05011002
DR ECACC; 94060607
DR KCB; KCB 200712YJ
DR NCBI_Iran; C590
DR TOKU-E; 945
RX DOI=10.3390/pr1030296;
RX PubMed=6287224;
RX PubMed=6933469;
RX PubMed=25887056;
WW https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
CC Doubling time: ~20-24 hours (DSMZ).
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5A23 ! CHO-UKB25
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-EE
AC CVCL_S542
DR NIH-ARP; 2238-251
RX PubMed=8230430;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-EM9
AC CVCL_3683
SY CHO EM9; EM9; EM-9; EM9-1
DR BTO; BTO:0002640
DR CLO; CLO_0002924
DR CLO; CLO_0050424
DR ATCC; CRL-1861
DR BCRC; 60500
DR RCB; RCB2327
RX PubMed=2218721;
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=6889677;
RX PubMed=7404270;
RX PubMed=7404271;
RX PubMed=8765433;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-EU-1
AC CVCL_CX58
SY EU-1; EU1
RX PubMed=2687628;
RX PubMed=7404271;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3683 ! CHO-EM9
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-EU-2
AC CVCL_CX59
SY EU-2; EU2
RX PubMed=2687628;
RX PubMed=7404271;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3683 ! CHO-EM9
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-FFAR2
AC CVCL_U005
DR ECACC; 10110202
RX PubMed=21335600;
CC Transfected with: HGNC; 4501; FFAR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-FLAG-hBLT1
AC CVCL_T763
SY CHO-hBLT1; CHO-LTBR
DR CLO; CLO_0050412
DR RCB; RCB1821
RX PubMed=9177352;
CC Transfected with: HGNC; 6713; LTB4R.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-GAT
AC CVCL_1N80
SY CHO GAT; CHO(GAT); GAT-; Gat-; GAT
RX PubMed=1235902;
RX PubMed=4525316;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-glyA
AC CVCL_U406
SY CHO-K1 glyA; glyA; Gly-A; Gly A; gly-A; CHO-77256; 772-56; 77256
RX PubMed=341370;
RX PubMed=2218721;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-137.html
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-glyB
AC CVCL_U407
SY glyB; Gly-B
RX PubMed=10978331;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-GPR120
AC CVCL_U007
DR ECACC; 10110205
RX PubMed=21335600;
CC Transfected with: HGNC; 19061; FFAR4.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-GS
AC CVCL_H215
SY GS-CHO
RX DOI=10.1016/j.enzmictec.2004.08.027;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-HA-hBLT2
AC CVCL_T764
SY CHO-hBLT2
DR CLO; CLO_0050413
DR RCB; RCB1822
RX PubMed=10934230;
CC Transfected with: HGNC; 19260; LTB4R2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-hD3
AC CVCL_1B31
DR ChEMBL-Cells; CHEMBL3307496
DR ChEMBL-Targets; CHEMBL614557
CC Transfected with: HGNC; 3024; DRD3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-hL1
AC CVCL_X975
SY hL1-CHO
RX PubMed=11706054;
CC Transfected with: HGNC; 6470; L1CAM.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-hNCX1
AC CVCL_1F91
WW http://www.addexbio.com/productdetail?pid=85
CC Transfected with: HGNC; 11068; SLC8A1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-hTRPV1
AC CVCL_1F92
WW http://www.addexbio.com/productdetail?pid=86
CC Transfected with: HGNC; 12716; TRPV1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-ICAM-1
AC CVCL_8849
DR CLO; CLO_0002461
DR ATCC; CRL-2093
RX PubMed=7682381;
CC Transfected with: HGNC; 5344; ICAM1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-ICAM-1Fc
AC CVCL_AS85
SY CHO ICAM-1Fc
DR Ximbio; 152756
RX PubMed=9452454;
CC Transfected with: HGNC; 5344; ICAM1 (five extracellular domains joined to the hinge, CH2 and CH3 domains of IgG1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1
AC CVCL_0214
SY CHO K1; CHOK1; CHO cell clone K1; GM15452
DR BTO; BTO:0000457
DR CLO; CLO_0002427
DR CLO; CLO_0002462
DR CLO; CLO_0002463
DR CLO; CLO_0026669
DR CLO; CLO_0050409
DR CLO; CLO_0050420
DR CLO; CLO_0050423
DR MCCL; MCC:0000103
DR CLDB; cl730
DR CLDB; cl731
DR CLDB; cl732
DR CLDB; cl734
DR CLDB; cl735
DR CLDB; cl738
DR CLDB; cl739
DR CLDB; cl740
DR CLDB; cl741
DR CLDB; cl4897
DR ATCC; CCL-61
DR ATCC; CRL-9618
DR BCRC; 60006
DR BCRJ; 0069
DR CCLV; CCLV-RIE 0134
DR CCLV; CCLV-RIE 0315
DR CCRID; 3111C0001CCC000004
DR CCRID; 3111C0002000000006
DR CCRID; 3131C0001000100007
DR CCRID; 3142C0001000000018
DR CCRID; 3142C0001000000406
DR CCRID; 3153C0001000000066
DR ChEMBL-Cells; CHEMBL3307512
DR ChEMBL-Targets; CHEMBL614031
DR CLS; 603480/p693_CHO-K1
DR Coriell; GM15452
DR DSMZ; ACC-110
DR ECACC; 85051005
DR ICLC; ATL98003
DR IFO; IFO50414
DR IZSLER; BS CL 15
DR JCRB; JCRB9018
DR KCB; KCB 88028YJ
DR KCLB; 10061
DR Lonza; 44
DR NCBI_Iran; C645
DR RCB; RCB0285
DR RCB; RCB2330
DR RCB; RCB2869
DR TKG; TKG 0328
DR TOKU-E; 949
DR TOKU-E; 950
RX DOI=10.3390/pr1030296;
RX PubMed=10320750;
RX PubMed=21804562;
RX PubMed=23873082;
WW https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
WW http://www.chogenome.org/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-30.html
WW http://biotechhistory.org/magazine-article/vital-tools-brief-history-cho-cells/
WW http://en.vircell.com/products/cho-k1-cell-line/
CC Doubling time: ~24 hours (DSMZ).
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1 (+Galpha16) AequoScreen
AC CVCL_5I89
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A24
CC Transfected with: UniProtKB; P07164; Aequorin.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1 (+Gqi5) AequoScreen
AC CVCL_5I90
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A21
CC Transfected with: UniProtKB; P07164; Aequorin.
CC Transfected with: HGNC; 4390; GNAQ (Gqi5, with 355-DCGLF-359 from GNAI1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1 (SC)
AC CVCL_U864
DR CLO; CLO_0050422
DR RCB; RCB0403
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1 AequoScreen
AC CVCL_5I91
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A12
CC Transfected with: UniProtKB; P07164; Aequorin.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1-AC-free
AC CVCL_AR65
DR ECACC; 13080801
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1-BH4
AC CVCL_Y502
SY CHO K1-BH4; K1-BH4; K1BH4
DR ChEMBL-Cells; CHEMBL3307354
DR ChEMBL-Targets; CHEMBL614256
RX PubMed=194347;
RX PubMed=1235913;
RX PubMed=2432598;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1-Gln(-)
AC CVCL_1F96
RX Patent=US20100221781;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1-SFM
AC CVCL_9U94
DR TKG; TKG 0587
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/5-HT1A/Galpalpha15
AC CVCL_H378
WW http://www.genscript.com/molecule/M00330-5-HT1A.html
CC Transfected with: HGNC; 5286; HTR1A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/5-HT2A
AC CVCL_H379
WW http://www.genscript.com/molecule/M00251-5-HT2A.html
CC Transfected with: HGNC; 5293; HTR2A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/5-HT2B
AC CVCL_H380
WW http://www.genscript.com/molecule/M00249-5-HT2B.html
CC Transfected with: HGNC; 5294; HTR2B.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/5-HT2C
AC CVCL_H381
WW http://www.genscript.com/molecule/M00253-5-HT2C.html
CC Transfected with: HGNC; 5295; HTR2C.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/5-HT4/Galpalpha15
AC CVCL_H382
WW http://www.genscript.com/molecule/M00444-5-HT4.html
CC Transfected with: HGNC; 5299; HTR4.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADORA1/Galpha15
AC CVCL_H383
WW http://www.genscript.com/molecule/M00324-ADORA1.html
CC Transfected with: HGNC; 262; ADORA1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADORA2A/Galpha15
AC CVCL_H384
WW http://www.genscript.com/molecule/M00246-ADORA2A.html
CC Transfected with: HGNC; 263; ADORA2A.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADORA2B/Galpha15
AC CVCL_H385
WW http://www.genscript.com/molecule/M00329-ADORA2B.html
CC Transfected with: HGNC; 264; ADORA2B.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADORA3/Gqi5
AC CVCL_H386
WW http://www.genscript.com/molecule/M00464-ADORA3.html
CC Transfected with: HGNC; 268; ADORA3.
CC Transfected with: HGNC; 4390; GNAQ (Gqi5, with 355-DCGLF-359 from GNAI1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRA1A
AC CVCL_H387
WW http://www.genscript.com/molecule/M00225-ADRA1A.html
CC Transfected with: HGNC; 277; ADRA1A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRA1B
AC CVCL_H388
WW http://www.genscript.com/molecule/M00260-ADRA1B.html
CC Transfected with: HGNC; 278; ADRA1B.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRA1D
AC CVCL_H389
WW http://www.genscript.com/molecule/M00340-ADRA1D.html
CC Transfected with: HGNC; 280; ADRA1D.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRA2A/Galpha15
AC CVCL_H390
WW http://www.genscript.com/molecule/M00281-ADRA2A.html
CC Transfected with: HGNC; 281; ADRA2A.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRA2B/Gqi5
AC CVCL_H391
WW http://www.genscript.com/molecule/M00454-ADRA2B.html
CC Transfected with: HGNC; 282; ADRA2B.
CC Transfected with: HGNC; 4390; GNAQ (Gqi5, with 355-DCGLF-359 from GNAI1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRA2C/Galpha15
AC CVCL_H392
WW http://www.genscript.com/molecule/M00252-ADRA2C.html
CC Transfected with: HGNC; 283; ADRA2C.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRB1/Galpha15
AC CVCL_H393
WW http://www.genscript.com/molecule/M00269-ADRB1.html
CC Transfected with: HGNC; 285; ADRB1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/ADRB2/Galpha15
AC CVCL_H394
WW http://www.genscript.com/molecule/M00308-ADRB2.html
CC Transfected with: HGNC; 286; ADRB2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AGTRL1/Galpha15
AC CVCL_H395
WW http://www.genscript.com/molecule/M00245-AGTRL1.html
CC Transfected with: HGNC; 339; APLNR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AM1
AC CVCL_H396
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 16709; CALCRL.
CC Transfected with: HGNC; 9844; RAMP2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AM2/Galpha15
AC CVCL_H397
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 16709; CALCRL.
CC Transfected with: HGNC; 9845; RAMP3.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AMY1/CRE-Luc
AC CVCL_H398
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 1440; CALCR.
CC Transfected with: HGNC; 9843; RAMP1.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_H414 ! CHO-K1/CRE-Luc
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AMY1/Galpha15
AC CVCL_H399
WW http://www.genscript.com/molecule/M00475-AMY1.html
CC Transfected with: HGNC; 1440; CALCR.
CC Transfected with: HGNC; 9843; RAMP1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AMY2/Galpha15
AC CVCL_H400
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 1440; CALCR.
CC Transfected with: HGNC; 9844; RAMP2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/AMY3/Galpha15
AC CVCL_H401
WW http://www.genscript.com/molecule/M00481-AMY3.html
CC Transfected with: HGNC; 1440; CALCR.
CC Transfected with: HGNC; 9845; RAMP3.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/B1/Galpha15
AC CVCL_H402
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 1029; BDKRB1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/B2/Galpha15
AC CVCL_H403
WW http://www.genscript.com/molecule/M00184-B2.html
CC Transfected with: HGNC; 1030; BDKRB2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/BB1
AC CVCL_H404
WW http://www.genscript.com/molecule/M00254-BB1.html
CC Transfected with: HGNC; 7843; NMBR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/BB2
AC CVCL_H405
WW http://www.genscript.com/molecule/M00182-BB2.html
CC Transfected with: HGNC; 4609; GRPR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/BB3
AC CVCL_H406
WW http://www.genscript.com/molecule/M00183-BB3.html
CC Transfected with: HGNC; 1113; BRS3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/C5a/Galpha15
AC CVCL_H407
WW http://www.genscript.com/molecule/M00327-C5a.html
CC Transfected with: HGNC; 1338; C5AR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CASR
AC CVCL_H408
WW http://www.genscript.com/molecule/M00434-CASR.html
CC Transfected with: HGNC; 1514; CASR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CB1/Galpha15
AC CVCL_H409
WW http://www.genscript.com/molecule/M00299-CB1.html
CC Transfected with: HGNC; 2159; CNR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CB2
AC CVCL_H410
WW http://www.genscript.com/molecule/M00433-CB2.html
CC Transfected with: HGNC; 2160; CNR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CCKA/Galpha15
AC CVCL_H411
WW http://www.genscript.com/molecule/M00271-CCKA.html
CC Transfected with: HGNC; 1570; CCKAR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CCKB
AC CVCL_H412
WW http://www.genscript.com/molecule/M00154-CCKB.html
CC Transfected with: HGNC; 1571; CCKBR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CMKLR1/Galpha15
AC CVCL_H413
WW http://www.genscript.com/molecule/M00301-CMKLR1.html
CC Transfected with: HGNC; 2121; CMKLR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CRE-Luc
AC CVCL_H414
SY CHO-K1/CRE-Luciferase
WW http://www.genscript.com/molecule/M00187-CRE_Luc.html
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CRF1/Galpha15
AC CVCL_H415
WW http://www.genscript.com/molecule/M00343-CRF1.html
CC Transfected with: HGNC; 2357; CRHR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CRF2/Galpha15
AC CVCL_H416
WW http://www.genscript.com/molecule/M00208-CRF2.html
CC Transfected with: HGNC; 2358; CRHR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CT/Galpha15
AC CVCL_H417
WW http://www.genscript.com/molecule/M00320-CT.html
CC Transfected with: HGNC; 1440; CALCR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CysLT1/Galpha15
AC CVCL_H418
WW http://www.genscript.com/molecule/M00462-CysLT1.html
CC Transfected with: HGNC; 17451; CYSLTR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/CysLT2
AC CVCL_H419
WW http://www.genscript.com/molecule/M00449-CysLT2.html
CC Transfected with: HGNC; 18274; CYSLTR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/D1
AC CVCL_H420
WW http://www.genscript.com/molecule/M00247-D1.html
CC Transfected with: HGNC; 3020; DRD1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/D2/Galpha15
AC CVCL_H421
WW http://www.genscript.com/molecule/M00152-D2.html
CC Transfected with: HGNC; 3023; DRD2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/D2S/Galpha15
AC CVCL_H422
WW http://www.genscript.com/molecule/M00274-D2S.html
CC Transfected with: HGNC; 3023; DRD2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/D5/Galpha15
AC CVCL_H423
WW http://www.genscript.com/molecule/M00322-D5.html
CC Transfected with: HGNC; 3026; DRD5.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/DP1/Galpha15
AC CVCL_H424
WW http://www.genscript.com/molecule/M00453-DP1.html
CC Transfected with: HGNC; 9591; PTGDR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/DP2/Galpha15
AC CVCL_H425
WW http://www.genscript.com/molecule/M00436-DP2.html
CC Transfected with: HGNC; 4502; PTGDR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/EDNRA
AC CVCL_H426
WW http://www.genscript.com/molecule/M00149-EDNRA.html
CC Transfected with: HGNC; 3179; EDNRA.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/EDNRB
AC CVCL_H427
WW http://www.genscript.com/molecule/M00150-EDNRB.html
CC Transfected with: HGNC; 3180; EDNRB.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/EP2/Galpha15
AC CVCL_H428
WW http://www.genscript.com/molecule/M00311-EP2.html
CC Transfected with: HGNC; 9594; PTGER2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/FFA1/Galpha15
AC CVCL_H429
WW http://www.genscript.com/molecule/M00273-FFA1.html
CC Transfected with: HGNC; 4498; FFAR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/FFA2/Galpha15
AC CVCL_H430
WW http://www.genscript.com/molecule/M00437-FFA2.html
CC Transfected with: HGNC; 4501; FFAR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/FPR1/Galpha15
AC CVCL_H431
WW http://www.genscript.com/molecule/M00429-FPR1.html
CC Transfected with: HGNC; 3826; FPR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/FPRL1/Galpha15
AC CVCL_H432
WW http://www.genscript.com/molecule/M00305-FPRL1.html
CC Transfected with: HGNC; 3827; FPR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GAL1/Galpha15
AC CVCL_H433
WW http://www.genscript.com/molecule/M00277-GAL1.html
CC Transfected with: HGNC; 4132; GALR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GAL2
AC CVCL_H434
WW http://www.genscript.com/molecule/M00209-GAL2.html
CC Transfected with: HGNC; 4133; GALR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/Galpha15
AC CVCL_H446
WW http://www.genscript.com/molecule/M00257-CHO-K1_Galpha15.html
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GCGR/Galpha15
AC CVCL_H435
WW http://www.genscript.com/molecule/M00345-GCGR.html
CC Transfected with: HGNC; 4192; GCGR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GHSR
AC CVCL_H436
WW http://www.genscript.com/molecule/M00189-GHSR.html
CC Transfected with: HGNC; 4267; GHSR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GIP/Galpha15
AC CVCL_H437
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 4271; GIPR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GLP1/Galpha15
AC CVCL_H438
WW http://www.genscript.com/molecule/M00451-GLP1.html
CC Transfected with: HGNC; 4324; GLP1R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GLP2/Galpha15
AC CVCL_H439
WW http://www.genscript.com/molecule/M00307-GLP2.html
CC Transfected with: HGNC; 4325; GLP2R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GNRHR/Galpha15
AC CVCL_H440
WW http://www.genscript.com/molecule/M00426-GNRHR.html
CC Transfected with: HGNC; 4421; GNRHR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GPBAR1
AC CVCL_H441
WW http://www.genscript.com/molecule/M00432-GPBAR1.html
CC Transfected with: HGNC; 19680; GPBAR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GPR103/Galpha15
AC CVCL_H442
WW http://www.genscript.com/molecule/M00321-GPR103.html
CC Transfected with: HGNC; 15565; QRFPR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GPR120/Galpha15
AC CVCL_H443
WW http://www.genscript.com/molecule/M00440-GPR120.html
CC Transfected with: HGNC; 19061; FFAR4.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GPR68/Galpha15
AC CVCL_H444
WW http://www.genscript.com/molecule/M00439-GPR68.html
CC Transfected with: HGNC; 4519; GPR68.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/Gqi5
AC CVCL_H447
WW http://www.genscript.com/molecule/M00455-Gqi5.html
CC Transfected with: HGNC; 4390; GNAQ (Gqi5, with 355-DCGLF-359 from GNAI1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/GRM2/Galpha15
AC CVCL_H445
WW http://www.genscript.com/molecule/M00427-GRM2.html
CC Transfected with: HGNC; 4594; GRM2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/H2/Galpha15
AC CVCL_H448
WW http://www.genscript.com/molecule/M00306-H2.html
CC Transfected with: HGNC; 5183; HRH2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/H3/Galpha15
AC CVCL_H449
WW http://www.genscript.com/molecule/M00331-H3.html
CC Transfected with: HGNC; 5184; HRH3.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/H4/Galpha15
AC CVCL_H450
WW http://www.genscript.com/molecule/M00289-H4.html
CC Transfected with: HGNC; 17383; HRH4.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/hERG
AC CVCL_H512
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 6251; KCNH2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/IP1/Galpha15
AC CVCL_H451
WW http://www.genscript.com/molecule/M00310-IP1.html
CC Transfected with: HGNC; 9602; PTGIR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/KiSS1
AC CVCL_H452
WW http://www.genscript.com/molecule/M00190-KiSS1.html
CC Transfected with: HGNC; 4510; KISS1R.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/LTB4/Galpha15
AC CVCL_H453
WW http://www.genscript.com/molecule/M00435-LTB4.html
CC Transfected with: HGNC; 6713; LTB4R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/M1
AC CVCL_H454
WW http://www.genscript.com/molecule/M00185-M1.html
CC Transfected with: HGNC; 1950; CHRM1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/M2/Galpha15
AC CVCL_H455
WW http://www.genscript.com/molecule/M00258-M2.html
CC Transfected with: HGNC; 1951; CHRM2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/M3
AC CVCL_H456
WW http://www.genscript.com/molecule/M00259-M3.html
CC Transfected with: HGNC; 1952; CHRM3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/M4/Galpha15
AC CVCL_H457
WW http://www.genscript.com/molecule/M00238-M4.html
CC Transfected with: HGNC; 1953; CHRM4.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/M5
AC CVCL_H458
WW http://www.genscript.com/molecule/M00186-M5.html
CC Transfected with: HGNC; 1954; CHRM5.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MC2/Galpha15
AC CVCL_H459
WW http://www.genscript.com/molecule/M00336-MC2.html
CC Transfected with: HGNC; 6930; MC2R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MC3/Galpha15
AC CVCL_H460
WW http://www.genscript.com/molecule/M00242-MC3.html
CC Transfected with: HGNC; 6931; MC3R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MC4/Galpha15
AC CVCL_H461
WW http://www.genscript.com/molecule/M00272-MC4.html
CC Transfected with: HGNC; 6932; MC4R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MC5/Galpha15
AC CVCL_H462
WW http://www.genscript.com/molecule/M00243-MC5.html
CC Transfected with: HGNC; 6933; MC5R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MCH2
AC CVCL_H463
WW http://www.genscript.com/molecule/M00280-MCH2.html
CC Transfected with: HGNC; 20867; MCHR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MRGPRD/Galpha15
AC CVCL_H464
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 29626; MRGPRD.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MRGPRX2
AC CVCL_H465
WW http://www.genscript.com/molecule/M00425-MRGPRX2.htm
CC Transfected with: HGNC; 17983; MRGPRX2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MT1/Galpha15
AC CVCL_H466
WW http://www.genscript.com/molecule/M00424-MT1.html
CC Transfected with: HGNC; 7463; MTNR1A.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MT2/Galpha15
AC CVCL_H467
WW http://www.genscript.com/molecule/M00312-MT2.html
CC Transfected with: HGNC; 7464; MTNR1B.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/MTLR/Galpha15
AC CVCL_H468
WW http://www.genscript.com/molecule/M00347-MTLR.html
CC Transfected with: HGNC; 4495; MLNR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NIACR1/Galpha15
AC CVCL_H469
WW http://www.genscript.com/molecule/M00428-NIACR1.html
CC Transfected with: HGNC; 24827; HCAR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NK1
AC CVCL_H470
WW http://www.genscript.com/molecule/M00199-NK1.html
CC Transfected with: HGNC; 11526; TACR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NK2
AC CVCL_H471
WW http://www.genscript.com/molecule/M00200-NK2.html
CC Transfected with: HGNC; 11527; TACR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NK3
AC CVCL_H472
WW http://www.genscript.com/molecule/M00201-NK3.html
CC Transfected with: HGNC; 11528; TACR3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NMU1
AC CVCL_H473
WW http://www.genscript.com/molecule/M00191-NMU1.html
CC Transfected with: HGNC; 4518; NMUR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPBW1/Galpha15
AC CVCL_H474
WW http://www.genscript.com/molecule/M00452-NPBW1.html
CC Transfected with: HGNC; 4522; NPBWR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPFF1/Galpha15
AC CVCL_H475
WW http://www.genscript.com/molecule/M00431-NPFF1.html
CC Transfected with: HGNC; 17425; NPFFR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPFF2/Galpha15
AC CVCL_H476
WW http://www.genscript.com/molecule/M00474-NPFF2.html
CC Transfected with: HGNC; 4525; NPFFR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPS1a/Galpha15
AC CVCL_H477
WW http://www.genscript.com/molecule/M00338-NPS1a.html
CC Transfected with: HGNC; 23631; NPSR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPS1b/Galpha15
AC CVCL_H478
WW http://www.genscript.com/molecule/M00344-NPS1b.html
CC Transfected with: HGNC; 23631; NPSR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPY1/Galpha15
AC CVCL_H479
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 7956; NPY1R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPY2/Gqi5
AC CVCL_H480
WW http://www.genscript.com/molecule/M00460-NPY2.html
CC Transfected with: HGNC; 7957; NPY2R.
CC Transfected with: HGNC; 4390; GNAQ (Gqi5, with 355-DCGLF-359 from GNAI1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NPY4/Galpha15
AC CVCL_H481
WW http://www.genscript.com/molecule/M00237-NPY4.html
CC Transfected with: HGNC; 9329; PPYR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/NTS1
AC CVCL_H482
WW http://www.genscript.com/molecule/M00194-NTS1.html
CC Transfected with: HGNC; 8039; NTSR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OPRD1/Galpha15
AC CVCL_H483
WW http://www.genscript.com/molecule/M00323-OPRD1.html
CC Transfected with: HGNC; 8153; OPRD1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OPRK1/Galpha15
AC CVCL_H484
WW http://www.genscript.com/molecule/M00290-OPRK1.html
CC Transfected with: HGNC; 8154; OPRK1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OPRL1/Galpha15
AC CVCL_H485
WW http://www.genscript.com/molecule/M00447-OPRL1.html
CC Transfected with: HGNC; 8155; OPRL1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OPRM1/Galpha15
AC CVCL_H486
WW http://www.genscript.com/molecule/M00304-OPRM1.html
CC Transfected with: HGNC; 8156; OPRM1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OX1
AC CVCL_H487
WW http://www.genscript.com/molecule/M00224-OX1.html
CC Transfected with: HGNC; 4848; HCRTR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OX2
AC CVCL_H488
WW http://www.genscript.com/molecule/M00316-OX2.html
CC Transfected with: HGNC; 4849; HCRTR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OXE-Flag/Galpha15
AC CVCL_H489
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 24884; OXER1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OXGR1/Galpha15
AC CVCL_H490
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 4531; OXGR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/OXTR
AC CVCL_H491
WW http://www.genscript.com/molecule/M00195-OXTR.html
CC Transfected with: HGNC; 8529; OXTR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/PAC1/Galpha15
AC CVCL_H492
WW http://www.genscript.com/molecule/M00203-PAC1.html
CC Transfected with: HGNC; 12695; VIPR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/PAR2/Galpha15
AC CVCL_H493
WW http://www.genscript.com/molecule/M00446-PAR2.html
CC Transfected with: HGNC; 3538; F2RL1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/PAR4
AC CVCL_H494
WW http://www.genscript.com/molecule/M00206-PAR4.html
CC Transfected with: HGNC; 3540; F2RL3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/PRLHR
AC CVCL_H495
WW http://www.genscript.com/molecule/M00341-PRLHR.html
CC Transfected with: HGNC; 4464; PRLHR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/PTAFR
AC CVCL_H496
WW http://www.genscript.com/molecule/M00262-PTAFR.html
CC Transfected with: HGNC; 9582; PTAFR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/PTH1/Galpha15
AC CVCL_H497
WW http://www.genscript.com/molecule/M00315-PTH1.html
CC Transfected with: HGNC; 9608; PTH1R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SCTR/Galpha15
AC CVCL_H498
WW http://www.genscript.com/molecule/M00326-SCTR.html
CC Transfected with: HGNC; 10608; SCTR.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SF
AC CVCL_8850
DR CLO; CLO_0002464
DR CLDB; cl742
DR ECACC; 93061607
RX PubMed=23873082;
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SST1/Gqi5
AC CVCL_H499
WW http://www.genscript.com/molecule/M00473-SST1.html
CC Transfected with: HGNC; 11330; SSTR1.
CC Transfected with: HGNC; 4390; GNAQ (Gqi5, with 355-DCGLF-359 from GNAI1).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SST2/Galpha15
AC CVCL_H500
WW http://www.genscript.com/molecule/M00325-SST2.html
CC Transfected with: HGNC; 11331; SSTR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SST3/Galpha15
AC CVCL_H501
WW http://www.genscript.com/molecule/M00285-SST3.html
CC Transfected with: HGNC; 11332; SSTR3.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SST4/Galpha15
AC CVCL_H502
WW http://www.genscript.com/molecule/M00334-SST4.html
CC Transfected with: HGNC; 11333; SSTR4.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SST5/Galpha15
AC CVCL_H503
WW http://www.genscript.com/molecule/M00286-SST5.html
CC Transfected with: HGNC; 11334; SSTR5.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/SUCNR1/Galpha15
AC CVCL_H504
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 4542; SUCNR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/TRH1
AC CVCL_H505
WW http://www.genscript.com/molecule/M00202-TRH1.html
CC Transfected with: HGNC; 12299; TRHR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/UT2/Galpha15
AC CVCL_H506
WW http://www.genscript.com/molecule/M00339-UT2.html
CC Transfected with: HGNC; 4468; UTS2R.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/V1A
AC CVCL_H507
WW http://www.genscript.com/molecule/M00181-V1A.html
CC Transfected with: HGNC; 895; AVPR1A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/V1B
AC CVCL_H508
WW http://www.genscript.com/molecule/M00205-V1B.html
CC Transfected with: HGNC; 896; AVPR1B.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/V2/Galpha15
AC CVCL_H509
WW http://www.genscript.com/molecule/M00170-V2.html
CC Transfected with: HGNC; 897; AVPR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/VPAC1/Galpha15
AC CVCL_H510
WW http://www.genscript.com/molecule/M00342-VPAC1.html
CC Transfected with: HGNC; 12694; VIPR1.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1/VPAC2/Galpha15
AC CVCL_H511
WW http://www.genscript.com/molecule/M00226-VPAC2.html
CC Transfected with: HGNC; 12695; VIPR2.
CC Transfected with: HGNC; 4383; GNA15.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0204
AC CVCL_DE93
DR ECACC; 15042903
CC Transfected with: HGNC; 3616; FCGR2A (with R-167).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0205
AC CVCL_DE94
DR ECACC; 15042905
CC Transfected with: HGNC; 3616; FCGR2A (with H-167).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0206
AC CVCL_DE95
DR ECACC; 15042907
CC Transfected with: HGNC; 3618; FCGR2B.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0235
AC CVCL_DE96
DR ECACC; 15042908
CC Transfected with: UniProtKB; H2RAL6; Pan troglodytes FCGR3A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0236
AC CVCL_DE97
DR ECACC; 15042909
CC Transfected with: Cercocebus torquatus FCGR3A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0237
AC CVCL_DE98
DR ECACC; 15042910
CC Transfected with: UniProtKB; A0A140HDP8; Macaca fascicularis FCGR3A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0238
AC CVCL_DE99
DR ECACC; 15042911
CC Transfected with: UniProtKB; A3RFZ7; Macaca mulatta FCGR3A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0239
AC CVCL_DF00
CC Transfected with: UniProtKB; A0A096MT85; Papio anubis FCGR3A.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl-0270
AC CVCL_DF01
DR ECACC; 15042912
CC Transfected with: UniProtKB; G7MEA7; Macaca mulatta FCGR2B.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl6
AC CVCL_DF02
DR ECACC; 15042901
CC Transfected with: HGNC; 3619; FCGR3A (with V-176).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1.Cl7
AC CVCL_DF03
DR ECACC; 15042902
CC Transfected with: HGNC; 3619; FCGR3A (with F-176).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-K1v
AC CVCL_6F16
SY CHO K1v
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/acho-k1v.htm
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-KK
AC CVCL_V245
SY CHO-kk
RX PubMed=730050;
RX PubMed=7360150;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-LY-A
AC CVCL_J422
SY LY-A
DR CLO; CLO_0050417
DR RCB; RCB1869
RX PubMed=9837968;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-LY-B
AC CVCL_4701
SY LY-B
DR BTO; BTO:0004897
DR CLO; CLO_0050415
DR RCB; RCB1698
RX PubMed=9837968;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-LY-B/cLCB1
AC CVCL_U862
SY LY-B/cLCB1
DR CLO; CLO_0050411
DR RCB; RCB1699
RX PubMed=9837968;
CC Transfected with: UniProtKB; O54695; Cricetulus griseus Sptlc1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4701 ! CHO-LY-B
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-M1
AC CVCL_T062
RX PubMed=23660994;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_8845 ! CHO DP-12 clone#1934
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-M19
AC CVCL_H628
SY CHO M19; M19
DR ChEMBL-Cells; CHEMBL3307785
DR ChEMBL-Targets; CHEMBL1909242
RX PubMed=7940020;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-mB7
AC CVCL_CW95
RX PubMed=1373896;
CC Transfected with: MGI; MGI:101775; Cd80.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-MCHR2
AC CVCL_U366
RX PubMed=20099459;
CC Transfected with: HGNC; 20867; MCHR2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-MG
AC CVCL_7181
SY CHOMG; CHO MG
DR BTO; BTO:0004065
DR ChEMBL-Cells; CHEMBL3307646
DR ChEMBL-Targets; CHEMBL614558
RX PubMed=2766456;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-MK42
AC CVCL_S408
SY CHO MK42; MK42
RX PubMed=281704;
RX PubMed=6287224;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-mL1
AC CVCL_X976
SY mL1-CHO
RX PubMed=11706054;
CC Transfected with: MGI; MGI:96721; L1cam.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-MOG
AC CVCL_DG55
RX PubMed=16461459;
CC Transfected with: HGNC; 7197; MOG.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-NPY1R
AC CVCL_U001
DR ECACC; 12110602
RX PubMed=21335600;
CC Transfected with: HGNC; 7956; NPY1R.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-OPRL1
AC CVCL_U008
DR ECACC; 10110201
RX PubMed=21335600;
CC Transfected with: HGNC; 8155; OPRL1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-P22
AC CVCL_4267
SY CHO P22; P22
DR CLO; CLO_0008311
DR CLDB; cl3821
DR ECACC; 89030317
RX PubMed=4033657;
RX PubMed=7988294;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_H340 ! CHO-A7
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-PI
AC CVCL_S541
DR NIH-ARP; 2284-250
RX PubMed=8230430;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-pro3-
AC CVCL_7182
SY CHO pro3-; CHO Pro-3; CHP PRO-3; CHO Toronto; CHO-Toronto; CHO WTB; WTB
RX DOI=10.3390/pr1030296;
WW https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO Pro-5
AC CVCL_4382
SY CHOpro-5; CHO clone Pro-5; Pro-5
DR BTO; BTO:0002176
DR CLO; CLO_0008486
DR ATCC; CRL-1781
RX DOI=10.3390/pr1030296;
RX PubMed=1182798;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-RD
AC CVCL_4669
DR CLO; CLO_0050421
DR RCB; RCB1477
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-S
AC CVCL_7183
SY CHOS
DR Lonza; 842
RX DOI=10.3390/pr1030296;
RX PubMed=837451;
RX PubMed=4585080;
RX PubMed=23873082;
WW http://www.thermofisher.com/order/catalog/product/A1155701
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-207.html
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-S/C0101
AC CVCL_5A26
SY C0101
RX PubMed=23873082;
CC Omics: Genome sequenced.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SEC
AC CVCL_S543
DR NIH-ARP; 2237-194
RX PubMed=8230430;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SIVmac239 gp130 Clone 3
AC CVCL_X696
SY CHO-1A-130
DR NIH-ARP; 1822-156
RX PubMed=1760229;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SIVsmH4 gp130 Clone AD5
AC CVCL_X695
DR NIH-ARP; 1821-157
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SNS22
AC CVCL_EP77
RX PubMed=12050667;
CC Transfected with: RGD; 3629; Scn10a.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SPB-1
AC CVCL_T760
SY SPB-1
DR CLO; CLO_0050414
DR RCB; RCB1696
RX PubMed=1429697;
RX PubMed=2125045;
RX PubMed=9837968;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SPB-1/cLCB1
AC CVCL_T761
SY SPB-1/cLCB1
DR CLO; CLO_0050410
DR RCB; RCB1697
RX PubMed=9405408;
CC Transfected with: UniProtKB; O54695; Cricetulus griseus Sptlc1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_T760 ! CHO-SPB-1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SSR1
AC CVCL_3364
SY CHO-SSTR1
DR CLO; CLO_0002465
DR CLDB; cl4905
DR ICLC; ATL98001
RX PubMed=7907016;
CC Transfected with: RGD; 3762; Sstr1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SSR2
AC CVCL_3365
SY CHO-SSTR2
DR CLO; CLO_0002466
DR CLDB; cl4906
DR ICLC; ATL98002
RX PubMed=7907016;
CC Transfected with: RGD; 3763; Sstr2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-SSTR1
AC CVCL_U009
DR ECACC; 10110206
RX PubMed=21335600;
CC Transfected with: HGNC; 11330; SSTR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-T
AC CVCL_9701
SY CHO.T
RX PubMed=3022282;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-Tax 11-3
AC CVCL_U352
SY CHO-TAX 11-3; Tax 11-3
RX PubMed=2870070;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-Tax 11-6
AC CVCL_U353
SY CHO-TAX 11-6; Tax 11-6
RX PubMed=2870070;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-Tax 2-3
AC CVCL_U350
SY CHO-TAX 2-3; Tax 2-3
RX PubMed=2870070;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-Tax 2-4
AC CVCL_U351
SY CHO-TAX 2-4; Tax 2-4
RX PubMed=2870070;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-Tax 5-6
AC CVCL_U346
SY CHO-TAX 5-6; Tax 5-6
DR ChEMBL-Cells; CHEMBL3307401
DR ChEMBL-Targets; CHEMBL614559
RX PubMed=2870070;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-TRVb
AC CVCL_U420
SY TRVb-CHO; TRVb; TRVb-1; TRVb1
RX PubMed=3611186;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-200.html
CC Transfected with: HGNC; 11763; TFRC.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-tsH1
AC CVCL_0F81
SY tsH1
RX PubMed=4361675;
RX PubMed=4585080;
RX PubMed=6965094;
RX PubMed=7444715;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-UKB25
AC CVCL_5A23
SY CHO UKB25; UKB25
RX PubMed=6287224;
RX PubMed=6933469;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-UV-1
AC CVCL_CX60
SY CHO UV-1; UV-1
RX PubMed=341370;
RX PubMed=2218721;
RX PubMed=2317821;
RX PubMed=7197403;
RX PubMed=7404271;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_U406 ! CHO-glyA
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-VV 3-2
AC CVCL_Y287
SY VLB 3-2
DR ChEMBL-Cells; CHEMBL3307402
DR ChEMBL-Targets; CHEMBL614560
RX PubMed=2563346;
CC Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4382 ! CHO Pro-5
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-WBL
AC CVCL_GP66
RX DOI=10.1016/j.mrgentox.2016.08.001;
RX PubMed=9118971;
RX PubMed=10320750;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-WBL (IVGT)
AC CVCL_AR56
SY CHO-WBL(IVGT)
DR ECACC; 14043001
DR JCRB; JCRB1702
RX DOI=10.1016/j.mrgentox.2016.08.001;
CC Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_GP66 ! CHO-WBL
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-WT
AC CVCL_S544
DR NIH-ARP; 2239-252
RX PubMed=8230430;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-X3/5
AC CVCL_Y503
SY X3/5
RX PubMed=2432598;
RX PubMed=6095070;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_Y502 ! CHO-K1-BH4
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-1
AC CVCL_5A38
SY CHO xrs-1; CHO-XRS1; xrs-1; xrs1
RX PubMed=6197643;
RX PubMed=9032253;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-4
AC CVCL_5A39
SY xrs-4; xrs4
RX PubMed=2564870;
RX PubMed=6197643;
RX PubMed=9032253;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-5
AC CVCL_4601
SY CHO-XRS5; CHO-xrs5; CHO Xrs5; XRS-5; Xrs-5; xrs-5; xrs 5; XrS5; xrs5
DR CLO; CLO_0009691
DR ATCC; CRL-2348
RX PubMed=2218721;
RX PubMed=2564870;
RX PubMed=6197643;
RX PubMed=7603335;
RX PubMed=9032253;
RX PubMed=22923057;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-6
AC CVCL_4340
SY CHO-XrS6; CHO-XRS6; CHO XrS6; xrs-6; xrs 6; XrS6; XRS6; xrs6
DR BTO; BTO:0004066
DR CLO; CLO_0009692
DR CLDB; cl4784
DR ChEMBL-Cells; CHEMBL3307295
DR ChEMBL-Targets; CHEMBL614060
DR ECACC; 92052128
RX PubMed=2564870;
RX PubMed=3785270;
RX PubMed=6197643;
RX PubMed=9032253;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-6-hamKu80
AC CVCL_4341
SY XrS6-hamKu80
DR CLO; CLO_0009693
DR ECACC; 96012301
RX PubMed=9032253;
CC Transfected with: UniProtKB; Q60449; Cricetulus griseus Xrcc5.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4340 ! CHO-xrs-6
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-6C
AC CVCL_5A41
SY xrs-6c; XRS-6C; XRS6C; xrs6c
RX PubMed=2034785;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4340 ! CHO-xrs-6
SX Female
CA Spontaneously immortalized cell line
//
ID CHO-xrs-7
AC CVCL_5A40
SY xrs-7; xrs7
RX PubMed=2564870;
RX PubMed=3785270;
RX PubMed=6197643;
RX PubMed=9032253;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/HGPRT
AC CVCL_8545
DR JCRB; JCRB0218
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/IR
AC CVCL_R864
SY CHO-IR
RX PubMed=10389839;
CC Transfected with: HGNC; 6091; INSR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/IR/IRS-1
AC CVCL_R865
SY CHO-IR/IRS-1; CHO IR/IRS-1; CHO-IR/IRS1
RX PubMed=10389839;
CC Transfected with: HGNC; 6091; INSR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_R864 ! CHO/IR
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/IRS-1
AC CVCL_R866
RX PubMed=10389839;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/IR/IRS-2
AC CVCL_R867
RX PubMed=10389839;
CC Transfected with: HGNC; 6091; INSR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_R864 ! CHO/IR
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/Kcnk3
AC CVCL_HC54
SY CHO/Task-1
WW https://www.kerafast.com/product/3027/rat-task-expressing-cho-cell-lines
CC Transfected with: RGD; 621451; Kcnk9.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/Kcnk3/Kcnk9
AC CVCL_HC55
SY CHO/Task-1/Task-3
WW https://www.kerafast.com/product/3027/rat-task-expressing-cho-cell-lines
CC Transfected with: RGD; 61997; Kcnk3.
CC Transfected with: RGD; 621451; Kcnk9.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/Kcnk9
AC CVCL_HC56
SY CHO/Task-3
WW https://www.kerafast.com/product/3027/rat-task-expressing-cho-cell-lines
CC Transfected with: RGD; 61997; Kcnk3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/OAR2-3
AC CVCL_F973
DR TKG; TKG 0407
RX PubMed=7916570;
CC Selected for resistance to: ChEBI; CHEBI:44658; Okadaic acid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/OAR6-6
AC CVCL_F974
DR TKG; TKG 0408
RX PubMed=7916570;
CC Selected for resistance to: ChEBI; CHEBI:44658; Okadaic acid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO/pS2P
AC CVCL_2H49
RX PubMed=9774448;
CC Transfected with: HGNC; 15455; MBTPS2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D893 ! CHO-7
SX Female
CA Spontaneously immortalized cell line
//
ID CHO.1F8
AC CVCL_T032
SY CHO-1F8
DR CLO; CLO_0050427
DR RCB; RCB1823
RX PubMed=7594622;
CC Transfected with: HGNC; 9582; PTAFR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO(His9)
AC CVCL_2875
DR JCRB; JCRB2209
RX PubMed=10919723;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0213 ! CHO
CA Hybrid cell line
//
ID CHO(pMAM-HSluc)
AC CVCL_U217
SY pMAM-HSluc
DR JCRB; JCRB0136.2
DR JCRB; NIHS0212.2
RX PubMed=9113384;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0212.2; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO(pMAM-luc)
AC CVCL_U218
SY pMAM-luc
DR JCRB; JCRB0136.1
DR JCRB; NIHS0212.1
RX PubMed=9113384;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0212.1; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHO12RO
AC CVCL_IM59
DR CLO; CLO_0002431
DR CLDB; cl744
RX PubMed=7135166;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID CHO33RO
AC CVCL_IM60
DR CLO; CLO_0002446
DR CLDB; cl758
RX PubMed=7135166;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID CHO43RO
AC CVCL_IM61
DR CLO; CLO_0002451
DR CLDB; cl763
RX PubMed=7135166;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID CHOC 400
AC CVCL_4Y55
SY CHOC400; CHO C400
RX PubMed=2841578;
RX PubMed=6273843;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID Choi-CK
AC CVCL_M269
RX CelloPub=CLPUB00275;
RX PubMed=1312890;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHOK1SV
AC CVCL_DR95
SY CHO-K1SV; CHO K1SV
DR PRIDE; PXD003462
RX Patent=US8241870;
RX PubMed=17172663;
RX PubMed=27070921;
WW http://www.lonza.com/custom-manufacturing/development-technologies/gs-gene-expression-system.aspx
CC Characteristics: Compared to CHO-K1 this cell line is adapted to growth in suspension and protein-free medium.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHOK1SV GS KO
AC CVCL_DR97
SY CHOK1SV GS-KO; CHO K1SV GS KO; CHOK1SV GS Knockout
RX PubMed=22068567;
RX PubMed=25502369;
WW http://www.lonza.com/custom-manufacturing/development-technologies/gs-xceed-gene-expression-system/advantages-of-the-gsxceed-system.aspx
CC Knockout cell: Method=ZFN; UniProtKB; P04773; Glul.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DR95 ! CHOK1SV
SX Female
CA Spontaneously immortalized cell line
//
ID CHON-001
AC CVCL_C462
DR ATCC; CRL-2846
DR BioSample; SAMN03471801
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C463 ! CHON-002
OI CVCL_0F16 ! CHON-003
OI CVCL_0F18 ! CHON-004
OI CVCL_0F19 ! CHON-005
SX Female
CA Telomerase immortalized cell line
//
ID CHON-002
AC CVCL_C463
DR ATCC; CRL-2847
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C462 ! CHON-001
OI CVCL_0F16 ! CHON-003
OI CVCL_0F18 ! CHON-004
OI CVCL_0F19 ! CHON-005
SX Female
CA Telomerase immortalized cell line
//
ID CHON-003
AC CVCL_0F16
DR ATCC; CRL-2848
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-2848; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C462 ! CHON-001
OI CVCL_C463 ! CHON-002
OI CVCL_0F18 ! CHON-004
OI CVCL_0F19 ! CHON-005
SX Female
CA Telomerase immortalized cell line
//
ID CHON-004
AC CVCL_0F18
DR ATCC; CRL-2856
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-2856; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C462 ! CHON-001
OI CVCL_C463 ! CHON-002
OI CVCL_0F16 ! CHON-003
OI CVCL_0F19 ! CHON-005
SX Female
CA Telomerase immortalized cell line
//
ID CHON-005
AC CVCL_0F19
DR ATCC; CRL-2857
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-2857; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C462 ! CHON-001
OI CVCL_C463 ! CHON-002
OI CVCL_0F16 ! CHON-003
OI CVCL_0F18 ! CHON-004
SX Female
CA Telomerase immortalized cell line
//
ID CHON-006
AC CVCL_0F20
DR ATCC; CRL-2858
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-2858; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID CHOP
AC CVCL_4702
DR BTO; BTO:0002426
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0213 ! CHO
SX Female
CA Spontaneously immortalized cell line
//
ID CHOP-KO-DR
AC CVCL_B046
DR ATCC; CRL-2979
CC Knockout cell: Method=KO mouse; MGI; MGI:109247; Ddit3.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CHOPHPS1
AC CVCL_DQ88
RX PubMed=27345974;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
DI NCIt; C37261; Hermansky-Pudlak syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0R45 ! GM14609
SX Female
CA Induced pluripotent stem cell
//
ID CHOPHPS2
AC CVCL_DQ89
RX PubMed=27345985;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
DI NCIt; C37261; Hermansky-Pudlak syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0R47 ! GM17890
SX Male
CA Induced pluripotent stem cell
//
ID CHOPWT1.1
AC CVCL_DR05
SY WT1.1
DR GEO; GSM1195654
DR GEO; GSM1195655
DR GEO; GSM1195656
RX PubMed=23940280;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7311 ! GM00969
SX Female
CA Induced pluripotent stem cell
//
ID CHOPWT1.2
AC CVCL_DR06
SY WT1.2
DR GEO; GSM1195657
DR GEO; GSM1195658
DR GEO; GSM1195659
RX PubMed=23940280;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7311 ! GM00969
SX Female
CA Induced pluripotent stem cell
//
ID CHOPWT1.3
AC CVCL_DR07
SY WT1.3
DR GEO; GSM1195660
DR GEO; GSM1195661
DR GEO; GSM1195662
RX PubMed=23940280;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7311 ! GM00969
SX Female
CA Induced pluripotent stem cell
//
ID CHOPWT10
AC CVCL_DQ90
RX PubMed=27345999;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID CHOPWT2.1
AC CVCL_DR08
SY WT2.1
DR GEO; GSM1195663
DR GEO; GSM1195664
DR GEO; GSM1195665
RX PubMed=23940280;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7432 ! GM05565
SX Male
CA Induced pluripotent stem cell
//
ID CHOPWT2.2
AC CVCL_DR09
SY WT2.2
DR GEO; GSM1195666
DR GEO; GSM1195667
DR GEO; GSM1195668
RX PubMed=23940280;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7432 ! GM05565
SX Male
CA Induced pluripotent stem cell
//
ID CHOPWT2.3
AC CVCL_DR10
SY WT2.3
DR GEO; GSM1195669
DR GEO; GSM1195670
DR GEO; GSM1195671
RX PubMed=23940280;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7432 ! GM05565
SX Male
CA Induced pluripotent stem cell
//
ID CHOPWT9
AC CVCL_9U75
RX PubMed=27345777;
CC From: Children's Hospital of Philadelphia; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID CHOR 3-4
AC CVCL_HA81
RX PubMed=9049097;
CC Selected for resistance to: UniProtKB; P11140; Abrus precatorius Abrin.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Chor-IN-1
AC CVCL_AV04
RX DOI=10.1158/1538-7445.AM2015-74;
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHOS
AC CVCL_CW30
RX PubMed=27017908;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 36 hours (PubMed=27017908).
DI NCIt; C4021; Chondroblastic osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHOS-XE
AC CVCL_Y012
SY CHOS-XBP-1S/ERO1-Lalpha
RX PubMed=23335490;
CC Transfected with: HGNC; 12801; XBP1.
CC Transfected with: HGNC; 13280; ERO1L.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7183 ! CHO-S
SX Female
CA Spontaneously immortalized cell line
//
ID CHOTKa
AC CVCL_HB34
SY CHO-TKa; CHO-K1, TKa; Tka
RX PubMed=9016792;
CC Transfected with: RGD; 61814; Pex2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID CHOTKaEG1
AC CVCL_HB36
SY TKaEG1
RX PubMed=23009329;
CC Characteristics: Contains a PTS1-fused EGFP.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Spontaneously immortalized cell line
//
ID CHOTKaEG2
AC CVCL_HB37
SY TKaEG2; TKa/EG2
RX PubMed=12054588;
CC Characteristics: Contains a PTS2-fused EGFP.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Spontaneously immortalized cell line
//
ID CHOTKaG1
AC CVCL_HB62
SY TKaG1
RX PubMed=10222140;
CC Characteristics: Contains a PTS1-fused GFP.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Spontaneously immortalized cell line
//
ID CHOTKaG2
AC CVCL_HB63
SY TKaG2
RX PubMed=10222140;
CC Characteristics: Contains a PTS2-fused GFP.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Spontaneously immortalized cell line
//
ID CHP 3 (M.W.)
AC CVCL_2778
SY CHP 3; CHP #3; CHP3; GM-53; GM00053
DR CLO; CLO_0002468
DR CLO; CLO_0002469
DR CLO; CLO_0025176
DR CLDB; cl772
DR CLDB; cl777
DR ATCC; CCL-132
DR BioSample; SAMN03472706
DR Coriell; GM00053
DR ECACC; 90102536
DR IZSLER; BS CL 16
RX CelloPub=CLPUB00290;
RX PubMed=1192846;
CC Discontinued: ECACC; 90102536; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,11
ST D13S317: 11,12
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 11,16
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID CHP 4 (W.W.)
AC CVCL_2779
AS CVCL_F482
SY CHP 4; CHP #4; CHP4; GM00052; GM052; GM-52; GM52
DR CLO; CLO_0002470
DR CLO; CLO_0002471
DR CLDB; cl774
DR CLDB; cl778
DR ATCC; CCL-133
DR BioSample; SAMN03470908
DR Coriell; GM00052
DR ECACC; 90102537
DR IZSLER; BS CL 17
RX CelloPub=CLPUB00290;
RX PubMed=1192846;
CC Discontinued: Coriell; GM00052; true.
ST Source(s): ATCC; ECACC; PubMed=11416159; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 12,14
ST D16S539: 10,11
ST D18S51: 14,16
ST D19S433: 11,14
ST D21S11: 30,31
ST D2S1338: 19,24
ST D3S1358: 14,15
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 23,24
ST Penta D: 10,11
ST Penta E: 7,15
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F483 ! GM01908
OI CVCL_F484 ! GM02796
SX Male
CA Finite cell line
//
ID CHP-1
AC CVCL_6E27
RX PubMed=26762899;
CC Breed/subspecies: Jack Russell Terrier.
DI NCIt; C128122; Canine prostate carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHP-100
AC CVCL_7166
SY CHP 100; CHP100
DR BTO; BTO:0005253
DR BioSample; SAMN03151800
DR Cosmic; 1167419
DR ECACC; 06122001
DR GEO; GSM510003
DR GEO; GSM1676329
DR GEO; GSM1701661
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=10079;
RX PubMed=19787792;
RX PubMed=26351324;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a IMR-32 derivative.
CC Doubling time: 45.8 hours (PubMed=10079).
CC Discontinued: ECACC; 06122001; true.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0346 ! IMR-32
SX Male
CA Cancer cell line
//
ID CHP-100L
AC CVCL_IV94
SY CHP-100-L; CHP100L
DR Cosmic; 2228221
RX PubMed=6825097;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Contaminated. Parent cell line (CHP-100) has been shown to be a IMR-32 derivative.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 21 hours (PubMed=6825097).
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-100S
AC CVCL_IV95
SY CHP-100-S; CHP100S
RX PubMed=6825097;
CC Problematic cell line: Contaminated. Parent cell line (CHP-100) has been shown to be a IMR-32 derivative.
CC Doubling time: 26 hours (PubMed=6825097).
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-126
AC CVCL_1123
SY CHP 126; CHP126
DR BTO; BTO:0005254
DR CLO; CLO_0002472
DR CLO; CLO_0050266
DR CLDB; cl776
DR BioSample; SAMN01821621
DR BioSample; SAMN03473117
DR CCLE; CHP126_AUTONOMIC_GANGLIA
DR ChEMBL-Cells; CHEMBL3308252
DR ChEMBL-Targets; CHEMBL2366137
DR CLS; 300432/NA
DR Cosmic; 688062
DR Cosmic; 910567
DR Cosmic; 1019935
DR Cosmic; 2485942
DR Cosmic-CLP; 910567
DR DSMZ; ACC-304
DR GDSC; 910567
DR GEO; GSM563360
DR GEO; GSM886929
DR GEO; GSM887995
DR GEO; GSM1366403
DR GEO; GSM1669676
DR RCB; RCB0486
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=10079;
RX PubMed=6888561;
RX PubMed=7139592;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 44.5 hours (PubMed=10079).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=11416159; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,9
ST D16S539: 12,13
ST D18S51: 13,16.1
ST D19S433: 13.2,14
ST D21S11: 30
ST D2S1338: 17,24
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 11,14
ST D8S1179: 12,15
ST FGA: 19,20
ST Penta D: 10,12
ST Penta E: 12,15
ST TH01: 9
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9506 ! CHP-126B1
SX Female
CA Cancer cell line
//
ID CHP-126B1
AC CVCL_9506
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=17466;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1123 ! CHP-126
SX Female
CA Cancer cell line
//
ID CHP-134
AC CVCL_1124
SY CHP 134; CHP_134; CHP134
DR BTO; BTO:0002989
DR CLO; CLO_0051417
DR BioSample; SAMN03472330
DR BioSample; SAMN03473466
DR CGH-DB; 75-1
DR CGH-DB; 9099-4
DR ChEMBL-Cells; CHEMBL3308253
DR ChEMBL-Targets; CHEMBL2366128
DR Cosmic; 688063
DR Cosmic; 801744
DR Cosmic; 848934
DR Cosmic; 910941
DR Cosmic; 920253
DR Cosmic; 930063
DR Cosmic; 947707
DR Cosmic; 1019934
DR Cosmic; 1037353
DR Cosmic; 1099150
DR Cosmic; 1109362
DR Cosmic; 1153779
DR Cosmic; 1161986
DR Cosmic; 1526620
DR Cosmic; 2131592
DR Cosmic; 2393629
DR Cosmic; 2485943
DR Cosmic-CLP; 910941
DR DSMZ; ACC-653
DR ECACC; 06122002
DR GDSC; 910941
DR GEO; GSM313800
DR GEO; GSM333795
DR GEO; GSM563356
DR GEO; GSM692863
DR GEO; GSM1366404
DR GEO; GSM1669677
DR RCB; RCB0487
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=10079;
RX PubMed=6888561;
RX PubMed=7139592;
RX PubMed=12702577;
RX PubMed=18923524;
RX PubMed=22213050;
RX PubMed=23202128;
RX PubMed=27397505;
CC Doubling time: 57.6 hours (PubMed=10079); ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; RCB
ST Amelogenin: X,Y
ST CSF1PO: 9,12 (Cosmic-CLP; RCB)
ST CSF1PO: 9,13 (DSMZ; ECACC)
ST D13S317: 8,11
ST D16S539: 11,13 (Cosmic-CLP; DSMZ; ECACC)
ST D16S539: 11 (RCB)
ST D5S818: 11,12
ST D7S820: 9
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-166
AC CVCL_9507
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=6488196;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-212
AC CVCL_1125
SY CHP 212; CHP212
DR CLO; CLO_0002473
DR CLO; CLO_0002467
DR EFO; EFO_0002133
DR CLDB; cl771
DR ATCC; CRL-2273
DR BioSample; SAMN03473208
DR CCLE; CHP212_AUTONOMIC_GANGLIA
DR ChEMBL-Cells; CHEMBL3308101
DR ChEMBL-Targets; CHEMBL1075423
DR Cosmic; 724826
DR Cosmic; 906820
DR Cosmic; 1161987
DR Cosmic-CLP; 906820
DR GDSC; 906820
DR GEO; GSM563361
DR GEO; GSM886930
DR GEO; GSM887996
DR GEO; GSM1366405
DR GEO; GSM1669678
DR IGRhCellID; CHP212
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,13
ST D16S539: 13
ST D18S51: 14,16
ST D21S11: 27,29
ST D3S1358: 15,17
ST D5S818: 10,12
ST D7S820: 11
ST D8S1179: 11,13
ST FGA: 20
ST Penta D: 9,10
ST Penta E: 5,15
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-234
AC CVCL_4359
SY CHP 234; CHP234
DR ATCC; CRL-2272
DR BioSample; SAMN03152004
DR BioSample; SAMN03471857
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=20143388;
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-2272; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-382
AC CVCL_5G77
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2582423;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-382/JK
AC CVCL_5G78
RX PubMed=2582423;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G77 ! CHP-382
SX Male
CA Cancer cell line
//
ID CHP-404
AC CVCL_5G79
SY CHP 404; CHP404
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHP-901
AC CVCL_6613
SY CHP 901; CHP901
DR Cosmic; 930064
DR Cosmic; 1019948
DR Cosmic; 1109363
DR Cosmic; 1161988
DR Cosmic; 1526621
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=11212268;
CC From: Ikegaki N.; Department of Anatomy and Cell Biology; College of Medicine; University of Illinois at Chicago; Chicago; USA.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHP-902
AC CVCL_6614
SY CHP902
CC From: Kuroda H.; The Children's Hospital of Philadelphia; Philadelphia; USA.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CHP-902R
AC CVCL_6615
SY CHP902R
DR Cosmic; 930065
DR Cosmic; 1526622
RX PubMed=11212268;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6614 ! CHP-902
CA Cancer cell line
//
ID CHP-903
AC CVCL_6616
SY CHP 903; CHP903
RX DOI=10.1007/0-306-46872-7_2;
CC From: Ikegaki N.; Department of Anatomy and Cell Biology; College of Medicine; University of Illinois at Chicago; Chicago; USA.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CHP01
AC CVCL_F377
DR CLO; CLO_0051137
DR RCB; HSC0002
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHP02
AC CVCL_F378
DR CLO; CLO_0051138
DR RCB; HSC0003
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHP04
AC CVCL_F379
DR CLO; CLO_0051140
DR RCB; HSC0007
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHP06
AC CVCL_F380
DR CLO; CLO_0051141
DR RCB; HSC0009
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHP07
AC CVCL_F381
DR CLO; CLO_0051146
DR RCB; HSC0028
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CHP08
AC CVCL_F382
DR CLO; CLO_0051133
DR RCB; HSC0004
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHP09
AC CVCL_F383
DR CLO; CLO_0051143
DR RCB; HSC0017
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Bolivia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CHQC-MCQ1-4
AC CVCL_9W50
SY MCQ 1-4
RX PubMed=72738;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Cancer cell line
//
ID CHQC-MCQ3-5
AC CVCL_9W51
SY MCQ 3-5
RX PubMed=72738;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Cancer cell line
//
ID CHQC-QMC
AC CVCL_T597
SY QMC
RX PubMed=74792;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Cancer cell line
//
ID CHR,KJ
AC CVCL_E527
SY CHR, KJ
DR dbMHC; 48726
DR IHW; IHW9203
DR IMGT/HLA; 11744
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl203.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CHRF-288-11
AC CVCL_A280
SY CHRF288-11
DR Cosmic; 787422
DR Cosmic; 975240
DR Cosmic; 1050595
RX PubMed=2310825;
CC Misspelling: Occasionally 'CHRF-28-11'.
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Chromhpi-1
AC CVCL_X544
SY chromhpi-1
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Chromhpi-2
AC CVCL_X545
SY chromhpi-2
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Chromhpi-3
AC CVCL_X546
SY chromhpi-3
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Chromhpi-4
AC CVCL_X547
SY chromhpi-4
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID chrompho-A
AC CVCL_X536
RX PubMed=7717462;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4146; Chromophobe renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X537 ! chrompho-B
SX Female
CA Cancer cell line
//
ID chrompho-B
AC CVCL_X537
RX PubMed=7717462;
DI NCIt; C4146; Chromophobe renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X536 ! chrompho-A
SX Female
CA Cancer cell line
//
ID CHS-1
AC CVCL_L314
SY Canine Histiocytic Sarcoma-1
RX PubMed=17213706;
CC Breed/subspecies: Maltese.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CHS-2
AC CVCL_L315
SY Canine Histiocytic Sarcoma-2
RX PubMed=17213706;
CC Breed/subspecies: Shetland sheepdog.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHS-3
AC CVCL_L316
SY Canine Histiocytic Sarcoma-3
RX PubMed=17213706;
CC Breed/subspecies: Bernese mountain dog.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHS-4
AC CVCL_L317
SY Canine Histiocytic Sarcoma-4
RX PubMed=17213706;
CC Breed/subspecies: Flat-coated Retriever.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CHS-5
AC CVCL_L318
SY Canine Histiocytic Sarcoma-5
RX PubMed=17213706;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHS-6
AC CVCL_L319
SY Canine Histiocytic Sarcoma-6
RX PubMed=17213706;
CC Breed/subspecies: Bernese mountain dog.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHS-7
AC CVCL_L320
SY Canine Histiocytic Sarcoma-7
RX PubMed=17213706;
CC Breed/subspecies: Flat-coated Retriever.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CHSA0011
AC CVCL_X483
SY CHSA 0011
DR Cosmic-CLP; 1290767
DR GDSC; 1290767
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHSA0108
AC CVCL_X484
SY CHSA 0108
DR Cosmic-CLP; 1290768
DR GDSC; 1290768
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,12
ST D16S539: 9,13
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHSA8926
AC CVCL_X485
SY CHSA 8926
DR Cosmic-CLP; 1303912
DR GDSC; 1303912
DR GEO; GSM1669679
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,15
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CHSE-114
AC CVCL_R822
SY CHinook Salmon Embryo-114
RX PubMed=6542066;
CC Group: Fish cell line.
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHSE-214
AC CVCL_2780
SY CHSE 214; CHSE214; CHinook Salmon Embryo-214
DR CLO; CLO_0002474
DR CLO; CLO_0002475
DR CLDB; cl779
DR CLDB; cl780
DR ATCC; CRL-1681
DR CCLV; CCLV-RIE 1104
DR ECACC; 91041114
DR IZSLER; BS CL 18
DR NCBI_Iran; C202
RX DOI=10.3147/jsfp.28.27;
RX PubMed=6542066;
RX PubMed=15825496;
RX PubMed=19002917;
RX PubMed=19941903;
CC Group: Fish cell line.
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHSE-E
AC CVCL_DG45
RX PubMed=27236514;
CC Group: Fish cell line.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
HI CVCL_2780 ! CHSE-214
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHSE-EC
AC CVCL_DG46
RX PubMed=27236514;
CC Group: Fish cell line.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (nuclear version; nCas9n).
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
HI CVCL_DG45 ! CHSE-E
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHSE-sp
AC CVCL_L017
RX DOI=10.1007/BF02631437;
RX PubMed=8320177;
CC Group: Fish cell line.
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHSE-TOF5
AC CVCL_R886
RX PubMed=22089998;
CC Group: Fish cell line.
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
HI CVCL_2780 ! CHSE-214
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHSE/F
AC CVCL_G347
SY CHSE-214
DR ECACC; 00021714
CC Group: Fish cell line.
CC Problematic cell line: Misidentified. Originally thought to be of Oncorhynchus tschawytscha origin and to be CHSE-214 but found to be from Lepomis macrochirus.
OX NCBI_TaxID=13106; ! Lepomis macrochirus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CHU-2
AC CVCL_U416
RX PubMed=1714402;
RX PubMed=3487449;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-427.html
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Chub-S7
AC CVCL_0239
SY CHUB-S7; CHUB S7; ChubS7
DR MCCL; MCC:0000129
RX PubMed=12934077;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Chula2.hES
AC CVCL_B031
SY CHULAe001-A
DR hPSCreg; CHULAe001-A
RX PubMed=23514952;
RX PubMed=26821869;
CC From: Chulalongkorn University; Thailand.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Chula3.hES
AC CVCL_AV08
RX PubMed=26821869;
CC From: Chulalongkorn University; Thailand.
CC Characteristics: Triploid karyotype.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Embryonic stem cell
//
ID Chula4.hES
AC CVCL_Y611
RX PubMed=23514952;
CC From: Chulalongkorn University; Thailand.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Chula5.hES
AC CVCL_Y612
RX PubMed=23514952;
CC From: Chulalongkorn University; Thailand.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CHW
AC CVCL_C575
SY GM00458
DR CLO; CLO_0025978
DR Coriell; GM00458
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Male
CA Spontaneously immortalized cell line
//
ID CHW-1102
AC CVCL_C574
SY CHW 1102; CHW1102; 1102; GM00459; GM459
DR CLO; CLO_0025977
DR Coriell; GM00459
RX PubMed=509993;
RX PubMed=4462979;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_C575 ! CHW
SX Male
CA Spontaneously immortalized cell line
//
ID CHW-1103
AC CVCL_1K14
SY CHW 1103; CHW1103
RX PubMed=509993;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_C574 ! CHW-1102
SX Male
CA Spontaneously immortalized cell line
//
ID CI
AC CVCL_Y548
DR DSMZ; ACC-770
RX PubMed=6263808;
RX PubMed=7239716;
CC Doubling time: ~30-60 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11,13
ST TH01: 7,8
ST TPOX: 8
ST vWA: 17
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0D73 ! CII
SX Female
CA Transformed cell line
//
ID Ci-1
AC CVCL_1861
SY CI-1
DR EFO; EFO_0006367
DR BioSample; SAMN03472964
DR CCLE; CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1086331
DR DSMZ; ACC-570
DR GEO; GSM886931
DR GEO; GSM887997
RX PubMed=3098690;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 8,12
ST D18S51: 13,17
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 14,16
ST FGA: 21
ST Penta D: 11
ST Penta E: 7,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CI0001
AC CVCL_8U01
DR ECACC; 94012016
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CI0004
AC CVCL_8U02
DR ECACC; 97052218
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CI78-1
AC CVCL_V526
SY CI 78-1
RX PubMed=3899078;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CI79-36
AC CVCL_D286
SY CI 79-36
RX PubMed=3899078;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CI80-13A
AC CVCL_D287
SY CI 80-13A; 80-13A
DR Cosmic; 1524362
RX PubMed=3899078;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D285 ! CI80-13S
SX Female
CA Cancer cell line
//
ID CI80-13S
AC CVCL_D285
SY CI-80-13S; CI 80-13S
DR ChEMBL-Cells; CHEMBL3307931
DR ChEMBL-Targets; CHEMBL614458
RX PubMed=3899078;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D287 ! CI80-13A
SX Female
CA Cancer cell line
//
ID CI81-1
AC CVCL_D288
SY CI 81-1
RX PubMed=3899078;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CIA-E-4.15
AC CVCL_H155
DR CLO; CLO_0002476
DR ATCC; HB-235
RX PubMed=6233363;
CC Monoclonal antibody target: UniProtKB; P01854; Human IgE heavy chain (IGHE).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4696 ! S194/5.XXO.BU.1
CA Hybridoma
//
ID CIA-E-7.12
AC CVCL_H156
DR CLO; CLO_0002477
DR ATCC; HB-236
RX PubMed=6233363;
CC Monoclonal antibody target: UniProtKB; P01854; Human IgE heavy chain (IGHE).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4696 ! S194/5.XXO.BU.1
CA Hybridoma
//
ID CIEB
AC CVCL_6A77
SY Calf small Intestinal Epithelial cells B
RX CelloPub=CLPUB00287;
RX PubMed=20444515;
RX PubMed=22193509;
CC Breed/subspecies: Limousin.
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID CiGEnC
AC CVCL_W185
SY Conditionally immortalized Glomerular Endothelial Cells
DR Ximbio; 152137
RX PubMed=16557232;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID Ciha-1
AC CVCL_Z281
RX PubMed=20019079;
CC Group: Insect cell line.
OX NCBI_TaxID=643112; ! Circulifer haematoceps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CIHGM-1
AC CVCL_W168
SY Conditionally Immortalized Human Glomerular Mesangial cells-1
DR Ximbio; 152138
RX PubMed=21653636;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Miscellaneous: Cell line name and gender from author direct submission.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Conditionally immortalized cell line
//
ID CIHP-1
AC CVCL_W186
SY Conditionally Immortalized Human Podocytes-1
DR Ximbio; 152135
RX PubMed=11856766;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID CII
AC CVCL_0D73
SY CLL-CII
DR DSMZ; ACC-773
DR NCBI_Iran; C582
RX PubMed=6263808;
RX PubMed=7239716;
CC Doubling time: ~40-60 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11,13
ST TH01: 7,8
ST TPOX: 8
ST vWA: 17
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CII3
AC CVCL_V068
DR CLO; CLO_0002479
DR CLDB; cl782
DR IHW; IHW8002
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID CIIC1
AC CVCL_L835
DR ECACC; 89083001
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CIK
AC CVCL_CV32
SY Ctenopharyngodon Idella Kidney
RX CelloPub=CLPUB00329;
RX PubMed=26911257;
CC Group: Fish cell line.
OX NCBI_TaxID=7959; ! Ctenopharyngodon idella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CIN-612
AC CVCL_ER24
SY CIN 612; CIN612
RX PubMed=1326657;
RX PubMed=1850010;
RX PubMed=7835777;
RX PubMed=8390960;
CC Characteristics: Contains about 50 HPV31b episomes per cell.
CC Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI NCIt; C3782; Cervical intraepithelial neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CIN-612 3E
AC CVCL_ER25
SY CIN-612-3E; CIN 612-3E
RX PubMed=7835777;
RX PubMed=8390960;
CC Characteristics: Contains about 50 HPV31b episomes per cell.
CC Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI NCIt; C3782; Cervical intraepithelial neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_ER24 ! CIN-612
SX Female
CA Transformed cell line
//
ID CIN-612 6E
AC CVCL_ER26
SY CIN-612-6E; CIN 612-6E
RX PubMed=7835777;
RX PubMed=8390960;
RX PubMed=8764055;
CC Characteristics: Contains 2 to 5 copies of integrated HPV31b genomes.
CC Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI NCIt; C3782; Cervical intraepithelial neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_ER24 ! CIN-612
SX Female
CA Transformed cell line
//
ID CIN-612 9E
AC CVCL_ER27
SY CIN 612-9E; CIN612-9E; CIN-612 clone 9E; CIN612 clone 9E; CIN612 subclone 9E
DR GEO; GSM1435014
DR GEO; GSM1435015
DR GEO; GSM1435016
DR GEO; GSM1435017
RX PubMed=1326657;
RX PubMed=7835777;
RX PubMed=8764055;
RX PubMed=12388689;
CC Characteristics: Contains about 50 HPV31b episomes per cell.
CC Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
CC Omics: Transcriptome analysis.
DI NCIt; C3782; Cervical intraepithelial neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_ER24 ! CIN-612
SX Female
CA Transformed cell line
//
ID CIN-680
AC CVCL_ER28
RX PubMed=7835777;
RX PubMed=8764055;
CC Characteristics: Contains integrated HPV16 genome(s).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI NCIt; C3782; Cervical intraepithelial neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CIPm
AC CVCL_L148
RX PubMed=19754820;
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: Shih Tzu.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L149 ! CIPp
SX Female
CA Cancer cell line
//
ID CIPp
AC CVCL_L149
RX PubMed=19754820;
CC Breed/subspecies: Shih Tzu.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L148 ! CIPm
SX Female
CA Cancer cell line
//
ID ciPTEC
AC CVCL_W184
SY conditionally immortalized Proximal Tubule Epithelial Cells
DR Ximbio; 152139
RX PubMed=19902259;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID CIPULLO
AC CVCL_M711
DR Cosmic; 2297021
DR GEO; GSM119490
RX PubMed=16960149;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CiRA-PD22
AC CVCL_DQ42
SY Cira22
DR GEO; GSM936056
DR GEO; GSM1489203
DR GEO; GSM1489226
DR GEO; GSM1489438
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ43 ! CiRA-PD23
OI CVCL_DQ44 ! CiRA-PD24
OI CVCL_DQ45 ! CiRA-PD25
OI CVCL_DR16 ! CiRA-PD82
OI CVCL_DR17 ! CiRA-PD83
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD23
AC CVCL_DQ43
SY Cira23
DR GEO; GSM936057
DR GEO; GSM1489204
DR GEO; GSM1489227
DR GEO; GSM1489439
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ42 ! CiRA-PD22
OI CVCL_DQ44 ! CiRA-PD24
OI CVCL_DQ45 ! CiRA-PD25
OI CVCL_DR16 ! CiRA-PD82
OI CVCL_DR17 ! CiRA-PD83
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD24
AC CVCL_DQ44
SY Cira24
DR GEO; GSM936058
DR GEO; GSM1489205
DR GEO; GSM1489237
DR GEO; GSM1489440
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ42 ! CiRA-PD22
OI CVCL_DQ43 ! CiRA-PD23
OI CVCL_DQ45 ! CiRA-PD25
OI CVCL_DR16 ! CiRA-PD82
OI CVCL_DR17 ! CiRA-PD83
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD25
AC CVCL_DQ45
SY Cira25; PD01-25
DR GEO; GSM701543
DR GEO; GSM936059
DR GEO; GSM1489291
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ42 ! CiRA-PD22
OI CVCL_DQ43 ! CiRA-PD23
OI CVCL_DQ44 ! CiRA-PD24
OI CVCL_DR16 ! CiRA-PD82
OI CVCL_DR17 ! CiRA-PD83
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD26
AC CVCL_DQ46
SY Cira26; PD01-26
DR GEO; GSM936060
DR GEO; GSM1489292
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ47 ! CiRA-PD27
OI CVCL_DQ48 ! CiRA-PD28
OI CVCL_DQ49 ! CiRA-PD29
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD27
AC CVCL_DQ47
SY Cira27
DR GEO; GSM936061
DR GEO; GSM1489200
DR GEO; GSM1489435
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ46 ! CiRA-PD26
OI CVCL_DQ48 ! CiRA-PD28
OI CVCL_DQ49 ! CiRA-PD29
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD28
AC CVCL_DQ48
SY Cira28
DR GEO; GSM936062
DR GEO; GSM1489293
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ46 ! CiRA-PD26
OI CVCL_DQ47 ! CiRA-PD27
OI CVCL_DQ49 ! CiRA-PD29
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD29
AC CVCL_DQ49
SY Cira29
DR GEO; GSM936063
DR GEO; GSM1489201
DR GEO; GSM1489436
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ46 ! CiRA-PD26
OI CVCL_DQ47 ! CiRA-PD27
OI CVCL_DQ48 ! CiRA-PD28
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD82
AC CVCL_DR16
SY Cira82
DR GEO; GSM1489202
DR GEO; GSM1489437
DR GEO; GSM1942575
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ42 ! CiRA-PD22
OI CVCL_DQ43 ! CiRA-PD23
OI CVCL_DQ44 ! CiRA-PD24
OI CVCL_DQ45 ! CiRA-PD25
OI CVCL_DR17 ! CiRA-PD83
SX Male
CA Induced pluripotent stem cell
//
ID CiRA-PD83
AC CVCL_DR17
SY Cira83
DR GEO; GSM1489206
DR GEO; GSM1489441
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ42 ! CiRA-PD22
OI CVCL_DQ43 ! CiRA-PD23
OI CVCL_DQ44 ! CiRA-PD24
OI CVCL_DQ45 ! CiRA-PD25
OI CVCL_DR16 ! CiRA-PD82
SX Male
CA Induced pluripotent stem cell
//
ID CiRA00021
AC CVCL_Y961
SY A21412
DR RCB; HPS0289
DR RCB; HPS0327
RX PubMed=22855461;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Discontinued: RCB; HPS0289; probable.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T779 ! CiRA00022
OI CVCL_T780 ! CiRA00023
SX Male
CA Induced pluripotent stem cell
//
ID CiRA00022
AC CVCL_T779
SY Cira22; A21421
DR RCB; HPS0290
DR SKIP; SKIP000228
RX PubMed=22855461;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y961 ! CiRA00021
OI CVCL_T780 ! CiRA00023
SX Male
CA Induced pluripotent stem cell
//
ID CiRA00023
AC CVCL_T780
SY A21428
DR RCB; HPS0291
DR SKIP; SKIP000229
RX PubMed=22855461;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y961 ! CiRA00021
OI CVCL_T779 ! CiRA00022
SX Male
CA Induced pluripotent stem cell
//
ID CiRA00024
AC CVCL_T781
SY A3411
DR RCB; HPS0292
DR SKIP; SKIP000230
RX PubMed=22855461;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T782 ! CiRA00025
OI CVCL_T783 ! CiRA00026
SX Female
CA Induced pluripotent stem cell
//
ID CiRA00025
AC CVCL_T782
SY A3415
DR RCB; HPS0293
DR SKIP; SKIP000231
RX PubMed=22855461;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T781 ! CiRA00024
OI CVCL_T783 ! CiRA00026
SX Female
CA Induced pluripotent stem cell
//
ID CiRA00026
AC CVCL_T783
SY A3416
DR RCB; HPS0294
DR SKIP; SKIP000232
RX PubMed=22855461;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T781 ! CiRA00024
OI CVCL_T782 ! CiRA00025
SX Female
CA Induced pluripotent stem cell
//
ID CiRA086Ai-m1
AC CVCL_T776
DR RCB; HPS0117
DR SKIP; SKIP000171
RX PubMed=22723549;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y542 ! CiRA086Ai-w1
SX Male
CA Induced pluripotent stem cell
//
ID CiRA086Ai-w1
AC CVCL_Y542
DR SKIP; SKIP000172
DR RCB; HPS0118
RX PubMed=22723549;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Misspelling: 'HSP0118' in SKIP SKIP000172.
DI NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T776 ! CiRA086Ai-m1
SX Male
CA Induced pluripotent stem cell
//
ID CiRA00139
AC CVCL_IP54
DR RCB; HPS0426
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CiRA00142
AC CVCL_IP55
DR RCB; HPS0429
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CiRA00160
AC CVCL_IP56
DR RCB; HPS0507
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CiRA00161
AC CVCL_IP57
DR RCB; HPS0508
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID CiRA188Ai-M1
AC CVCL_T777
DR RCB; HPS0119
DR SKIP; SKIP000173
RX PubMed=22723549;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T778 ! CiRA188Ai-W1
SX Male
CA Induced pluripotent stem cell
//
ID CiRA188Ai-W1
AC CVCL_T778
DR RCB; HPS0120
DR SKIP; SKIP000174
RX PubMed=22723549;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
DI NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T777 ! CiRA188Ai-M1
SX Male
CA Induced pluripotent stem cell
//
ID CIRC-HLF
AC CVCL_CW31
DR NCBI_Iran; C580
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CIRC-HLF-CI
AC CVCL_CW32
DR NCBI_Iran; C581
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Citrullinemia
AC CVCL_3301
AS CVCL_U513
SY citrullinemia; GM00063; GM-63; GM63
DR CLO; CLO_0002480
DR CLO; CLO_0002481
DR CLDB; cl783
DR ATCC; CCL-76
DR BioSample; SAMN03471287
DR Coriell; GM00063
DR ECACC; 90102532
RX CelloPub=CLPUB00290;
CC Discontinued: Coriell; GM00063; probable.
CC Discontinued: ECACC; 90102532; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D5S818: 9,12
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C84639; Citrullinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Cj11
AC CVCL_2Z80
RX Patent=US5843780;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID Cj11.2
AC CVCL_2U74
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
HI CVCL_2Z80 ! Cj11
SX Female
CA Embryonic stem cell
//
ID CJ18
AC CVCL_M708
RX PubMed=4081642;
CC Doubling time: 3-4 days (PubMed=4081642).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Cj25.1
AC CVCL_2U75
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID Cj28
AC CVCL_2U76
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Embryonic stem cell
//
ID Cj33
AC CVCL_2U77
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID Cj35
AC CVCL_2U78
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID Cj36
AC CVCL_2U79
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID Cj39
AC CVCL_2U80
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID Cj62
AC CVCL_2U81
RX PubMed=8828827;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID CJ7
AC CVCL_C316
SY ES-CJ7; CJ7-mESC; CJ-7
DR BTO; BTO:0004413
DR EFO; EFO_0005916
DR ENCODE; ENCBS028ENC
DR ENCODE; ENCBS816RMP
DR GEO; GSM1014187
RX PubMed=8224839;
RX PubMed=17828574;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-149.html
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ES-CJ7_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Breed/subspecies: 129S1/SvImJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID CJA00369IN
AC CVCL_E152
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Transformed cell line
//
ID CJA00370IN
AC CVCL_E153
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Transformed cell line
//
ID CJA00371IN
AC CVCL_E154
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Transformed cell line
//
ID CJA00372IN
AC CVCL_E155
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Transformed cell line
//
ID CJA00373IN
AC CVCL_E156
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Transformed cell line
//
ID CJA00374IN
AC CVCL_E157
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Transformed cell line
//
ID CJA00375IN
AC CVCL_E158
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Transformed cell line
//
ID CJA00376IN
AC CVCL_E159
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Transformed cell line
//
ID CJA00377IN
AC CVCL_E160
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Transformed cell line
//
ID CJM [Human melanoma]
AC CVCL_U797
DR CCLE; CJM_SKIN
DR Cosmic; 888989
DR Cosmic; 928720
DR GEO; GSM170865
DR GEO; GSM215722
DR GEO; GSM886932
DR GEO; GSM887998
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=22460905;
WW http://biogps.org/dataset/1409/63-melanoma-cell-lines/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CJM [Human OCSCC]
AC CVCL_8663
DR CLO; CLO_0050092
DR BioSample; SAMN03472153
DR RCB; RCB1034
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 10,13
ST D7S820: 12,13
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8289 ! T3M-1
SX Male
CA Cancer cell line
//
ID CJM Cl4
AC CVCL_8664
DR CLO; CLO_0050093
DR RCB; RCB1035
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8663 ! CJM [Human OCSCC]
SX Male
CA Cancer cell line
//
ID CJM Cl5
AC CVCL_8665
DR CLO; CLO_0050094
DR RCB; RCB1036
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8663 ! CJM [Human OCSCC]
SX Male
CA Cancer cell line
//
ID CJM Cl6
AC CVCL_8666
DR CLO; CLO_0050095
DR RCB; RCB1037
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8663 ! CJM [Human OCSCC]
SX Male
CA Cancer cell line
//
ID CJM Cl7
AC CVCL_8667
DR CLO; CLO_0050096
DR RCB; RCB1038
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8663 ! CJM [Human OCSCC]
SX Male
CA Cancer cell line
//
ID CJM Cl8
AC CVCL_8668
DR CLO; CLO_0050097
DR RCB; RCB1039
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8663 ! CJM [Human OCSCC]
SX Male
CA Cancer cell line
//
ID CJO-A
AC CVCL_E528
SY CJO
DR dbMHC; 48727
DR ECACC; 85022808
DR IHW; IHW9243
DR IMGT/HLA; 10418
RX PubMed=6417008;
WW http://bioinformatics.hsanmartino.it/ecbr/cl243.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CK
AC CVCL_W462
SY Calf Kidney
RX PubMed=4280232;
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID CKMM 14.15
AC CVCL_8851
DR CLO; CLO_0002482
DR ATCC; HB-9419
RX Patent=US4950592;
CC Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CKMM 14.5
AC CVCL_8852
DR CLO; CLO_0002483
DR ATCC; HB-9420
RX Patent=US4950592;
CC Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CKMM 14.52
AC CVCL_8853
DR CLO; CLO_0002484
DR ATCC; HB-9421
RX Patent=US4950592;
CC Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CKS
AC CVCL_4826
RX PubMed=6268719;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CKT-1
AC CVCL_2403
SY CKT clone 1; Calf Kidney Tokushima-1
DR CLO; CLO_0050863
DR IFO; IFO50003
DR JCRB; JCRB0008
DR RCB; RCB0249
RX PubMed=4303468;
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Spontaneously immortalized cell line
//
ID CL 21
AC CVCL_7252
SY Cl 21; CL21; Clone 21
DR ECACC; 86080602
RX PubMed=3763403;
RX PubMed=4371646;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7908 ! GM00847
CA Hybrid cell line
//
ID CL-01
AC CVCL_0082
SY CL01; BL16 sub-line CL-01
RX PubMed=9498752;
WW http://www.novusbio.com/about/press-release/human-monoclonal-igmigd-b-cell-line-announced-novus-biologicals
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C137 ! BL-16
SX Female
CA Cancer cell line
//
ID CL-1
AC CVCL_L321
SY CL1
RX PubMed=9437822;
RX PubMed=22236332;
RX PubMed=23365669;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Japanese Terrier.
DI NCIt; C128120; Canine leukemia
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CL-11
AC CVCL_1978
SY CL11
DR EFO; EFO_0006368
DR BioSample; SAMN03471897
DR BioSample; SAMN03473558
DR CCLE; CL11_LARGE_INTESTINE
DR Cosmic-CLP; 1290769
DR DSMZ; ACC-467
DR GDSC; 1290769
DR GEO; GSM206455
DR GEO; GSM513931
DR GEO; GSM514183
DR GEO; GSM886933
DR GEO; GSM887999
DR GEO; GSM1448148
DR GEO; GSM1669680
RX PubMed=19003396;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~3-4 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 13,14
ST D16S539: 11,13
ST D18S51: 14
ST D21S11: 31,32.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 9 (DSMZ)
ST D7S820: 9,10 (Cosmic-CLP; PubMed=25877200)
ST D8S1179: 14
ST FGA: 22,23
ST Penta D: 9,13
ST Penta E: 10,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D331 ! CL-11m
SX Male
CA Cancer cell line
//
ID CL-11m
AC CVCL_D331
SY CL-11M; CL11m
RX PubMed=19003396;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1978 ! CL-11
SX Male
CA Cancer cell line
//
ID CL-14
AC CVCL_1979
SY CL14
DR BioSample; SAMN03473569
DR CCLE; CL14_LARGE_INTESTINE
DR DSMZ; ACC-504
DR GEO; GSM513932
DR GEO; GSM514184
DR GEO; GSM886934
DR GEO; GSM888000
DR GEO; GSM1448171
RX PubMed=19003396;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~1 week (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL-19
AC CVCL_D332
SY CL19
RX PubMed=19003396;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-21
AC CVCL_D333
SY CL21
RX PubMed=19003396;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-23
AC CVCL_D334
SY CL23
RX PubMed=19003396;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-30
AC CVCL_D335
SY CL30
RX PubMed=19003396;
CC Derived from metastatic site: Spleen.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-34
AC CVCL_1980
SY CL34
DR EFO; EFO_0006369
DR BioSample; SAMN03471564
DR BioSample; SAMN03473518
DR CCLE; CL34_LARGE_INTESTINE
DR Cosmic-CLP; 1290771
DR DSMZ; ACC-520
DR GDSC; 1290771
DR GEO; GSM206456
DR GEO; GSM513933
DR GEO; GSM514185
DR GEO; GSM886935
DR GEO; GSM888001
DR GEO; GSM1448119
RX PubMed=19003396;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~70 hours (DSMZ).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053); Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,16 (Cosmic-CLP; DSMZ)
ST CSF1PO: 11 (PubMed=25877200)
ST D13S317: 11,13
ST D16S539: 9,11
ST D18S51: 12,17,18
ST D21S11: 30
ST D3S1358: 12,17,18
ST D5S818: 9,11
ST D7S820: 10,15 (Cosmic-CLP; DSMZ)
ST D7S820: 10 (PubMed=25877200)
ST D8S1179: 10,11
ST FGA: 22,24,25
ST Penta D: 9,10
ST Penta E: 7
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CL-36
AC CVCL_D336
SY CL36
RX PubMed=19003396;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-38
AC CVCL_1981
SY CL 38; CL38
DR DSMZ; ACC-621
RX PubMed=2684400;
RX PubMed=2720663;
CC Doubling time: ~30-40 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: Wistar-AF/Han.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CL-39
AC CVCL_V481
SY CL39
RX PubMed=19003396;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-40
AC CVCL_1982
SY CL40
DR EFO; EFO_0006370
DR BioSample; SAMN03471322
DR CCLE; CL40_LARGE_INTESTINE
DR Cosmic-CLP; 1240124
DR DSMZ; ACC-535
DR GDSC; 1240124
DR GEO; GSM206457
DR GEO; GSM513934
DR GEO; GSM514186
DR GEO; GSM886936
DR GEO; GSM888002
DR GEO; GSM1448149
DR GEO; GSM1669681
RX PubMed=19003396;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~3-4 days (DSMZ).
CC Microsatellite instability: Instable (MSI) (PubMed=25926053); Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 30,32.2
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 12,14
ST FGA: 21,24
ST Penta D: 10
ST Penta E: 14
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CL-44
AC CVCL_1983
SY CL 44; CL44
DR DSMZ; ACC-622
RX PubMed=2720663;
CC Doubling time: ~30-40 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: Wistar-AF/Han.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CL-49IV
AC CVCL_1984
SY CL49IV
DR DSMZ; ACC-628
CC Doubling time: ~60-100 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: Wistar-AF/Han.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CL-50IIa
AC CVCL_1985
SY CL50IIa
DR DSMZ; ACC-623
RX PubMed=2684400;
CC Doubling time: ~50-60 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: Wistar-AF/Han.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CL-52
AC CVCL_HM43
SY CL 52
RX PubMed=8625260;
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC Breed/subspecies: Wistar-AF/Han.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID Cl-66M1
AC CVCL_B394
SY Cl66M1
RX PubMed=10651311;
CC Doubling time: 29.1 +- 1.4 hours (PubMed=10651311).
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9722 ! 66 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID Cl-66M2
AC CVCL_B395
SY Cl66M2
DR BTO; BTO:0004310
RX PubMed=10651311;
CC Doubling time: 28.1 +- 2.2 hours (PubMed=10651311).
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9722 ! 66 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID CL-9
AC CVCL_D337
SY CL9
RX PubMed=19003396;
CC Derived from metastatic site: Liver.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CL-S1
AC CVCL_3500
DR CLO; CLO_0002512
DR CLDB; cl787
DR ATCC; CRL-1615
DR ECACC; 90110502
RX PubMed=232056;
RX PubMed=7306960;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID Cl. Ly1+2-/9
AC CVCL_6317
SY T-cell clone Ly1+2(-)/9
DR CLO; CLO_0002485
DR ATCC; CRL-8179
RX PubMed=6785749;
RX PubMed=6971154;
CC Breed/subspecies: C57BL/6-TL+.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID CL01
AC CVCL_C864
SY UPS-FRe001-A; UPSFRe001-A
DR hPSCreg; UPSFRe001-A
RX PubMed=22514597;
WW http://www.agence-biomedecine.fr/IMG/pdf/inserm_cl01.pdf
CC From: Universite Paris-Sud 11; Paris; France.
CC Registration: French Agence de la Biomedecine; FE06-024-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CL02
AC CVCL_C797
SY UPS-FRe002-A; UPSFRe002-A
DR hPSCreg; UPSFRe002-A
RX PubMed=22514597;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CL03
AC CVCL_C798
SY UPS-FRe003-A; UPSFRe003-A
DR hPSCreg; UPSFRe003-A
RX PubMed=22514597;
WW http://www.agence-biomedecine.fr/IMG/pdf/inserm_cl03.pdf
CC From: Universite Paris-Sud 11; Paris; France.
CC Registration: French Agence de la Biomedecine; FE10-131-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CL04
AC CVCL_Y594
WW http://www.agence-biomedecine.fr/IMG/pdf/inserm_cl04.pdf
CC From: Universite Paris-Sud 11; Paris; France.
CC Registration: French Agence de la Biomedecine; FE10-151-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CL1 [Dog mastocytoma]
AC CVCL_GT43
RX PubMed=19054577;
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C129077; Canine mastocytoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CL1 [Human ESC]
AC CVCL_L883
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CL1-0
AC CVCL_3871
AS CVCL_D516
SY CL 1-0; CL1.0; CL1
DR BTO; BTO:0002875
DR BTO; BTO:0003345
DR GEO; GSM185873
DR GEO; GSM997731
DR GEO; GSM997732
DR GEO; GSM997733
DR GEO; GSM997734
DR GEO; GSM997739
DR GEO; GSM997740
DR GEO; GSM997741
DR GEO; GSM997742
DR GEO; GSM997747
DR GEO; GSM997748
DR GEO; GSM997749
DR GEO; GSM997750
DR GEO; GSM1039261
DR GEO; GSM1039262
DR GEO; GSM1039263
DR TOKU-E; 4035
DR TOKU-E; 4044
RX PubMed=1497905;
RX PubMed=9308922;
RX PubMed=11431363;
RX PubMed=16354588;
CC Omics: Transcriptome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL1-1
AC CVCL_D517
SY CL 1-1
DR BTO; BTO:0003341
DR GEO; GSM185874
RX PubMed=9308922;
RX PubMed=11431363;
CC Omics: Transcriptome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3871 ! CL1-0
SX Male
CA Cancer cell line
//
ID CL1-2
AC CVCL_D518
DR BTO; BTO:0003342
RX PubMed=9308922;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3871 ! CL1-0
SX Male
CA Cancer cell line
//
ID CL1-3
AC CVCL_D519
DR BTO; BTO:0003343
RX PubMed=9308922;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3871 ! CL1-0
SX Male
CA Cancer cell line
//
ID CL1-4
AC CVCL_D520
DR BTO; BTO:0003344
RX PubMed=9308922;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3871 ! CL1-0
SX Male
CA Cancer cell line
//
ID CL1-5
AC CVCL_D521
SY CL 1-5
DR BTO; BTO:0002876
DR GEO; GSM185875
DR GEO; GSM997743
DR GEO; GSM997744
DR GEO; GSM997745
DR GEO; GSM997746
DR GEO; GSM997735
DR GEO; GSM997736
DR GEO; GSM997737
DR GEO; GSM997738
DR GEO; GSM997751
DR GEO; GSM997752
DR GEO; GSM997753
DR GEO; GSM997754
DR GEO; GSM1039264
DR GEO; GSM1039265
DR GEO; GSM1039266
DR TOKU-E; 3876
RX PubMed=9308922;
RX PubMed=11431363;
RX PubMed=16354588;
RX PubMed=21998723;
CC Omics: Transcriptome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3871 ! CL1-0
SX Male
CA Cancer cell line
//
ID CL1-5-F4
AC CVCL_IN56
SY CL 1-5-F 4; CL1-5F4
DR GEO; GSM185876
RX PubMed=11431363;
CC Omics: Transcriptome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D521 ! CL1-5
SX Male
CA Cancer cell line
//
ID CL100
AC CVCL_Y428
DR PRIDE; PXD002224
RX PubMed=26202522;
CC Omics: Deep membrane proteome analysis.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CL141
AC CVCL_N822
DR Cosmic; 1790393
DR PRIDE; PXD002224
RX PubMed=23024022;
RX PubMed=26202522;
CC Omics: Deep membrane proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL152
AC CVCL_N823
DR Cosmic; 1790394
DR PRIDE; PXD002224
RX PubMed=23024022;
RX PubMed=26202522;
CC Omics: Deep membrane proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL18/1D8
AC CVCL_K204
SY CL18/1
DR ATCC; CRL-2517
RX PubMed=1680878;
CC Monoclonal antibody target: UniProtKB; P33729; Dog ICAM1/CD54.
CC Discontinued: ATCC; CRL-2517; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CL18/6
AC CVCL_K205
DR CLO; CLO_0002487
DR ATCC; CRL-2518
RX PubMed=1680878;
CC Monoclonal antibody target: UniProtKB; P33729; Dog ICAM1/CD54.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CL2 [Human lung adenocarcinoma]
AC CVCL_W144
RX PubMed=1497905;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL2 [Mouse hybridoma]
AC CVCL_K206
DR CLO; CLO_0002488
DR ATCC; CRL-2514
RX PubMed=1713515;
CC Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CL25
AC CVCL_N824
DR Cosmic; 1790395
DR PRIDE; PXD002224
RX PubMed=23024022;
RX PubMed=26202522;
CC Omics: Deep membrane proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL3 [Human lung adenocarcinoma]
AC CVCL_W145
RX PubMed=1497905;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL3 [Mouse hybridoma]
AC CVCL_K207
DR CLO; CLO_0002489
DR ATCC; CRL-2515
RX PubMed=1713515;
CC Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CL37
AC CVCL_K208
DR CLO; CLO_0002490
DR ATCC; CRL-2516
CC Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID CL83
AC CVCL_N825
DR Cosmic; 1790392
DR PRIDE; PXD002224
RX PubMed=23024022;
RX PubMed=26202522;
CC Omics: Deep membrane proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL97
AC CVCL_N826
SY CL97TM/GA
DR Cosmic; 1790396
DR PRIDE; PXD002224
RX PubMed=23024022;
RX PubMed=26202522;
CC Characteristics: Has EGFR p.Gly719Ala and p.Thr790Met mutations.
CC Omics: Deep membrane proteome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CL97-L2G
AC CVCL_IQ77
RX PubMed=23024022;
CC Characteristics: Has EGFR p.Gly719Ala and p.Thr790Met mutations.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N826 ! CL97
SX Male
CA Cancer cell line
//
ID CLA
AC CVCL_E529
DR dbMHC; 48728
DR ECACC; 94022525
DR IHW; IHW9209
DR IMGT/HLA; 10422
WW http://bioinformatics.hsanmartino.it/ecbr/cl209.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CLA1RGB
AC CVCL_R887
DR CLO; CLO_0050714
DR BioSample; SAMN03472351
DR RCB; RCB0266
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 7
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C98969; Lactic acidosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID CLA4
AC CVCL_A601
SY CLA-4
RX PubMed=1181076;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CLAB
AC CVCL_6A78
RX CelloPub=CLPUB00287;
RX DOI=10.3390/foods1010040;
RX PubMed=20444515;
RX PubMed=22193509;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID CLAC
AC CVCL_J360
SY Canine Lung Adenocarcinoma Cells
DR JCRB; JCRB1453
RX PubMed=21245282;
CC Breed/subspecies: Pointer.
DI NCIt; C129299; Canine lung adenocarcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CLB-Ba
AC CVCL_9517
SY CLB-BA
DR Cosmic; 1153808
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=18534018;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Bac
AC CVCL_9518
SY CLB-BAC
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Bar
AC CVCL_9519
SY CLB-BAR
RX PubMed=20160348;
CC Miscellaneous: Gender from personal communication of Combaret V.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GP62 ! CLB-BARrec
SX Female
CA Cancer cell line
//
ID CLB-BARrec
AC CVCL_GP62
SY CLB-BARREC
RX PubMed=20160348;
CC Miscellaneous: Gender from personal communication of Combaret V.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9519 ! CLB-Bar
SX Female
CA Cancer cell line
//
ID CLB-Be
AC CVCL_9520
SY CLB-BE
RX DOI=10.1007/0-306-46872-7_2;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Bel
AC CVCL_9521
SY CLB-BEL
RX PubMed=18534018;
RX PubMed=20160348;
CC Miscellaneous: Gender from personal communication of Combaret V.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-BerLud1
AC CVCL_9522
SY CLB-Ber1
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9523 ! CLB-BerLud2
SX Male
CA Cancer cell line
//
ID CLB-BerLud2
AC CVCL_9523
SY CLB-Ber2
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9522 ! CLB-BerLud1
SX Male
CA Cancer cell line
//
ID CLB-Bou
AC CVCL_9524
RX PubMed=18534018;
CC Miscellaneous: Gender from personal communication of Combaret V.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB-Br
AC CVCL_9525
RX PubMed=7705946;
RX DOI=10.1007/0-306-46872-7_2;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB-Ca
AC CVCL_9526
SY CLB-CA; CLB-CAR
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB-Chas
AC CVCL_9527
RX PubMed=18534018;
CC Miscellaneous: Gender from personal communication of Combaret V.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Es
AC CVCL_9528
SY CLB-ES; CLB-ESP
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Ga
AC CVCL_9529
SY CLB-GA; CLB-GAR
DR Cosmic; 1153805
DR Cosmic; 1526623
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=11550280;
RX PubMed=18534018;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Ge1
AC CVCL_9530
SY CLB-Ge
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9531 ! CLB-Ge2
SX Male
CA Cancer cell line
//
ID CLB-Ge2
AC CVCL_9531
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=19349462;
RX PubMed=20160348;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9530 ! CLB-Ge1
SX Male
CA Cancer cell line
//
ID CLB-Hu-TT-1
AC CVCL_EY25
RX PubMed=6327321;
CC Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CLB-Hut
AC CVCL_EY24
SY CLB-HUT
RX PubMed=20160348;
CC Miscellaneous: Gender and metastatic site from personal communication of Combaret V.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Ma1
AC CVCL_9532
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=18534018;
RX PubMed=20160348;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9533 ! CLB-Ma2
SX Female
CA Cancer cell line
//
ID CLB-Ma2
AC CVCL_9533
SY CLB-Ma
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9532 ! CLB-Ma1
SX Female
CA Cancer cell line
//
ID CLB-Pe
AC CVCL_9534
SY CLB-PE; CLB-PEC
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=18534018;
RX PubMed=20160348;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB-Re
AC CVCL_9535
SY CLB-RE; CLB-REM
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLB-Sedp
AC CVCL_9536
SY CLB Sedp; CLB-Sed; CLB-SED
RX PubMed=18534018;
RX PubMed=20160348;
CC Miscellaneous: Gender from personal communication of Combaret V.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB-Tr
AC CVCL_9537
SY CLB-TR; CLB-Tra; CLB-TRA
DR Cosmic; 1153810
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7705946;
RX PubMed=20160348;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB-VolMo
AC CVCL_9538
SY CLB-VOL
RX PubMed=19349462;
RX PubMed=20160348;
CC Miscellaneous: Gender and metastatic site from personal communication of Combaret V.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLB70
AC CVCL_FA11
RX PubMed=27506920;
CC Doubling time: ~28 hours (PubMed=27506920).
CC Breed/subspecies: Shih Tzu.
DI NCIt; C128120; Canine leukemia
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CLBL-1
AC CVCL_L322
SY CLBL1
DR GEO; GSM1974779
DR GEO; GSM2143059
RX PubMed=20153049;
RX PubMed=22761949;
RX PubMed=23365669;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Bernese mountain dog.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CLBL-1M
AC CVCL_L323
RX PubMed=22761949;
CC Breed/subspecies: Bernese mountain dog.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L322 ! CLBL-1
SX Male
CA Cancer cell line
//
ID CLC [Carp]
AC CVCL_4144
SY Carp Leukocyte Culture
DR CLO; CLO_0002494
DR CLDB; cl791
DR ATCC; CRL-2763
DR ECACC; 95070628
RX PubMed=2369971;
CC Group: Fish cell line.
CC Discontinued: ATCC; CRL-2763; true.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Female
CA Spontaneously immortalized cell line
//
ID CLC [Dog lymphoma]
AC CVCL_L324
RX PubMed=23196801;
CC Doubling time: 14.5 hours (PubMed=23196801).
CC Breed/subspecies: French Bulldog.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CLCL
AC CVCL_Y302
DR ATCC; CL-99
RX Patent=US3871954;
CC Discontinued: ATCC; CL-99; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Finite cell line
//
ID Cle-H3
AC CVCL_F498
SY H-3
DR CLO; CLO_0050551
DR RCB; RCB0549
RX PubMed=1505125;
CC Transfected with: HGNC; 6407; KRAS (with V-12).
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID Cle-H3^(neo+)
AC CVCL_T378
SY H-3neo
DR CLO; CLO_0050552
DR RCB; RCB0550
RX PubMed=1505125;
CC Transfected with: HGNC; 6407; KRAS (with V-12).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F498 ! Cle-H3
SX Male
CA Spontaneously immortalized cell line
//
ID ClearCa-1
AC CVCL_X548
SY clearCa-1
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-10
AC CVCL_X549
SY clearCa-10
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-11
AC CVCL_X550
SY clearCa-11
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-12
AC CVCL_X551
SY clearCa-12
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-13
AC CVCL_X552
SY clearCa-13
DR Cosmic; 972656
RX PubMed=9146668;
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-14
AC CVCL_X553
SY clearCa-14
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-15
AC CVCL_X554
SY clearCa-15
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-16
AC CVCL_X555
SY clearCa-16
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-17
AC CVCL_X556
SY clearCa-17
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-18
AC CVCL_X557
SY clearCa-18
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-19
AC CVCL_X558
SY clearCa-19
RX PubMed=10737390;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-2
AC CVCL_X559
SY clearCa-2
DR Cosmic; 972663
RX PubMed=9146668;
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-20
AC CVCL_X560
SY clearCa-20
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-21
AC CVCL_X561
SY clearCa-21
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-22
AC CVCL_X562
SY clearCa-22
DR Cosmic; 972664
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-23
AC CVCL_X563
SY clearCa-23
DR Cosmic; 972666
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-24
AC CVCL_X564
SY clearCa-24
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-25
AC CVCL_X565
SY clearCa-25
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-26
AC CVCL_X566
SY clearCa-26
DR Cosmic; 972658
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-27
AC CVCL_X567
SY clearCa-27
DR Cosmic; 972660
DR Cosmic; 972667
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-28
AC CVCL_X579
SY clearCa-28
RX PubMed=10737390;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-29
AC CVCL_X581
SY clearCa-29
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-3
AC CVCL_X568
SY clearCa-3
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-31
AC CVCL_X569
SY clearCa-31
DR Cosmic; 972659
RX PubMed=10925357;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-32
AC CVCL_X570
SY clearCa-32
DR Cosmic; 972665
RX PubMed=10925357;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-35
AC CVCL_X571
SY clearCa-35
DR Cosmic; 972661
RX PubMed=10925357;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-36
AC CVCL_X572
SY clearCa-36
DR Cosmic; 972657
RX PubMed=10925357;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-39
AC CVCL_X580
SY clearCa-39
RX PubMed=10737390;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ClearCa-4
AC CVCL_X573
SY clearCa-4
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-5
AC CVCL_X574
SY clearCa-5
RX PubMed=9146668;
RX PubMed=10737390;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ClearCa-6
AC CVCL_X575
SY clearCa-6
DR Cosmic; 972662
RX PubMed=9146668;
RX PubMed=10925357;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-7
AC CVCL_X576
SY clearCa-7
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-8
AC CVCL_X577
SY clearCa-8
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ClearCa-9
AC CVCL_X578
SY clearCa-9
RX PubMed=9146668;
WW http://docserv.uni-duesseldorf.de/servlets/DerivateServlet/Derivate-3116/1116.pdf
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLF
AC CVCL_6F77
SY Cyclopterus Lumpus Fin
RX DOI=10.1139/f77-017;
CC Group: Fish cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.
OX NCBI_TaxID=8103; ! Cyclopterus lumpus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CLGL-90
AC CVCL_DI62
SY CLGL90
RX PubMed=15746063;
RX PubMed=22236332;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C128120; Canine leukemia
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CLH 6
AC CVCL_J673
SY CLH6
DR ATCC; HB-8232
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLH 68
AC CVCL_J674
SY CLH68
DR ATCC; HB-8243
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLH 70
AC CVCL_J675
SY CLH70
DR ATCC; HB-8245
RX Patent=US4579827;
CC Discontinued: ATCC; HB-8245; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLK
AC CVCL_L325
RX PubMed=23196801;
CC Doubling time: 36.2 hours (PubMed=23196801).
CC Breed/subspecies: Pyrenean mountain dog.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CLL 36A/76
AC CVCL_DC64
DR ATCC; CRL-1407
RX Patent=US4477567;
CC Discontinued: ATCC; CRL-1407; probable.
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID CLL-1390
AC CVCL_DI61
SY CLL1390
DR GEO; GSM1974780
RX PubMed=15746063;
RX PubMed=22236332;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C128120; Canine leukemia
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CLL-AAT
AC CVCL_CY99
SY CLL-MT
DR ATCC; PTA-3920
RX Patent=US8840885;
RX PubMed=16418292;
CC Discontinued: ATCC; PTA-3920; probable.
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CLM-7
AC CVCL_4W28
RX PubMed=3365701;
RX PubMed=5533992;
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Male
CA Spontaneously immortalized cell line
//
ID CLM-7/AD XV
AC CVCL_5A46
RX PubMed=3365701;
CC Selected for resistance to: ChEBI; CHEBI:27666; Actinomycin D (ActD).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4W28 ! CLM-7
SX Male
CA Spontaneously immortalized cell line
//
ID CLN
AC CVCL_3663
DR CLO; CLO_0002496
DR ATCC; CRL-6245
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6245; true.
CC Breed/subspecies: Dachshund.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_N778 ! CSN
SX Female
CA Cancer cell line
//
ID CLNH11.4
AC CVCL_3664
SY CLN H11.4; CLNH11
DR CLO; CLO_0002497
DR ATCC; HB-8307
DR BioSample; SAMN03471081
RX Patent=US6090924;
RX PubMed=6604917;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 11
ST D16S539: 9,11,12
ST D5S818: 10,11,12,13
ST D7S820: 9,11
ST TH01: 6,7,8,9.3
ST TPOX: 8,11
ST vWA: 14,17,19,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID CLNH5.5
AC CVCL_3665
SY CLNH5
DR CLO; CLO_0002498
DR ATCC; HB-8206
DR BioSample; SAMN03471080
RX Patent=US6090924;
RX PubMed=6604917;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,11,12
ST D5S818: 10,11,13
ST D7S820: 9,11
ST TH01: 6,7,8,9
ST TPOX: 8,11
ST vWA: 14,17,19,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID Clom 15
AC CVCL_1R52
DR BioSample; SAMN03152005
RX PubMed=20951163;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID Clone 197
AC CVCL_M377
DR ECACC; 91060548
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Clone 1A
AC CVCL_1T03
DR BioSample; SAMN03151624
RX PubMed=19002917;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Fish cell line.
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of Oncorhynchus mykiss origin but found to be a Oncorhynchus tshawytscha CHSE-214 derivative (PubMed=19002917).
OX NCBI_TaxID=74940; ! Oncorhynchus tshawytscha
HI CVCL_2780 ! CHSE-214
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Clone 218
AC CVCL_M393
DR ECACC; 91060545
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Clone 69T1RevEnv
AC CVCL_1H05
SY Env-expressing cell clone 69
DR NIH-ARP; 3336-92
RX PubMed=8676479;
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2523 ! HtTA-1
SX Female
CA Cancer cell line
//
ID Clone 707
AC CVCL_4145
DR CLO; CLO_0002502
DR CLDB; cl796
DR CLDB; cl806
DR ECACC; 86052101
RX PubMed=4527816;
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Clone 81
AC CVCL_7216
AS CVCL_9495
SY CCC clone 81; CCC3a subline 8C clone 81; CC81; CC 81; 8C81
DR CLO; CLO_0002232
DR CLO; CLO_0002503
DR CLDB; cl652
DR CLDB; cl797
DR ECACC; 90031403
RX PubMed=4365331;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/acc81.htm
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_W183 ! CCC3a subline 8C
SX Female
CA Transformed cell line
//
ID Clone C
AC CVCL_6483
SY IC250 clone C
DR CLO; CLO_0002505
DR ATCC; CRL-2531
RX PubMed=1325122;
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Conditionally immortalized cell line
//
ID Clone HXBdeltaPdeltaEnv-T1RevEnv
AC CVCL_1H06
DR NIH-ARP; 3337-93
RX PubMed=8676479;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2523 ! HtTA-1
SX Female
CA Cancer cell line
//
ID Clone M-3
AC CVCL_4512
AS CVCL_7682
SY Cloudman S91 melanoma clone M-3; CLONE M3; M3 Clone M-3
DR CLO; CLO_0002511
DR CLO; CLO_0007474
DR CLDB; cl804
DR CLDB; cl805
DR CLDB; cl3315
DR ATCC; CCL-53.1
DR BCRC; 60075
DR ECACC; 87081806
DR ECACC; 93120827
DR IZSLER; BS TCL 37
DR KCLB; 10053.1
DR RCB; RCB2616
RX PubMed=3348949;
RX PubMed=3667379;
RX PubMed=6581509;
CC Discontinued: RCB; RCB2616; true.
CC Breed/subspecies: DBA.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J817 ! S91
SX Male
CA Cancer cell line
//
ID CLS-103
AC CVCL_5725
SY CLS 103; CLS103
DR CLS; 400176/p575_CLS-103
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: NMRI.
DI NCIt; C24234; Mouse gastric squamous cell carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CLS-117
AC CVCL_B271
DR CLS; 300329/p512_CLS-117
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 11
ST D18S51: 11
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 11
ST vWA: 14
ST D7S820: 11
ST D8S1179: 15
ST FGA: 22
ST Penta D: 10
ST Penta E: 18
ST TH01: 6
ST TPOX: 8
DI NCIt; C6041; Thyroid gland sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLS-138
AC CVCL_5726
DR CLS; 400177/p570_CLS-138
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC Breed/subspecies: NMRI.
DI NCIt; C21613; Mouse spindle cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID CLS-145
AC CVCL_5727
DR CLS; 300180/p499_CLS-145
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 17
ST D21S11: 30.2,32.2
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 11
ST D8S1179: 11,14
ST FGA: 22
ST Penta D: 9,10
ST Penta E: 12,13,14
ST TH01: 7
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CLS-354
AC CVCL_5971
SY XF354; XF 354
DR BTO; BTO:0004443
DR CLS; 300152/p786_CLS-354
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,13
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 9,12
ST D7S820: 7,9
ST D8S1179: 12,14
ST FGA: 21,23
ST Penta D: 13
ST Penta E: 10,14
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLS-439
AC CVCL_5982
SY CLS439
DR CLS; 300150/p508_CLS-439
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 10,13
ST D18S51: 14
ST D21S11: 29,31
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 11,13
ST FGA: 20
ST Penta D: 9,12
ST Penta E: 12,16
ST TH01: 7
ST TPOX: 9,10
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLS-54
AC CVCL_5728
DR CLS; 300227/p725_CLS-54
DR GEO; GSM513974
DR GEO; GSM514320
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 11,17,18
ST D21S11: 30,31.2
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 10,11
ST D8S1179: 11
ST FGA: 20
ST Penta D: 9
ST Penta E: 12,15
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CLS-79
AC CVCL_Z543
SY CLS79
DR ATCC; CRL-9373
RX Patent=US5266314;
RX PubMed=10358729;
RX DOI=10.1007/BF02372123;
CC Group: Insect cell line.
CC Discontinued: ATCC; CRL-9373; probable.
OX NCBI_TaxID=7109; ! Spodoptera littoralis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CLS-79-C7
AC CVCL_Z544
RX Patent=US5145775;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2723.
OX NCBI_TaxID=7109; ! Spodoptera littoralis
HI CVCL_Z543 ! CLS-79
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CLS-ACI-1
AC CVCL_5729
SY CLS-ACI-I
DR CLS; 500459/p624_CLS-ACI-1
RX PubMed=26536200;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: ACI.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID CLS-CD3575
AC CVCL_5730
SY CLS-CD-3575
DR CLS; 400146/NA
CC Discontinued: CLS; 400146; true.
DI NCIt; C124802; Mouse kidney carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CLS1
AC CVCL_C740
SY AAUe001-A
DR hPSCreg; AAUe001-A
DR ISCR; 1963
RX PubMed=16454946;
RX PubMed=20177991;
CC From: Aalborg University; Aalborg; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CLS2
AC CVCL_C741
SY AAUe002-A
DR hPSCreg; AAUe002-A
DR ISCR; 1964
RX PubMed=16454946;
RX PubMed=20177991;
CC From: Aalborg University; Aalborg; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CLS3
AC CVCL_C742
SY AAUe003-A
DR hPSCreg; AAUe003-A
DR ISCR; 1965
RX PubMed=16454946;
RX PubMed=20177991;
CC From: Aalborg University; Aalborg; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID CLS4
AC CVCL_C743
SY AAUe004-A
DR hPSCreg; AAUe004-A
DR ISCR; 1966
RX PubMed=16454946;
RX PubMed=20177991;
CC From: Aalborg University; Aalborg; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID CLT 15
AC CVCL_J676
SY CLT15
DR ATCC; HB-8250
RX Patent=US4579827;
CC Discontinued: ATCC; HB-8250; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 152
AC CVCL_J677
SY CLT152; SKI 294/CLT 152; SKI294/CLT152
DR CLO; CLO_0002513
DR ATCC; HB-8244
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 174
AC CVCL_J678
SY CLT174; T 174
DR ATCC; HB-8242
RX Patent=US4579827;
RX Patent=US5168043;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 218
AC CVCL_J679
SY CLT218; T 218
DR ATCC; HB-8249
RX Patent=US4579827;
RX Patent=US5168043;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 307
AC CVCL_J680
SY CLT307
DR ATCC; HB-8251
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 479
AC CVCL_J681
SY CLT479
DR ATCC; HB-8241
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 85
AC CVCL_J682
SY CLT85; SKI 294/CLT 85; SKI294/CLT85
DR CLO; CLO_0002514
DR ATCC; HB-8240
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLT 86
AC CVCL_J683
SY CLT86
DR ATCC; HB-8252
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CLVIII-3A6-E3
AC CVCL_U030
DR ECACC; 08041720
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CLXXVI-3C11-F14
AC CVCL_U048
SY V-1; V1
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania venezuelensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID CLY
AC CVCL_IQ58
RX PubMed=17342324;
CC Doubling time: ~29.5 hours (PubMed=17342324).
CC Derived from metastatic site: Liver.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CM
AC CVCL_H246
DR Cosmic; 1620108
DR Cosmic; 2530676
RX CelloPub=CLPUB00031;
RX PubMed=10194529;
RX PubMed=17492774;
RX PubMed=18384119;
RX PubMed=22538498;
CC Derived from metastatic site: Ascites.
DI NCIt; C95598; Pancreatic insulinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CM-1
AC CVCL_Y613
SY CM1; CM 1
RX PubMed=20038950;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-10
AC CVCL_Y614
SY CM10; CM 10
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-11
AC CVCL_Y615
SY CM11; CM 11
RX PubMed=20038950;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-12
AC CVCL_Y616
SY CM12; CM 12
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-13
AC CVCL_Y617
SY CM13; CM 13
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-14
AC CVCL_Y618
SY CM14; CM 14
RX PubMed=20038950;
RX PubMed=21861759;
RX PubMed=23954875;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-16
AC CVCL_Y619
SY CM16; CM 16
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-2 [Human ESC]
AC CVCL_C716
SY CM2; CM 2
RX PubMed=20038950;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
WW http://grants.nih.gov/stem_cells/registry/not_approved.htm
CC From: Children's Memorial Hospital; Chicago; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-2 [Human leukemia]
AC CVCL_N718
RX PubMed=7613515;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CM-3 [Human ESC]
AC CVCL_Y620
SY CM3; CM 3
RX PubMed=21861759;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-3 [Human leukemia]
AC CVCL_N719
RX PubMed=7613515;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N718 ! CM-2 [Human leukemia]
SX Male
CA Cancer cell line
//
ID CM-319
AC CVCL_M022
SY CM319
RX PubMed=12839683;
RX PubMed=21253487;
CC Characteristics: Potentially comes from a dedifferentiated or atypical chordoma (PubMed=21253487).
CC Doubling time: ~33 hours (PubMed=12839683).
ST Source(s): PubMed=21253487
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C2947; Chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CM-4 [Human ESC]
AC CVCL_Y621
SY CM4; CM 4
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-4 [Human leukemia]
AC CVCL_N720
RX PubMed=7613515;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N718 ! CM-2 [Human leukemia]
SX Male
CA Cancer cell line
//
ID CM-5 [Human ESC]
AC CVCL_Y622
SY CM5; CM 5
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-5 [Human leukemia]
AC CVCL_N721
RX PubMed=7613515;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N718 ! CM-2 [Human leukemia]
SX Male
CA Cancer cell line
//
ID CM-6
AC CVCL_C717
SY CM6; CM 6
RX PubMed=20038950;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
WW http://grants.nih.gov/stem_cells/registry/not_approved.htm
CC From: Children's Memorial Hospital; Chicago; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-7
AC CVCL_C718
SY CM7; CM 7
RX PubMed=20038950;
RX PubMed=21861759;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
WW http://grants.nih.gov/stem_cells/registry/not_approved.htm
CC From: Children's Memorial Hospital; Chicago; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-8
AC CVCL_Y623
SY CM8; CM 8
RX PubMed=20038950;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-9
AC CVCL_Y624
SY CM9; CM 9
RX PubMed=23954875;
WW https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC From: Children's Memorial Hospital; Chicago; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID CM-S
AC CVCL_F327
RX PubMed=2543775;
RX PubMed=2993032;
RX PubMed=3465677;
RX PubMed=3971383;
RX PubMed=6707103;
RX PubMed=7105012;
DI NCIt; C61236; Congenital pure red cell aplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CM-SM
AC CVCL_DE05
RX PubMed=6688425;
DI NCIt; C61236; Congenital pure red cell aplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F327 ! CM-S
SX Male
CA Cancer cell line
//
ID CM-S/Tum
AC CVCL_3367
DR CLDB; cl7205
DR ICLC; HTL08001
DI NCIt; C61236; Congenital pure red cell aplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F327 ! CM-S
SX Male
CA Cancer cell line
//
ID CM-S/un
AC CVCL_3366
DR CLDB; cl7179
DR ICLC; HTL06005
DI NCIt; C61236; Congenital pure red cell aplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F327 ! CM-S
SX Male
CA Cancer cell line
//
ID CM0007
AC CVCL_8U03
DR ECACC; 94050303
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CM0035
AC CVCL_8U04
DR ECACC; 95102502
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CM0036
AC CVCL_8U05
DR ECACC; 95111406
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34415; Beckwith-Wiedemann syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID CM1-1
AC CVCL_2Z40
SY CM1-1.2; WC00009
DR CLO; CLO_0013437
DR BioSamples; SAME17777
DR Coriell; WC00009
RX PubMed=9712021;
CC Discontinued: Coriell; WC00009; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID CM2005.1
AC CVCL_M592
RX PubMed=17947278;
DI NCIt; C4550; Conjunctival melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CM3.B6
AC CVCL_2404
DR ECACC; 11060101
RX PubMed=7518528;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 9,11
ST vWA: 14,16
DI NCIt; C3098; Hepatitis C infection
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2301 ! B12.F8
CA Transformed cell line
//
ID CM7/1
AC CVCL_D045
SY CM7-1; Clone CM 7/1
DR EFO; EFO_0002820
RX PubMed=14578102;
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6412 ! J1
SX Male
CA Embryonic stem cell
//
ID CMA-01
AC CVCL_M484
DR GEO; GSM143348
DR GEO; GSM290286
RX PubMed=16266902;
RX PubMed=17171682;
RX PubMed=18700954;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CMA-02
AC CVCL_M485
DR GEO; GSM143342
DR GEO; GSM290287
RX PubMed=16266902;
RX PubMed=17171682;
RX PubMed=18700954;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CMA-03
AC CVCL_M486
SY CMA03
DR EFO; EFO_0006552
DR Cosmic; 2391808
DR GEO; GSM143344
DR GEO; GSM290288
DR GEO; GSM977751
DR GEO; GSM977752
DR GEO; GSM977753
DR GEO; GSM977754
DR GEO; GSM977755
DR GEO; GSM977756
RX PubMed=16266902;
RX PubMed=17171682;
RX PubMed=18700954;
RX PubMed=19306352;
RX PubMed=24327544;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CMA-03/06
AC CVCL_2G61
SY CMA-03_06; CMA03/06
DR EFO; EFO_0006553
DR Cosmic; 2391809
DR GEO; GSM977757
DR GEO; GSM977758
DR GEO; GSM977759
RX PubMed=24327544;
CC Doubling time: ~80 hours (PubMed=24327544).
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M486 ! CMA-03
SX Male
CA Cancer cell line
//
ID CmA40
AC CVCL_L096
DR ATCC; PTA-11304
RX Patent=US8232048;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CMBS-BS
AC CVCL_S716
DR SKY/M-FISH/CGH; 2750
RX PubMed=15721631;
DI NCIt; C4265; Pancreatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CMCSCC-1
AC CVCL_0I25
RX PubMed=25784373;
CC Doubling time: 24 hours (PubMed=25784373).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CMD004AN
AC CVCL_G710
DR IMGT/HLA; 10424
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CMDCl12
AC CVCL_6B25
RX PubMed=22040608;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C84910; Muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID CME L1
AC CVCL_Z786
SY CME-L1; L1
DR EFO; EFO_0005650
DR DGRC; 156
DR ENCODE; ENCBS089KAQ
DR GEO; GSE16270
RX CelloPub=CLPUB00204;
RX PubMed=1905427;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
WW http://flybase.org/reports/FBtc0000156.html
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME L1A
AC CVCL_Z787
SY CME-L1A
DR DGRC; 158
WW http://flybase.org/reports/FBtc0000158.html
CC Group: Insect cell line.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z786 ! CME L1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME L2
AC CVCL_Z788
SY CME-L2
DR DGRC; 157
RX CelloPub=CLPUB00204;
RX PubMed=1905427;
CC Group: Insect cell line.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME W1
AC CVCL_Z789
SY CME-W1
DR DGRC; 180
RX CelloPub=CLPUB00204;
RX DOI=10.1007/BF00399059;
RX PubMed=1905427;
CC Group: Insect cell line.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME W1 cl.8+
AC CVCL_Z790
SY CME-W1-Cl.8+; CME W1 clone 8; CME Cl.8+; Cl8+
DR EFO; EFO_0005743
DR DGRC; 151
DR ENCODE; ENCBS075HTX
DR ENCODE; ENCBS115NHU
DR ENCODE; ENCBS172BFS
DR ENCODE; ENCBS244JXW
DR ENCODE; ENCBS337HVD
DR ENCODE; ENCBS371JYE
DR ENCODE; ENCBS378YVD
DR ENCODE; ENCBS554CPV
DR ENCODE; ENCBS648NZI
DR ENCODE; ENCBS668VWE
DR ENCODE; ENCBS674BMY
DR ENCODE; ENCBS945PPB
DR GEO; GSE28136
RX DOI=10.1007/BF00399059;
RX PubMed=9467932;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
WW http://www.entu.cas.cz/zurovec/eng/research/cultures.html
CC Group: Insect cell line.
CC Part of: modENCODE project cell lines.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z789 ! CME W1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME W1 Cl.8R
AC CVCL_Z892
SY CME-W1-Cl.8R
DR DGRC; 162
CC Group: Insect cell line.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z790 ! CME W1 cl.8+
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME W2
AC CVCL_Z791
SY CME-W2; W2
DR EFO; EFO_0005744
DR DGRC; 155
DR ENCODE; ENCBS996YBY
DR GEO; GSE37440
RX CelloPub=CLPUB00204;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CME-1
AC CVCL_N586
SY CME
DR Cosmic; 2307727
RX PubMed=7736791;
RX PubMed=24726063;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CMeC-1
AC CVCL_L326
SY CMeC1
RX PubMed=15585963;
CC Breed/subspecies: Chow.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CMeC-2
AC CVCL_L327
SY CMeC2
RX PubMed=15585963;
CC Breed/subspecies: Chow.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L326 ! CMeC-1
SX Male
CA Cancer cell line
//
ID CMEC-UCONN
AC CVCL_HL94
SY CMEC; Caprine Mammary Epithelial Cells - University of CONNecticut
RX PubMed=10451220;
RX PubMed=10691038;
CC Doubling time: 28 hours (PubMed=10691038).
CC Breed/subspecies: Anglo-Nubian.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Spontaneously immortalized cell line
//
ID CMEE-1
AC CVCL_D791
SY Chinchilla Middle Ear Epithelial cell line-1
RX PubMed=10526847;
RX PubMed=12382283;
CC Transformant: Ad12-SV40.
OX NCBI_TaxID=10152; ! Chinchilla chinchilla
CA Transformed cell line
//
ID CMel 136
AC CVCL_U910
RX PubMed=3485457;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CMES20
AC CVCL_B948
SY CMESC 20; Common Marmoset Embryonic Stem cell 20
RX PubMed=16109758;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID CMES30
AC CVCL_B947
SY CMESC 30; Common Marmoset Embryonic Stem cell 30
RX PubMed=16109758;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Female
CA Embryonic stem cell
//
ID CMES40
AC CVCL_B946
SY CMESC 40; Common Marmoset Embryonic Stem cell 40
DR RCB; AES0053
DR RCB; AES0166
DR RCB; RCB2294
RX PubMed=16109758;
CC Group: Non-human primate cell line.
CC Caution: Indicated as male in RCB and as female in PubMed=16109758.
CC Discontinued: RCB; AES0053; probable.
CC Discontinued: RCB; RCB2294; true.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Embryonic stem cell
//
ID CMGD-2
AC CVCL_0D66
SY CMGD2
RX PubMed=12944992;
WW http://www.modianolab.org/resources/resources_reagents.shtml
WW https://www.kerafast.com/product/2259/canine-melanoma-cell-line-cmgd-2
CC Doubling time: ~24-48 hours (Kerafast).
CC Breed/subspecies: Mixed breed.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CMGD-3
AC CVCL_0D67
SY CMG3
RX PubMed=12944992;
WW http://www.modianolab.org/resources/resources_reagents.shtml
CC Breed/subspecies: Mixed breed.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMGD-4
AC CVCL_0D68
SY CMGD4
RX PubMed=12944992;
WW http://www.modianolab.org/resources/resources_reagents.shtml
CC Breed/subspecies: Mixed breed.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CMGD-5
AC CVCL_0D69
SY CMGD5
RX PubMed=12944992;
WW http://www.modianolab.org/resources/resources_reagents.shtml
WW https://www.kerafast.com/product/2260/canine-melanoma-cell-line-cmgd-5
CC Doubling time: 24-48 hours (Kerafast).
CC Breed/subspecies: Miniature Poodle.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CMH1a
AC CVCL_3501
DR CLO; CLO_0002525
DR ATCC; CRL-8399
CC Breed/subspecies: RIII.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3882 ! C127I
SX Female
CA Cancer cell line
//
ID CMI00339IN
AC CVCL_E161
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=36225; ! Cercopithecus mitis
SX Sex undetermined
CA Transformed cell line
//
ID CMK
AC CVCL_0216
DR BTO; BTO:0000978
DR CLO; CLO_0002526
DR EFO; EFO_0003037
DR MCCL; MCC:0000105
DR BioSample; SAMN03473574
DR CCLE; CMK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308149
DR ChEMBL-Targets; CHEMBL2366177
DR Cosmic; 787423
DR Cosmic; 910566
DR Cosmic; 919131
DR Cosmic; 975241
DR Cosmic; 1012061
DR Cosmic; 1070695
DR Cosmic; 1176598
DR Cosmic; 1191081
DR Cosmic; 1191702
DR Cosmic; 1281307
DR Cosmic; 1286955
DR Cosmic; 1315742
DR Cosmic; 1524829
DR Cosmic; 1559970
DR Cosmic; 2089668
DR Cosmic; 2131535
DR Cosmic; 2306202
DR Cosmic-CLP; 910566
DR DSMZ; ACC-392
DR ENCODE; ENCBS071ENC
DR GDSC; 910566
DR GEO; GSM236781
DR GEO; GSM236817
DR GEO; GSM510583
DR GEO; GSM886938
DR GEO; GSM888005
DR GEO; GSM1374449
DR TOKU-E; 4113
RX PubMed=2217443;
RX PubMed=2527057;
RX PubMed=2665839;
RX PubMed=9738977;
RX PubMed=10674912;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23325432;
RX PubMed=23955599;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/CMK_Stam_protocol.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CMK-11-5
AC CVCL_0217
SY CMK 11-5; CMK11-5; CMK115
DR MCCL; MCC:0000106
DR CCLE; CMK115_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR GEO; GSM886937
DR GEO; GSM888003
DR IFO; IFO50430
RX PubMed=1391807;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0216 ! CMK
SX Male
CA Cancer cell line
//
ID CMK-86
AC CVCL_2804
SY CMK86
DR BTO; BTO:0004960
DR CCLE; CMK86_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 2089670
DR GEO; GSM888004
DR IFO; IFO50428
RX PubMed=22460905;
RX PubMed=23955599;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0216 ! CMK
SX Male
CA Cancer cell line
//
ID CMK5
AC CVCL_2U82
RX PubMed=11668604;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Embryonic stem cell
//
ID CMK6
AC CVCL_2U83
SY CMK-6
RX PubMed=11668604;
RX PubMed=16728281;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Embryonic stem cell
//
ID CMK7
AC CVCL_2U84
RX PubMed=11668604;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Female
CA Embryonic stem cell
//
ID CMK9
AC CVCL_2U85
RX PubMed=11668604;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Female
CA Embryonic stem cell
//
ID CML-1
AC CVCL_0D19
SY CML1
RX PubMed=3434911;
RX PubMed=15965647;
RX PubMed=22901430;
RX PubMed=23410087;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CML-10
AC CVCL_0D24
SY CML-6M; CML_6M; CML6M
DR GEO; GSM1974782
RX PubMed=3434911;
RX PubMed=8239507;
RX PubMed=15965647;
RX PubMed=21908323;
RX PubMed=22901430;
RX PubMed=23410087;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CML-10C2
AC CVCL_0D25
SY CML-10c2; CML_10C2; CML10C2; CML-6MC2; CML-6M-C2
DR GEO; GSM1974781
RX PubMed=8239507;
RX PubMed=11467477;
RX PubMed=21908323;
RX PubMed=22901430;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0D24 ! CML-10
CA Cancer cell line
//
ID CML-13
AC CVCL_0D22
RX PubMed=3434911;
RX PubMed=11467477;
RX PubMed=12944992;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CML-2
AC CVCL_0D23
SY CML2
RX PubMed=3434911;
RX PubMed=11467477;
RX PubMed=12944992;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CML-C-1
AC CVCL_X930
RX PubMed=7540608;
CC Characteristics: Dependent on mouse bone marrow stromal cells for growth.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CML-T1
AC CVCL_1126
SY CML T1; CMLT1; CMLT-1
DR CLO; CLO_0002527
DR EFO; EFO_0002134
DR CLDB; cl815
DR BioSample; SAMN03473449
DR CCLE; CMLT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 910951
DR Cosmic; 913424
DR Cosmic; 1012062
DR Cosmic; 1026574
DR Cosmic; 1151775
DR Cosmic-CLP; 910951
DR DSMZ; ACC-7
DR GDSC; 910951
DR GEO; GSM886939
DR GEO; GSM888006
DR GEO; GSM1669682
DR IGRhCellID; CMLT1
RX PubMed=2788468;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48-60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,13 (Cosmic-CLP)
ST D13S317: 10,13,14 (DSMZ)
ST D16S539: 10,11 (Cosmic-CLP)
ST D16S539: 10,11,12 (DSMZ)
ST D5S818: 9,11
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,20
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CMM1
AC CVCL_0C75
RX PubMed=11217070;
CC Breed/subspecies: Toy Poodle.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CMM2
AC CVCL_0C76
RX PubMed=11217070;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CMMT
AC CVCL_3456
DR CLO; CLO_0002528
DR ATCC; CRL-6299
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Cancer cell line
//
ID CMMT 110/C1
AC CVCL_U241
DR ATCC; CRL-6300
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6300; true.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Cancer cell line
//
ID CMMT-CD4-LTR-beta-Gal
AC CVCL_1H34
SY Simian MAGI; sMAGI
DR NIH-ARP; 2955-158
RX PubMed=7491763;
CC Group: Non-human primate cell line.
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
OX NCBI_TaxID=9544; ! Macaca mulatta
HI CVCL_3456 ! CMMT
SX Female
CA Cancer cell line
//
ID CMP
AC CVCL_D297
DR BioSample; SAMN03151674
RX PubMed=1246601;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a rectal adenocarcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID CMPII C2
AC CVCL_L115
DR BioSample; SAMN03151675
RX PubMed=1246601;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID CMS
AC CVCL_H248
DR Cosmic; 996322
DR Cosmic; 1037674
DR Cosmic; 2089660
RX PubMed=10674912;
RX PubMed=23955599;
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CMS-5
AC CVCL_H247
SY CMS 5; CMS5
RX PubMed=197192;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID CMS-C
AC CVCL_L328
RX PubMed=21519159;
CC Breed/subspecies: Mixed breed.
DI NCIt; C129300; Canine rhabdomyosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CMT-U111
AC CVCL_L331
SY Cell line 111
RX PubMed=1375928;
CC Breed/subspecies: Poodle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U131
AC CVCL_L332
SY Cell line 131
RX PubMed=1375928;
CC Breed/subspecies: German Shepherd.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U155
AC CVCL_L333
SY Cell line 155
RX PubMed=1375928;
CC Breed/subspecies: Borzoi.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U229
AC CVCL_L334
SY Cell line 229
RX PubMed=1375928;
CC Breed/subspecies: German Shepherd.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U27
AC CVCL_L335
SY Cell line 27
DR GEO; GSM724825
DR GEO; GSM724826
DR GEO; GSM724833
DR GEO; GSM724834
DR GEO; GSM1075089
DR GEO; GSM1075093
DR GEO; GSM1075097
DR GEO; GSM1290250
DR GEO; GSM1290251
DR GEO; GSM1889009
DR GEO; GSM1889010
RX PubMed=1375928;
RX PubMed=19609018;
RX PubMed=20453304;
RX PubMed=22235976;
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Poodle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U304
AC CVCL_J400
RX PubMed=10965996;
CC Breed/subspecies: Jamthund.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_J403 ! CMT-U335
SX Female
CA Cancer cell line
//
ID CMT-U309
AC CVCL_J401
SY CMTU309
DR GEO; GSM724831
DR GEO; GSM724832
DR GEO; GSM724839
DR GEO; GSM724840
DR GEO; GSM1075088
DR GEO; GSM1075092
DR GEO; GSM1075098
DR GEO; GSM1290252
DR GEO; GSM1290253
RX PubMed=10965996;
RX PubMed=19609018;
RX PubMed=20453304;
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Newfoundland.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U334
AC CVCL_J402
RX PubMed=10965996;
CC Breed/subspecies: Cocker Spaniel.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT-U335
AC CVCL_J403
SY CMTU335
RX PubMed=10965996;
CC Breed/subspecies: Jamthund.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_J400 ! CMT-U304
SX Female
CA Cancer cell line
//
ID CMT-W1
AC CVCL_L336
DR GEO; GSM724835
DR GEO; GSM724836
DR GEO; GSM724843
DR GEO; GSM724844
DR GEO; GSM1075091
DR GEO; GSM1075095
DR GEO; GSM1075100
RX PubMed=20145299;
RX PubMed=20453304;
RX PubMed=24116159;
CC Omics: Transcriptome analysis.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L337 ! CMT-W1M
SX Female
CA Cancer cell line
//
ID CMT-W1M
AC CVCL_L337
RX PubMed=20145299;
RX PubMed=24116159;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lung.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L336 ! CMT-W1
SX Female
CA Cancer cell line
//
ID CMT-W2
AC CVCL_L338
DR GEO; GSM724829
DR GEO; GSM724830
DR GEO; GSM724837
DR GEO; GSM724838
DR GEO; GSM1075101
DR GEO; GSM1075102
DR GEO; GSM1075103
RX PubMed=20145299;
RX PubMed=20453304;
RX PubMed=24116159;
CC Omics: Transcriptome analysis.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L339 ! CMT-W2M
SX Female
CA Cancer cell line
//
ID CMT-W2M
AC CVCL_L339
RX PubMed=20145299;
RX PubMed=24116159;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lung.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L338 ! CMT-W2
SX Female
CA Cancer cell line
//
ID CMT1
AC CVCL_X218
SY CMT-1
RX PubMed=3462415;
CC Breed/subspecies: Poodle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT12
AC CVCL_L329
SY CMT-12; Canine Mammary Tumor 12
DR GEO; GSM1974783
RX PubMed=19130492;
RX PubMed=21801068;
RX PubMed=21908323;
RX PubMed=23238983;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT167
AC CVCL_2405
SY CMT-167; CMT 167
DR BTO; BTO:0005821
DR ECACC; 10032302
DR Ximbio; 151448
RX PubMed=6324836;
RX PubMed=9347924;
RX PubMed=19003861;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: C57BL/ICRF-a(t).
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2406 ! CMT64
SX Female
CA Cancer cell line
//
ID CMT170
AC CVCL_B492
SY CMT-170; CMT 170
RX PubMed=6324836;
RX PubMed=9347924;
RX PubMed=19003861;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: C57BL/ICRF-a(t).
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2405 ! CMT167
SX Female
CA Cancer cell line
//
ID CMT175
AC CVCL_B493
SY CMT-175; CMT 175
RX PubMed=6324836;
RX PubMed=9347924;
CC Breed/subspecies: C57BL/ICRF-a(t).
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B492 ! CMT170
SX Female
CA Cancer cell line
//
ID CMT181
AC CVCL_B494
SY CMT-181; CMT 181
RX PubMed=6324836;
RX PubMed=9347924;
CC Breed/subspecies: C57BL/ICRF-a(t).
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B493 ! CMT175
SX Female
CA Cancer cell line
//
ID CMT2
AC CVCL_X219
SY CMT-2; Canine Mammary Tumor 2
RX PubMed=3462415;
CC Breed/subspecies: Poodle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT25
AC CVCL_L330
SY CMT-25; Canine Mammary Tumor 25
RX PubMed=21801068;
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT27
AC CVCL_1R41
SY CMT-27; Canine Mammary Tumor 27
DR GEO; GSM1974784
RX PubMed=19130492;
RX PubMed=21908323;
RX PubMed=23238983;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT28
AC CVCL_1R42
SY Canine Mammary Tumor 28
RX PubMed=19130492;
RX PubMed=23238983;
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT3
AC CVCL_U520
SY CMT-3; Canine Mammary Tumor 3
RX PubMed=3462415;
CC Breed/subspecies: Doberman Pinscher.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT4
AC CVCL_U521
SY CMT-4; Canine Mammary Tumor 4
RX PubMed=3462415;
CC Breed/subspecies: German Shepherd.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT5
AC CVCL_X220
SY CMT-5; Canine Mammary Tumor 5
RX PubMed=3462415;
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT6
AC CVCL_X221
SY CMT-6; Canine Mammary Tumor 6
RX PubMed=3462415;
CC Breed/subspecies: Poodle.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT64
AC CVCL_2406
SY CMT-64; CMT.64; CMT 64; C57 Mouse Tumor 64
DR ECACC; 10032301
DR Ximbio; 151447
RX PubMed=1253168;
RX PubMed=9347924;
RX PubMed=19003861;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: C57BL/ICRF-a(t).
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID CMT64/61
AC CVCL_4146
DR CLO; CLO_0002531
DR CLDB; cl819
DR ECACC; 86082105
DR Ximbio; 152751
CC Breed/subspecies: C57BL/ICRF-a(t).
DI NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2406 ! CMT64
SX Female
CA Cancer cell line
//
ID CMT9
AC CVCL_U522
SY CMT-9; Canine Mammary Tumor 9
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID CMT93
AC CVCL_1986
SY CMT-93; CMT 93; C57 Mouse Tumor 93
DR BTO; BTO:0003864
DR CLO; CLO_0002530
DR CLO; CLO_0002532
DR CLDB; cl817
DR CLDB; cl818
DR ATCC; CCL-223
DR ECACC; 89111413
DR IZSLER; BS TCL 14
DR KCLB; 10223
DR Ximbio; 152752
RX PubMed=722371;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-434.html
CC Breed/subspecies: C57BL/ICRF.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID CMT93/69
AC CVCL_4147
DR BTO; BTO:0001361
DR CLO; CLO_0002533
DR CLDB; cl820
DR ECACC; 86082106
DR Ximbio; 152753
CC Breed/subspecies: C57BL/ICRF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1986 ! CMT93
SX Male
CA Cancer cell line
//
ID CMT93tk
AC CVCL_S837
SY CMT93-tk
RX PubMed=9813657;
CC Transfected with: UniProtKB; Q9QNF7; HHV-1 TK.
CC Breed/subspecies: C57BL/ICRF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1986 ! CMT93
SX Male
CA Cancer cell line
//
ID CMTI-1
AC CVCL_GS41
SY CMTI1; EmbryoMax 129/SVEV
DR Millipore; CMTI-1
CC Breed/subspecies: 129S6/SvEvTac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID CMY
AC CVCL_A602
DR Cosmic; 787424
DR Cosmic; 975242
DR Cosmic; 996323
DR Cosmic; 1012063
DR Cosmic; 1037675
DR Cosmic; 1191082
DR Cosmic; 1281308
DR Cosmic; 2089669
RX PubMed=9852262;
RX PubMed=10674912;
RX PubMed=16408098;
RX PubMed=23955599;
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CN-Mel
AC CVCL_7037
SY CNMel
DR Cosmic; 1109804
DR Cosmic; 1295332
DR GEO; GSM276749
RX PubMed=11121133;
RX PubMed=18384130;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CN1.4
AC CVCL_B396
DR BTO; BTO:0002514
RX PubMed=9819136;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CN96
AC CVCL_5937
DR CLO; CLO_0002536
DR CLDB; cl821
CC From: Galliera Genetic Bank; E.O. Ospedali Galliera; Genova; Italy.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID CNDT2
AC CVCL_L293
DR BioSample; SAMN03152007
RX PubMed=17699847;
RX PubMed=20959409;
RX PubMed=22538498;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Possibly misidentified; not certain if this a midgut carcinoid cell line (PubMed=20959409).
DI NCIt; C6422; Midgut carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CNDT2.5
AC CVCL_L294
RX PubMed=17699847;
RX PubMed=20959409;
CC Problematic cell line: Possibly misidentified; not certain if this a midgut carcinoid cell line (PubMed=20959409).
DI NCIt; C6422; Midgut carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L293 ! CNDT2
SX Female
CA Cancer cell line
//
ID CNE-1
AC CVCL_6888
AS CVCL_6887
SY CNE1; CNE
DR ChEMBL-Cells; CHEMBL3308055
DR ChEMBL-Targets; CHEMBL613824
DR Cosmic; 755504
DR Cosmic; 923773
DR Cosmic; 944909
DR Cosmic; 1193457
DR Cosmic; 1322946
DR Cosmic; 2366879
DR GEO; GSM375845
DR TOKU-E; 3588
RX PubMed=206962;
RX PubMed=1813165;
RX PubMed=7129938;
RX PubMed=12645650;
RX PubMed=18196576;
RX PubMed=24991015;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Probably contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-2 and seems to be a hybrid of Hela and of cell line of unknow origin. This is also confirmed by RNASeq data from PubMed=24991015. Was originally thought to originate from a nasopharyngeal carcinoma from a female patient.
CC Omics: Deep RNAseq analysis.
ST Source(s): PubMed=18196576
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12,13.3
ST D16S539: 9,10
ST D18S51: 13,16
ST D19S433: 13
ST D21S11: 27,30
ST D2S1338: 17,23
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,16
ST FGA: 18,21
ST TH01: 6,7,9
ST TPOX: 8,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
CA Hybrid cell line
//
ID CNE-2
AC CVCL_6889
SY CNE2
DR BTO; BTO:0005250
DR CCRID; 3131C0001000700013
DR CCRID; 3153C0001000000016
DR Cosmic; 755505
DR Cosmic; 923774
DR Cosmic; 944910
DR Cosmic; 1017619
DR Cosmic; 1300999
DR Cosmic; 1322947
DR Cosmic; 2366880
DR GEO; GSM375846
RX CelloPub=CLPUB00143;
RX PubMed=6852976;
RX PubMed=18196576;
RX PubMed=24991015;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Probably contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-1 and seems to be a hybrid of Hela and of cell line of unknow origin. Was originally thought to originate from a nasopharyngeal carcinoma from a male patient.
CC Omics: Deep RNAseq analysis.
ST Source(s): PubMed=18196576
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12,13.3
ST D16S539: 9,10
ST D18S51: 13,16
ST D19S433: 13
ST D21S11: 27,30
ST D2S1338: 17,23
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,17
ST FGA: 18,21
ST TH01: 6,7,9
ST TPOX: 8,9,12
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
CA Hybrid cell line
//
ID CNE-2Z
AC CVCL_6890
SY CNE-2z; CNE2Z
DR CCRID; 3111C0001CCC000151
RX PubMed=1813165;
CC Problematic cell line: Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of Hela and of cell line of unknow origin.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6889 ! CNE-2
CA Hybrid cell line
//
ID CNE-3
AC CVCL_M598
RX PubMed=1400565;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CNh
AC CVCL_9W60
SY CNH
RX Patent=US8337829;
RX PubMed=10203336;
RX PubMed=22203612;
CC Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.
CC Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID CNLBC1
AC CVCL_V650
DR Cosmic; 1465953
RX PubMed=14999297;
DI NCIt; C3179; Chronic neutrophilic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2121 ! MOLM-20
SX Female
CA Cancer cell line
//
ID CNLMG-B5537LC
AC CVCL_J117
DR CCRID; 3142C0001000000536
RX Patent=EP0838526A1;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J118 ! CNLMG-B5537SKIN
SX Male
CA Transformed cell line
//
ID CNLMG-B5537SKIN
AC CVCL_J118
DR CCRID; 3142C0001000000537
RX Patent=EP0838526A1;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J117 ! CNLMG-B5537LC
SX Male
CA Finite cell line
//
ID CNLMG-B5538LC
AC CVCL_J119
DR CCRID; 3142C0001000000538
RX Patent=EP0838526A1;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J120 ! CNLMG-B5538SKIN
SX Male
CA Transformed cell line
//
ID CNLMG-B5538SKIN
AC CVCL_J120
DR CCRID; 3142C0001000000539
RX Patent=EP0838526A1;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J119 ! CNLMG-B5538LC
SX Male
CA Finite cell line
//
ID CNMm
AC CVCL_L152
RX PubMed=19754820;
CC Derived from metastatic site: Lymph node.
CC Breed/subspecies: Maltese.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L153 ! CNMp
SX Male
CA Cancer cell line
//
ID CNMp
AC CVCL_L153
RX PubMed=19754820;
CC Breed/subspecies: Maltese.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_L152 ! CNMm
SX Male
CA Cancer cell line
//
ID CNS-1
AC CVCL_5276
RX PubMed=7760095;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=CNS-1
CC Breed/subspecies: Lewis.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID CNS1-hiPSC1
AC CVCL_C004
SY CNS.1.H.iPSC.1
DR RSCB; RSCB0131
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC10
AC CVCL_C005
SY CNS.1.H.iPSC.10; RIi015-A
DR hPSCreg; RIi015-A
DR ISCR; 1323
DR RSCB; RSCB0139
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC2
AC CVCL_C006
SY CNS.1.H.iPSC.2
DR RSCB; RSCB0132
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC4
AC CVCL_C007
SY CNS.1.H.iPSC.4
DR RSCB; RSCB0133
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC5
AC CVCL_C008
SY CNS.1.H.iPSC.5
DR RSCB; RSCB0134
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC6
AC CVCL_C009
SY CNS.1.H.iPSC.6
DR RSCB; RSCB0135
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC7
AC CVCL_C010
SY CNS.1.H.iPSC.7
DR RSCB; RSCB0136
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC8
AC CVCL_C011
SY CNS.1.H.iPSC.8
DR RSCB; RSCB0137
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C012 ! CNS1-hiPSC9
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS1-hiPSC9
AC CVCL_C012
SY CNS.1.H.iPSC.9
DR RSCB; RSCB0138
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C004 ! CNS1-hiPSC1
OI CVCL_C006 ! CNS1-hiPSC2
OI CVCL_C007 ! CNS1-hiPSC4
OI CVCL_C008 ! CNS1-hiPSC5
OI CVCL_C009 ! CNS1-hiPSC6
OI CVCL_C010 ! CNS1-hiPSC7
OI CVCL_C011 ! CNS1-hiPSC8
OI CVCL_C005 ! CNS1-hiPSC10
SX Female
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC1
AC CVCL_C013
SY CNS.2.H.iPSC.1
DR RSCB; RSCB0140
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C019 ! CNS2-hiPSC7
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC2
AC CVCL_C014
SY CNS.2.H.iPSC.2
DR RSCB; RSCB0141
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C019 ! CNS2-hiPSC7
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC3
AC CVCL_C015
SY CNS.2.H.iPSC.3
DR RSCB; RSCB0142
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C019 ! CNS2-hiPSC7
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC4
AC CVCL_C016
SY CNS.2.H.iPSC.4
DR RSCB; RSCB0143
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C019 ! CNS2-hiPSC7
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC5
AC CVCL_C017
SY CNS.2.H.iPSC.5
DR RSCB; RSCB0144
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C019 ! CNS2-hiPSC7
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC6
AC CVCL_C018
SY CNS.2.H.iPSC.6
DR RSCB; RSCB0145
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C019 ! CNS2-hiPSC7
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC7
AC CVCL_C019
SY CNS.2.H.iPSC.7; RIi016-A
DR hPSCreg; RIi016-A
DR ISCR; 1324
DR RSCB; RSCB0146
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C020 ! CNS2-hiPSC8
SX Male
CA Induced pluripotent stem cell
//
ID CNS2-hiPSC8
AC CVCL_C020
SY CNS.2.H.iPSC.8
DR RSCB; RSCB0147
RX PubMed=20821352;
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84656; Crigler-Najjar syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C013 ! CNS2-hiPSC1
OI CVCL_C014 ! CNS2-hiPSC2
OI CVCL_C015 ! CNS2-hiPSC3
OI CVCL_C016 ! CNS2-hiPSC4
OI CVCL_C017 ! CNS2-hiPSC5
OI CVCL_C018 ! CNS2-hiPSC6
OI CVCL_C019 ! CNS2-hiPSC7
SX Male
CA Induced pluripotent stem cell
//
ID CNT
AC CVCL_4677
DR CLO; CLO_0050251
DR RCB; RCB1912
RX PubMed=8022100;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Male
CA Transformed cell line
//
ID CNUH-HNSCC-1
AC CVCL_S890
RX PubMed=22111066;
CC Doubling time: 48 hours (PubMed=22111066).
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CO
AC CVCL_J653
SY COLE; Cole; Co
DR BioSample; SAMN03151618
DR Cosmic; 1086354
DR Cosmic; 1486583
RX PubMed=2602651;
RX PubMed=2690233;
RX PubMed=4018743;
RX PubMed=12581897;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12581897, PubMed=12592342, PubMed=20143388).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID Co-115
AC CVCL_D102
SY CO-115; Co 115; CO115; Co115
DR Cosmic; 711254
DR Cosmic; 887213
DR Cosmic; 1057757
DR Cosmic; 1132574
DR Cosmic; 1303885
DR Cosmic; 1479610
DR Cosmic; 2036658
DR GEO; GSM1448067
DR TOKU-E; 4097
RX PubMed=975046;
RX PubMed=1389533;
RX PubMed=3349466;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=24042735;
RX PubMed=25926053;
RX PubMed=26537799;
CC Doubling time: ~36 hours, at 26th passage (PubMed=975046).
CC Microsatellite instability: Instable (MSI) (PubMed=9000147; PubMed=24042735; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Transcriptome analysis.
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
ST Source(s): PubMed=24042735
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 13,16
ST D16S539: 10,11
ST D18S51: 14,15
ST D19S433: 10,14,15
ST D21S11: 35,35.2
ST D2S1338: 22,25
ST D3S1358: 13,15,16
ST D5S818: 10,11
ST D7S820: 7
ST D8S1179: 11,12
ST FGA: 19,21
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 15,20
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CO-13-7
AC CVCL_5H91
RX PubMed=3456614;
RX PubMed=6165598;
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5H90 ! C6TK-
CA Hybrid cell line
//
ID CO-MZ-1
AC CVCL_W157
RX PubMed=7510115;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CO-MZ-2
AC CVCL_W158
RX PubMed=7510115;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CO-MZ-4
AC CVCL_W159
RX PubMed=7510115;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CO-MZ-5
AC CVCL_F745
RX PubMed=7510115;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CO-MZ-6
AC CVCL_F746
RX PubMed=7510115;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Co108
AC CVCL_D109
DR Cosmic; 1235041
DR Cosmic; 1430352
RX PubMed=16959974;
RX PubMed=17932254;
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CO2
AC CVCL_L340
RX PubMed=10643981;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CO3
AC CVCL_L341
RX PubMed=10643981;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Co403
AC CVCL_6617
SY Co-403
DR BTO; BTO:0002569
RX PubMed=16446362;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID CO5
AC CVCL_L342
RX PubMed=10643981;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID CO7
AC CVCL_L343
RX PubMed=10643981;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Co74
AC CVCL_D110
DR Cosmic; 1235039
DR Cosmic; 1430353
DR Cosmic; 1473132
RX PubMed=16959974;
RX PubMed=17932254;
CC Omics: Transcriptome analysis.
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Co79
AC CVCL_D111
DR Cosmic; 1235050
DR Cosmic; 1473076
RX PubMed=16959974;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CO8
AC CVCL_L344
RX PubMed=10643981;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Co82
AC CVCL_D112
DR Cosmic; 1235051
DR Cosmic; 1430382
RX PubMed=16959974;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Co84
AC CVCL_D113
DR Cosmic; 1235052
DR Cosmic; 1430383
RX PubMed=16959974;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Co88BV59-1
AC CVCL_3666
SY CO 88BV59-1
DR CLO; CLO_0002538
DR ATCC; CRL-10624
DR BioSample; SAMN03471303
RX Patent=US5474755;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Co88BV59H21-2
AC CVCL_3667
DR CLO; CLO_0002539
DR ATCC; CRL-11538
RX Patent=US5474755;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3666 ! Co88BV59-1
CA Hybrid cell line
//
ID Co88BV59H21-2V67-66
AC CVCL_3668
DR CLO; CLO_0002540
DR ATCC; CRL-11539
RX Patent=US5474755;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3667 ! Co88BV59H21-2
CA Hybrid cell line
//
ID Co92
AC CVCL_D114
DR Cosmic; 1235040
DR Cosmic; 1430354
DR Cosmic; 1473015
RX PubMed=16959974;
RX PubMed=17932254;
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Co94
AC CVCL_D115
DR Cosmic; 1235053
RX PubMed=16959974;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CO95
AC CVCL_9T89
SY Co95
RX PubMed=9515795;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID CoC1
AC CVCL_6891
SY COC1
DR CCRID; 3111C0001CCC000368
DR CCRID; 3142C0001000000003
RX PubMed=9275551;
RX PubMed=23464471;
RX PubMed=25502083;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: Transcriptome analysis.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID CoC1/DDP
AC CVCL_6892
SY COC1/DDP
DR CCRID; 3111C0001CCC000369
DR CCRID; 3142C0001000000057
RX PubMed=9275551;
RX PubMed=23464471;
RX PubMed=25502083;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: Transcriptome analysis.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6891 ! CoC1
SX Female
CA Cancer cell line
//
ID COCA
AC CVCL_G362
DR ECACC; 10112001
RX PubMed=21510892;
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID Cocca-6A
AC CVCL_V013
SY Cocca 6A
RX CelloPub=CLPUB00247;
RX PubMed=22666387;
CC Doubling time: ~27 hours (PubMed=22666387).
CC Anecdotal: Cell line name is derived from the cat name 'Cocca'.
CC Breed/subspecies: Domestic Calico.
OX NCBI_TaxID=9685; ! Felis catus
SX Female
CA Cancer cell line
//
ID CoCM-1
AC CVCL_1127
SY CoCM1; COCM1
DR BioSample; SAMN03470823
DR ChEMBL-Cells; CHEMBL3308133
DR Cosmic; 910783
DR Cosmic; 1479618
DR Cosmic; 2301966
DR GEO; GSM827287
DR GEO; GSM1346832
DR GEO; GSM1448167
DR JCRB; JCRB0257
RX PubMed=2570482;
RX PubMed=9290701;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 12,13
ST D18S51: 14
ST D21S11: 29,31
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9
ST Penta E: 18,20
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CODI
AC CVCL_E530
SY 5192
DR dbMHC; 48729
DR ECACC; 94071404
DR IHW; IHW9272
DR IMGT/HLA; 10427
WW http://bioinformatics.hsanmartino.it/ecbr/cl272.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94071404; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID CoE 115
AC CVCL_R888
SY Coho Embryo 115
RX DOI=10.1577/1548-8667(1994)006<0260:sofnsc>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8019; ! Oncorhynchus kisutch
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CoE 345
AC CVCL_R889
SY Coho Embryo 345
RX DOI=10.1577/1548-8667(1994)006<0260:sofnsc>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8019; ! Oncorhynchus kisutch
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CoE 45
AC CVCL_R890
SY Coho Embryo 45
RX DOI=10.1577/1548-8667(1994)006<0260:sofnsc>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8019; ! Oncorhynchus kisutch
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID COG-E-352
AC CVCL_M153
SY CHLA-352; CHLA352
DR Cosmic; 2228219
DR GEO; GSM1676350
DR GEO; GSM1701627
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/COG-E-352_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=24312454
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9
ST D18S51: 12,14
ST D19S433: 14,14.2
ST D21S11: 29,30
ST D2S1338: 19,24
ST D3S1358: 17,18
ST D5S818: 10,13
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 19,21
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18,20
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-LL-317
AC CVCL_M159
RX PubMed=19298590;
RX PubMed=20922763;
WW http://www.cogcell.org/cellreqs-leuk.php
WW http://www.cogcell.org/suppdata/dl/3karyotypes_2007-02-09.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 30-40 hours (COG).
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 9,11
ST D18S51: 14,18
ST D19S433: 14,16
ST D21S11: 30
ST D2S1338: 17,18
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 11,13
ST D8S1179: 15
ST FGA: 20,23
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M160 ! COG-LL-317h
SX Male
CA Cancer cell line
//
ID COG-LL-317h
AC CVCL_M160
RX PubMed=22137317;
RX PubMed=26080839;
WW http://www.cogcell.org/cellreqs-leuk.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 19-20 hours (COG).
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 9,11
ST D18S51: 14,18
ST D19S433: 14,16
ST D21S11: 30
ST D2S1338: 17,18
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 11,13
ST D8S1179: 15
ST FGA: 20,23
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M159 ! COG-LL-317
SX Male
CA Cancer cell line
//
ID COG-LL-319h
AC CVCL_M161
RX PubMed=19298590;
RX PubMed=22137317;
RX PubMed=26080839;
WW http://www.cogcell.org/cellreqs-leuk.php
WW http://www.cogcell.org/suppdata/dl/3karyotypes_2007-02-09.pdf
CC Doubling time: 50-62 hours (COG).
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 9,14
ST D18S51: 12,14
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 19,25
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 11,15
ST FGA: 22,23
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COG-LL-329h
AC CVCL_M162
RX PubMed=19298590;
RX PubMed=22137317;
RX PubMed=26080839;
WW http://www.cogcell.org/cellreqs-leuk.php
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 17,18
ST D19S433: 13.2,15
ST D21S11: 29,31.2
ST D2S1338: 17,19
ST D3S1358: 15
ST D5S818: 10,13
ST D7S820: 8,12
ST D8S1179: 10,13
ST FGA: 25,26
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-LL-332h
AC CVCL_M163
RX PubMed=19298590;
RX PubMed=22137317;
RX PubMed=26080839;
WW http://www.cogcell.org/cellreqs-leuk.php
WW http://www.cogcell.org/suppdata/dl/3karyotypes_2007-02-09.pdf
CC Doubling time: 30-34 hours (COG).
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 17,18
ST D19S433: 13.2,15
ST D21S11: 29,31.2
ST D2S1338: 17,19
ST D3S1358: 15,16
ST D5S818: 10,13
ST D7S820: 8,12
ST D8S1179: 10,13
ST FGA: 24,25
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-LL-355h
AC CVCL_M164
RX PubMed=19298590;
RX PubMed=22137317;
RX PubMed=26080839;
WW http://www.cogcell.org/cellreqs-leuk.php
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 9,11
ST D18S51: 12
ST D19S433: 14
ST D21S11: 28,30
ST D2S1338: 19
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 12,16
ST FGA: 19,23
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-LL-356h
AC CVCL_M165
RX PubMed=19298590;
WW http://www.cogcell.org/cellreqs-leuk.php
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 14,17
ST D19S433: 14,14.2
ST D21S11: 30,31
ST D2S1338: 21,23
ST D3S1358: 15,16
ST D5S818: 9,12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 21,24
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-LL-384h
AC CVCL_M166
RX PubMed=19298590;
RX PubMed=22137317;
WW http://www.cogcell.org/cellreqs-leuk.php
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9,12
ST D18S51: 12,21
ST D19S433: 13,15.2
ST D21S11: 29
ST D2S1338: 19,20
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,13
ST FGA: 23,24
ST TH01: 6
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-LL-402h
AC CVCL_AQ49
RX PubMed=26080839;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,14
ST D13S317: 10,11
ST D16S539: 12,13
ST D18S51: 16,18
ST D19S433: 13,15
ST D21S11: 28
ST D2S1338: 19,22
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 24
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-253
AC CVCL_AX66
RX PubMed=24792489;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-261h
AC CVCL_AX54
SY COG_N_261_H
RX PubMed=23202128;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-263
AC CVCL_AX46
SY COGN_263
DR Cosmic; 1890111
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 9,12
ST D18S51: 12,17
ST D19S433: 14,15
ST D21S11: 30,32.2
ST D2S1338: 17,21
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 23
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-265
AC CVCL_AX55
SY COGN265
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,11
ST D18S51: 16
ST D19S433: 15.2,16.2
ST D21S11: 29,30
ST D2S1338: 23
ST D3S1358: 17
ST D5S818: 10,11
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 20,22
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-276h
AC CVCL_AX56
SY COG_N_276_H
DR Cosmic; 1890090
RX PubMed=23202128;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-278
AC CVCL_AX49
SY NB06C
DR Cosmic; 1890076
RX PubMed=23202128;
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 14,15
ST D19S433: 14,16
ST D21S11: 29,30
ST D2S1338: 22,25
ST D3S1358: 16,18
ST D5S818: 9,11
ST D7S820: 9
ST D8S1179: 12,14
ST FGA: 21,22
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-289
AC CVCL_AX45
SY COGN289
DR Cosmic; 1890091
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 13
ST D18S51: 18
ST D19S433: 13,14
ST D21S11: 28,30
ST D2S1338: 17,19
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,12
ST D8S1179: 10,13
ST FGA: 21,23
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-291
AC CVCL_AQ18
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 12,15
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 19,23
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 12,14
ST FGA: 21,22
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-294
AC CVCL_AX67
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 10
ST D18S51: 15
ST D19S433: 14,16.2
ST D21S11: 28,33.2
ST D2S1338: 23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 14,15
ST FGA: 21,23
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AQ20 ! COG-N-321
SX Male
CA Cancer cell line
//
ID COG-N-295
AC CVCL_AX43
SY COGN_295
DR Cosmic; 1890125
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 17,18
ST D19S433: 14,15
ST D21S11: 31
ST D2S1338: 23,25
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-297
AC CVCL_AX57
SY COGN297
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 12,13
ST D18S51: 15,17
ST D19S433: 14,15
ST D21S11: 31
ST D2S1338: 18,24
ST D3S1358: 14,18
ST D5S818: 11,13
ST D7S820: 10,13
ST D8S1179: 10,12
ST FGA: 22
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-299
AC CVCL_AX58
SY COGN_299
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 11,12
ST D16S539: 9,11
ST D18S51: 15,17
ST D19S433: 13,14
ST D21S11: 28,30.2
ST D2S1338: 16,19
ST D3S1358: 14,16
ST D5S818: 9,11
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 19,21
ST TH01: 7,8
ST TPOX: 11,12
ST vWA: 14,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-305
AC CVCL_AX42
SY COGN305
DR Cosmic; 1890106
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10,14
ST D16S539: 10,11
ST D18S51: 17
ST D19S433: 14,15.2
ST D21S11: 28,33.2
ST D2S1338: 19,23
ST D3S1358: 15,16
ST D5S818: 10,13
ST D7S820: 12
ST D8S1179: 12,13
ST FGA: 20,21
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-316
AC CVCL_AQ19
SY COGN316
DR Cosmic; 1890096
RX PubMed=23202128;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 12
ST D18S51: 13,15
ST D19S433: 12,13
ST D21S11: 31.2
ST D2S1338: 18
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 21,22.2
ST TH01: 6,8
ST TPOX: 9,10
ST vWA: 15,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-318
AC CVCL_AX44
SY COG_N_318
DR Cosmic; 1890092
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 14,15
ST D19S433: 13,14.2
ST D21S11: 31.2,34
ST D2S1338: 17,23
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 11,17
ST FGA: 21,26
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-321
AC CVCL_AQ20
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 10
ST D18S51: 15
ST D19S433: 14,16.2
ST D21S11: 28,33.2
ST D2S1338: 23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 14,15
ST FGA: 21,23
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AX67 ! COG-N-294
SX Male
CA Cancer cell line
//
ID COG-N-324
AC CVCL_AX59
SY COGN324
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11
ST D18S51: 11,15
ST D19S433: 12,14
ST D21S11: 29,31.2
ST D2S1338: 18,21
ST D3S1358: 14,19
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 10,12
ST FGA: 22,23
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-327h
AC CVCL_AX47
SY COGN327h
DR Cosmic; 1890094
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 10,11
ST D18S51: 18,19
ST D19S433: 12,15
ST D21S11: 30
ST D2S1338: 18,25
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 10
ST FGA: 21,24
ST TH01: 6
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-328h
AC CVCL_AX60
SY COGN_328h
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 12
ST D18S51: 16,17
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 23,24
ST D3S1358: 18,19
ST D5S818: 11
ST D7S820: 7,10
ST D8S1179: 11,14
ST FGA: 18,25
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-331
AC CVCL_AX61
SY COGN331
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13,14
ST D18S51: 12,16
ST D19S433: 11,14
ST D21S11: 28,30
ST D2S1338: 16,25
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 26,28
ST TH01: 9
ST TPOX: 9,11
ST vWA: 15,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-334
AC CVCL_AX62
SY COGN334
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 29,31
ST D2S1338: 20,26
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 14,15
ST FGA: 19,25
ST TH01: 8,9
ST TPOX: 6,8
ST vWA: 15,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-346h
AC CVCL_AX63
SY COGN346h
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 12
ST D18S51: 12,15
ST D19S433: 14,15
ST D21S11: 29,32.2
ST D2S1338: 19,20
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 8,11
ST D8S1179: 10,15
ST FGA: 23
ST TH01: 9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-347
AC CVCL_AQ21
SY COGN347
RX PubMed=23202128;
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 10,12
ST D18S51: 14,19
ST D19S433: 13,14
ST D21S11: 31,33.2
ST D2S1338: 17,19
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 24,26
ST TH01: 6,7
ST TPOX: 8
ST vWA: 18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-349
AC CVCL_AX50
SY NB03C
DR Cosmic; 1890073
RX PubMed=23202128;
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12
ST D18S51: 12,14
ST D19S433: 14,15
ST D21S11: 29,31.2
ST D2S1338: 20,21
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 11,14
ST FGA: 20,26
ST TH01: 7,9
ST TPOX: 11
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-354
AC CVCL_AX64
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 13
ST D21S11: 28
ST D2S1338: 24,25
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 15,16
ST FGA: 21,25
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-354h
AC CVCL_AX65
SY COGN354h
RX PubMed=23202128;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 13
ST D21S11: 28
ST D2S1338: 24,25
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 15,16
ST FGA: 21,25
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-367h
AC CVCL_AX51
SY NB05C
DR Cosmic; 1890075
RX PubMed=23202128;
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 15,18
ST D19S433: 14,14.2
ST D21S11: 28,30
ST D2S1338: 19,20
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 10,13
ST FGA: 22,23
ST TH01: 8,9.3
ST TPOX: 11,12
ST vWA: 16,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-386h
AC CVCL_AX52
SY NB04C
DR Cosmic; 1890074
RX PubMed=23202128;
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,13
ST D16S539: 13,14
ST D18S51: 14,18
ST D19S433: 12,15
ST D21S11: 28,32.2
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 10,12
ST FGA: 21,25
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 15
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-387h
AC CVCL_AX53
SY NB02C
DR Cosmic; 1890072
RX PubMed=23202128;
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 13
ST D19S433: 15,17
ST D21S11: 27,31
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 9,12
ST D7S820: 9,11
ST D8S1179: 14,16
ST FGA: 23.2,24
ST TH01: 6,9.3
ST TPOX: 9
ST vWA: 14,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-399
AC CVCL_AQ22
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 15,17
ST D19S433: 14
ST D21S11: 30,31
ST D2S1338: 20,25
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 12
ST D8S1179: 11,12
ST FGA: 18,24
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-415
AC CVCL_AQ23
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 12,15
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 19,21
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 11,13,14
ST FGA: 19,22
ST TH01: 7,8
ST TPOX: 11
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG-N-421
AC CVCL_AQ24
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9
ST D18S51: 16,18
ST D19S433: 13,14
ST D21S11: 29,32.2
ST D2S1338: 17,25
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 22,25
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COG-N-440
AC CVCL_AQ25
RX PubMed=24792489;
ST Source(s): COG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 9,11
ST D18S51: 13,17
ST D19S433: 13,14
ST D21S11: 28
ST D2S1338: 17,19
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 11
ST FGA: 21,24
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COG203C
AC CVCL_8U06
DR ECACC; 03082236
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C75019; Sotos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COG583
AC CVCL_8U07
DR ECACC; 05090602
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COGA-1
AC CVCL_A071
DR Cosmic; 877900
RX PubMed=12096341;
CC Microsatellite instability: Instable (MSI) (PubMed=12096341).
DI NCIt; C4910; Colon carcinoma
DI NCIt; C8494; Lynch syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COGA-1A
AC CVCL_Z583
SY Coga1A; COGA1
DR BTO; BTO:0005664
DR GEO; GSM1448099
RX PubMed=18205904;
RX PubMed=22940288;
RX PubMed=24176760;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
DI NCIt; C8494; Lynch syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A071 ! COGA-1
SX Female
CA Cancer cell line
//
ID COGA-10
AC CVCL_A072
DR Cosmic; 877902
RX PubMed=12096341;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COGA-12
AC CVCL_A073
SY COGA12
DR Cosmic; 877905
DR GEO; GSM1448103
RX PubMed=12096341;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COGA-13
AC CVCL_Z584
SY Coga13
DR BTO; BTO:0005665
RX PubMed=18205904;
RX PubMed=22940288;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COGA-2
AC CVCL_A074
SY COGA2
DR Cosmic; 877906
DR GEO; GSM1448100
RX PubMed=12096341;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COGA-3
AC CVCL_A075
SY COGA3
DR Cosmic; 877907
DR GEO; GSM1448101
RX PubMed=12096341;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COGA-5
AC CVCL_A076
SY COGA5
DR Cosmic; 877901
DR GEO; GSM1448150
RX PubMed=12096341;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A077 ! COGA-5L
SX Male
CA Cancer cell line
//
ID COGA-5L
AC CVCL_A077
SY COGA5L
DR Cosmic; 877903
DR GEO; GSM1448151
RX PubMed=12096341;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A076 ! COGA-5
SX Male
CA Cancer cell line
//
ID COGA-8
AC CVCL_A078
SY COGA8
DR Cosmic; 877904
DR GEO; GSM1448102
RX PubMed=12096341;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COH
AC CVCL_U564
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-575.html
CC From: Delattre O.; Institut Curie; Paris; France.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COL
AC CVCL_FA09
RX PubMed=15026342;
RX PubMed=22415601;
RX PubMed=24046071;
CC Problematic cell line: Misidentified. Was originally thought to originate from an osteosarcoma and is now identified as a neuroblastoma cell line (PubMed=22415601, PubMed=24046071).
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Col 2
AC CVCL_D645
SY Col-2; Col2
DR BTO; BTO:0005289
DR ChEMBL-Cells; CHEMBL3307622
DR ChEMBL-Targets; CHEMBL614462
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Col-1
AC CVCL_2A40
SY COL-1
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID Col-10
AC CVCL_4604
SY COL-10
DR CLO; CLO_0002541
DR CLDB; cl823
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4605 ! Col-7
SX Female
CA Cancer cell line
//
ID Col-7
AC CVCL_4605
SY COL-7
DR CLO; CLO_0002542
DR CLDB; cl824
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2A40 ! Col-1
SX Female
CA Cancer cell line
//
ID COL,E
AC CVCL_E531
SY COL, E
DR dbMHC; 48730
DR ECACC; 94082246
DR IHW; IHW9146
DR IMGT/HLA; 11689
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl146.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COL,S
AC CVCL_E532
SY COL, S
DR dbMHC; 48731
DR ECACC; 94082297
DR IHW; IHW9197
DR IMGT/HLA; 11738
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl197.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Colin
AC CVCL_6F56
RX PubMed=1690682;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID COLM-6
AC CVCL_W467
RX PubMed=16143030;
DI NCIt; C7973; Rectal mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 103
AC CVCL_X381
RX DOI=10.1093/jnci/59.2.301;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COLO 110
AC CVCL_5450
RX PubMed=498076;
RX PubMed=6277475;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 16
AC CVCL_D607
SY COLO-16; Colo16
DR BTO; BTO:0005163
RX PubMed=1157043;
RX PubMed=6277475;
RX PubMed=21868764;
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C4819; Skin squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 197
AC CVCL_9976
SY COLO-197
RX PubMed=565251;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9977 ! COLO 200
OI CVCL_1987 ! COLO 201
OI CVCL_0218 ! COLO 205
OI CVCL_1988 ! COLO 206F
SX Male
CA Finite cell line
//
ID COLO 200
AC CVCL_9977
SY COLO-200
RX PubMed=565251;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9976 ! COLO 197
OI CVCL_1987 ! COLO 201
OI CVCL_0218 ! COLO 205
OI CVCL_1988 ! COLO 206F
SX Male
CA Finite cell line
//
ID COLO 201
AC CVCL_1987
SY Colo 201; Colo-201; COLO-201; COLO201; Colo201
DR BTO; BTO:0002568
DR CLO; CLO_0002543
DR EFO; EFO_0002135
DR CLDB; cl825
DR ATCC; CCL-224
DR BioSample; SAMN03471321
DR CCLE; COLO201_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000340
DR Cosmic; 738935
DR Cosmic; 876710
DR Cosmic; 948822
DR Cosmic; 1001661
DR Cosmic; 1154650
DR Cosmic; 1184100
DR Cosmic; 1187302
DR Cosmic; 1223134
DR Cosmic; 1479611
DR Cosmic; 1609481
DR Cosmic; 1676731
DR Cosmic; 1805248
DR Cosmic; 2301967
DR ECACC; 87091201
DR GEO; GSM206458
DR GEO; GSM827324
DR GEO; GSM1346833
DR GEO; GSM1374450
DR GEO; GSM1448068
DR IGRhCellID; COLO201
DR JCRB; JCRB0226
DR KCLB; 10224
DR Lonza; 252
DR SKY/M-FISH/CGH; 2837
RX PubMed=565251;
RX PubMed=9290701;
RX PubMed=10051639;
RX PubMed=10612807;
RX PubMed=11414198;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'Colo210' in Cosmic 1184100.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10 (ATCC; ECACC; JCRB; PubMed=25877200)
ST D13S317: 10,12 (KCLB)
ST D16S539: 12,13
ST D18S51: 18
ST D21S11: 30.2,33.2
ST D3S1358: 16
ST D5S818: 10,13
ST D7S820: 9,10
ST D8S1179: 9,14
ST FGA: 21,23
ST Penta D: 9,11
ST Penta E: 13,15
ST TH01: 8,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9976 ! COLO 197
OI CVCL_9977 ! COLO 200
OI CVCL_0218 ! COLO 205
OI CVCL_1988 ! COLO 206F
SX Male
CA Cancer cell line
//
ID COLO 205
AC CVCL_0218
SY Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205
DR BTO; BTO:0000179
DR CLO; CLO_0002544
DR CLO; CLO_0050630
DR EFO; EFO_0003082
DR MCCL; MCC:0000107
DR CLDB; cl826
DR CLDB; cl5096
DR ATCC; CCL-222
DR BCRC; 60054
DR BioSample; SAMN03470991
DR CCLE; COLO205_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000132
DR CCRID; 3131C0001000700102
DR ChEMBL-Cells; CHEMBL3308348
DR ChEMBL-Targets; CHEMBL614561
DR CLS; 300380/p807_COLO-205
DR Cosmic; 685865
DR Cosmic; 720342
DR Cosmic; 738936
DR Cosmic; 875901
DR Cosmic; 876711
DR Cosmic; 887242
DR Cosmic; 889524
DR Cosmic; 897456
DR Cosmic; 902796
DR Cosmic; 905961
DR Cosmic; 948130
DR Cosmic; 948823
DR Cosmic; 974244
DR Cosmic; 995391
DR Cosmic; 1043806
DR Cosmic; 1044256
DR Cosmic; 1045404
DR Cosmic; 1066207
DR Cosmic; 1067224
DR Cosmic; 1092596
DR Cosmic; 1132577
DR Cosmic; 1154651
DR Cosmic; 1175838
DR Cosmic; 1184101
DR Cosmic; 1187303
DR Cosmic; 1223135
DR Cosmic; 1305351
DR Cosmic; 1310944
DR Cosmic; 1312336
DR Cosmic; 1374634
DR Cosmic; 1479612
DR Cosmic; 1609485
DR Cosmic; 1676745
DR Cosmic; 1708401
DR Cosmic; 1945864
DR Cosmic; 1995368
DR Cosmic; 1998438
DR Cosmic; 2036651
DR Cosmic; 2301968
DR Cosmic-CLP; 905961
DR ECACC; 87061208
DR GDSC; 905961
DR GEO; GSM50186
DR GEO; GSM50250
DR GEO; GSM206459
DR GEO; GSM741249
DR GEO; GSM750794
DR GEO; GSM799329
DR GEO; GSM799392
DR GEO; GSM827422
DR GEO; GSM846289
DR GEO; GSM843490
DR GEO; GSM886940
DR GEO; GSM888007
DR GEO; GSM1153400
DR GEO; GSM1181248
DR GEO; GSM1181264
DR GEO; GSM1346867
DR GEO; GSM1374451
DR GEO; GSM1374452
DR GEO; GSM1448172
DR GEO; GSM1669683
DR ICLC; HTL00010
DR KCB; KCB 200719YJ
DR KCLB; 10222
DR Lonza; 253
DR RCB; RCB2127
DR SKY/M-FISH/CGH; 2801
DR TKG; TKG 0457
RX PubMed=565251;
RX PubMed=2041050;
RX PubMed=6277475;
RX PubMed=10051639;
RX PubMed=10674020;
RX PubMed=10737795;
RX PubMed=11414198;
RX PubMed=12584437;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=19
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-194.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 25 hours (PubMed=25984343); 23.8 hours (DTP).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=19372543; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 12,13
ST D18S51: 18
ST D19S433: 13,14
ST D21S11: 30.2,33.2 (CLS; PubMed=25877200)
ST D21S11: 30.2 (PubMed=19372543)
ST D2S1338: 17,18
ST D3S1358: 16
ST D5S818: 10,13
ST D7S820: 9,10
ST D8S1179: 9,14 (CLS; PubMed=25877200)
ST D8S1179: 9 (PubMed=19372543)
ST FGA: 21,23
ST Penta D: 9,11
ST Penta E: 13,15
ST TH01: 8,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9976 ! COLO 197
OI CVCL_9977 ! COLO 200
OI CVCL_1987 ! COLO 201
OI CVCL_1988 ! COLO 206F
SX Male
CA Cancer cell line
//
ID COLO 205 SimpleCell O-GalNAc
AC CVCL_S023
SY Colo205 SimpleCell; Colo205 SC
RX PubMed=21983924;
RX PubMed=23399548;
RX PubMed=23584533;
CC Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.
CC Derived from metastatic site: Ascites.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0218 ! COLO 205
SX Male
CA Cancer cell line
//
ID COLO 205/CMV-Luc
AC CVCL_J248
DR JCRB; JCRB1451
DR JCRB; NIHS0703
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0218 ! COLO 205
SX Male
CA Cancer cell line
//
ID COLO 206F
AC CVCL_1988
SY Colo-206F; COLO-206F; Colo 206F; COLO206F; COLO 206; COLO206
DR BTO; BTO:0002199
DR CLO; CLO_0002570
DR EFO; EFO_0006554
DR CLDB; cl864
DR DSMZ; ACC-21
DR ECACC; 93052620
DR GEO; GSM206460
DR GEO; GSM513935
DR GEO; GSM514188
DR GEO; GSM784009
DR GEO; GSM1374453
RX PubMed=6277475;
RX PubMed=10051639;
RX PubMed=20606684;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~2-3 days (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9976 ! COLO 197
OI CVCL_9977 ! COLO 200
OI CVCL_1987 ! COLO 201
OI CVCL_0218 ! COLO 205
SX Male
CA Cancer cell line
//
ID COLO 232
AC CVCL_L279
SY COLO-232; Colo-232; COLO232; COLO 232F
DR Cosmic; 925823
RX PubMed=208962;
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=6277475;
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 17
ST D21S11: 28,32.2
ST D8S1179: 15
ST FGA: 20
ST TH01: 9
ST vWA: 17,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COLO 239F
AC CVCL_9975
SY COLO239F; Colo239F; COLOF; COLO-F
DR Cosmic; 888990
DR Cosmic; 928709
DR GEO; GSM162934
RX PubMed=6277475;
RX PubMed=7379029;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 293
AC CVCL_X397
SY Colo 293
RX PubMed=6277475;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 297F
AC CVCL_X382
RX PubMed=6349783;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 298
AC CVCL_X388
RX PubMed=6277475;
RX PubMed=6349783;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 316
AC CVCL_5451
SY Colo 316; COLO-316; COLO316; Colo316
DR GEO; GSM784568
RX PubMed=498076;
RX PubMed=2714338;
RX PubMed=6277475;
RX PubMed=6582512;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 319
AC CVCL_5452
SY COLO 319F
RX PubMed=498076;
RX PubMed=6277475;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 320
AC CVCL_1989
SY COLO-320; Colo-320; Colo320; CoLo320; Co320; COLO 320F
DR BTO; BTO:0002047
DR CLO; CLO_0002571
DR CLO; CLO_0050628
DR CLDB; cl828
DR BioSample; SAMN01821622
DR BioSample; SAMN03470903
DR CCLE; COLO320_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3307577
DR ChEMBL-Targets; CHEMBL614257
DR Cosmic; 687518
DR Cosmic; 711268
DR Cosmic; 738934
DR Cosmic; 873698
DR Cosmic; 876712
DR Cosmic; 887238
DR Cosmic; 905008
DR Cosmic; 913888
DR Cosmic; 948129
DR Cosmic; 948848
DR Cosmic; 973606
DR Cosmic; 995400
DR Cosmic; 1057763
DR Cosmic; 1122322
DR Cosmic; 1132572
DR Cosmic; 1154642
DR Cosmic; 1184085
DR Cosmic; 1187304
DR Cosmic; 1479627
DR Cosmic; 1609493
DR Cosmic; 1676752
DR Cosmic; 1805249
DR Cosmic; 2550351
DR DSMZ; ACC-144
DR GEO; GSM794
DR GEO; GSM741256
DR GEO; GSM747237
DR GEO; GSM886941
DR GEO; GSM888008
DR GEO; GSM1448152
DR GEO; GSM1669684
DR RCB; RCB1193
RX PubMed=498117;
RX PubMed=6277475;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=10737795;
RX PubMed=11526487;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~38 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 16.2
ST D21S11: 33.2
ST D2S1338: 18,25
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 20
ST Penta D: 9,12
ST Penta E: 11,13
ST TH01: 9
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K030 ! COLO 321
SX Female
CA Cancer cell line
//
ID COLO 320DM
AC CVCL_0219
SY COLO-320DM; COLO-320-DM; COLO320/DM; COLO320-DM; COLO320DM; Colo320DM; COLO320 DM; COLO 320 DM
DR CLO; CLO_0002546
DR EFO; EFO_0002136
DR MCCL; MCC:0000108
DR CLDB; cl827
DR ATCC; CCL-220
DR BCRC; 60108
DR BioSample; SAMN03471612
DR CCRID; 3131C0001000700014
DR CCRID; 3111C0001CCC000133
DR CCRID; 3142C0001000000042
DR ChEMBL-Cells; CHEMBL3307647
DR ChEMBL-Targets; CHEMBL614562
DR CLS; 300153/p521_Colo-320_DM
DR Cosmic; 808509
DR Cosmic; 1043807
DR Cosmic; 1223136
DR Cosmic; 1310932
DR Cosmic; 1312298
DR Cosmic; 1374635
DR Cosmic; 1466812
DR Cosmic; 2301969
DR ECACC; 87061205
DR GEO; GSM206461
DR GEO; GSM513909
DR GEO; GSM514187
DR GEO; GSM739989
DR GEO; GSM739990
DR GEO; GSM739991
DR GEO; GSM740012
DR GEO; GSM784007
DR GEO; GSM827245
DR GEO; GSM1346834
DR GEO; GSM1374454
DR GEO; GSM1374455
DR GEO; GSM1448173
DR JCRB; JCRB0225
DR KCB; KCB 200694YJ
DR KCLB; 10220
DR SKY/M-FISH/CGH; 5014
DR TOKU-E; 985
RX PubMed=498117;
RX PubMed=9290701;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22538498;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'COLD-320-DM' in Cosmic 1466812.
ST Source(s): ATCC; CLS; ECACC; JCRB; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11 (ATCC; CLS; JCRB; KCLB; PubMed=25877200)
ST CSF1PO: 11,12 (ECACC)
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 33.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 20
ST Penta D: 9,12
ST Penta E: 11
ST TH01: 9 (ATCC; CLS; JCRB; KCLB; PubMed=25877200)
ST TH01: 8,9 (ECACC)
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1989 ! COLO 320
SX Female
CA Cancer cell line
//
ID COLO 320DMF
AC CVCL_1990
SY COLO-320DMF; COLO-320-DMF; COLO 320 DMF; COLO320DMF
DR CLO; CLO_0002545
DR CLDB; cl830
DR CLDB; cl831
DR Cosmic; 1609480
DR ECACC; 93051118
DR ICLC; HTL95027
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 15
ST D21S11: 31,33.2
ST D8S1179: 13
ST FGA: 20
ST TH01: 8,9
ST vWA: 18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0219 ! COLO 320DM
SX Female
CA Cancer cell line
//
ID COLO 320HSR
AC CVCL_0220
SY COLO-320HSR; COLO320HSR; COLO 320 HSR; COLO-320-HSR; COLO-HSR
DR CLO; CLO_0002547
DR EFO; EFO_0002137
DR MCCL; MCC:0000109
DR CLDB; cl832
DR CLDB; cl833
DR ATCC; CCL-220.1
DR BCRC; 60109
DR BioSample; SAMN03473155
DR ChEMBL-Cells; CHEMBL3308337
DR ChEMBL-Targets; CHEMBL2366265
DR Cosmic; 720341
DR Cosmic; 808508
DR Cosmic; 910569
DR Cosmic; 1609506
DR Cosmic; 1995369
DR Cosmic-CLP; 910569
DR ECACC; 87101501
DR GDSC; 910569
DR GEO; GSM206462
DR GEO; GSM784008
DR GEO; GSM843491
DR GEO; GSM1448182
DR GEO; GSM1669685
DR IGRhCellID; COLO320HSR
DR KCLB; 10220.1
DR TOKU-E; 986
RX PubMed=498117;
RX PubMed=27397505;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 31,33.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 20
ST Penta D: 9,12
ST Penta E: 11,13
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0219 ! COLO 320DM
SX Female
CA Cancer cell line
//
ID COLO 321
AC CVCL_K030
RX PubMed=498117;
RX PubMed=6277475;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1989 ! COLO 320
SX Female
CA Cancer cell line
//
ID COLO 324
AC CVCL_X383
RX PubMed=6349783;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 330
AC CVCL_5453
RX PubMed=498076;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 338
AC CVCL_X394
SY Colo 338
RX CelloPub=CLPUB00149;
RX PubMed=6277475;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COLO 346
AC CVCL_X404
SY COLO 346F
RX PubMed=6277475;
RX PubMed=7262900;
CC Derived from metastatic site: Liver.
DI NCIt; C9166; Gallbladder adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 349
AC CVCL_X385
RX PubMed=6277475;
RX PubMed=6349783;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 353
AC CVCL_X392
RX PubMed=6277475;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 357
AC CVCL_0221
SY COLO-357; Colo 357; COLO357; Colo357
DR BTO; BTO:0003440
DR CLO; CLO_0002548
DR EFO; EFO_0002710
DR MCCL; MCC:0000506
DR CLDB; cl5052
DR ChEMBL-Cells; CHEMBL3307702
DR ChEMBL-Targets; CHEMBL614778
DR Cosmic; 685615
DR Cosmic; 724642
DR Cosmic; 736272
DR Cosmic; 808167
DR Cosmic; 922258
DR Cosmic; 933529
DR Cosmic; 949233
DR Cosmic; 1006371
DR Cosmic; 1198206
DR ECACC; 94072245
DR GEO; GSM621898
DR Lonza; 254
RX PubMed=3815343;
RX PubMed=6277475;
RX PubMed=6435863;
RX PubMed=6989766;
RX PubMed=11169959;
RX PubMed=12692724;
RX PubMed=12800145;
RX PubMed=14695172;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/Colo%20357.html
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 94072245; probable.
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 357/FG
AC CVCL_8196
SY FG; Colo 357 FG; COLO 357 Fast Growing; Colo 357/FG; Colo357FG; COLO357FG; FG/COLO357
RX PubMed=1544114;
RX PubMed=3815343;
RX PubMed=15235133;
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0221 ! COLO 357
SX Female
CA Cancer cell line
//
ID COLO 357/SG
AC CVCL_IP74
SY SG; Colo 357 SG; COLO 357 Slow Growing
RX PubMed=1544114;
RX PubMed=3815343;
CC Derived from metastatic site: Celiac axis lymph node.
DI NCIt; C5721; Pancreatic adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0221 ! COLO 357
SX Female
CA Cancer cell line
//
ID COLO 368
AC CVCL_X389
RX PubMed=6277475;
CC Derived from metastatic site: Bone.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 38
AC CVCL_3934
SY Colo-38; Colo 38; Colo38; COLO38
DR BTO; BTO:0002941
DR CLS; 300151/NA
DR Cosmic; 928682
DR Cosmic; 1477405
RX DOI=10.1093/jnci/59.2.301;
RX PubMed=15661905;
CC Discontinued: CLS; 300151; true.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X377 ! COLO 93
SX Female
CA Cancer cell line
//
ID COLO 381
AC CVCL_X384
RX PubMed=6349783;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 394
AC CVCL_6976
SY COLO-394; COLO394
DR CCRID; 3142C0001000000474
RX PubMed=6277475;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X398 ! COLO 397
OI CVCL_X399 ! COLO 463
CA Cancer cell line
//
ID COLO 397
AC CVCL_X398
SY Colo 397
RX PubMed=6277475;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6976 ! COLO 394
OI CVCL_X399 ! COLO 463
CA Cancer cell line
//
ID COLO 415
AC CVCL_X386
RX PubMed=6277475;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 417
AC CVCL_X387
RX PubMed=6349783;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 463
AC CVCL_X399
RX PubMed=6277475;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6976 ! COLO 394
OI CVCL_X398 ! COLO 397
CA Cancer cell line
//
ID COLO 508
AC CVCL_X402
RX CelloPub=CLPUB00149;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X395 ! COLO 509
OI CVCL_X401 ! COLO 510
OI CVCL_X396 ! COLO 511
SX Male
CA Cancer cell line
//
ID COLO 509
AC CVCL_X395
RX CelloPub=CLPUB00149;
RX PubMed=6277475;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X402 ! COLO 508
OI CVCL_X401 ! COLO 510
OI CVCL_X396 ! COLO 511
SX Male
CA Cancer cell line
//
ID COLO 510
AC CVCL_X401
RX CelloPub=CLPUB00149;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X402 ! COLO 508
OI CVCL_X395 ! COLO 509
OI CVCL_X396 ! COLO 511
SX Male
CA Cancer cell line
//
ID COLO 511
AC CVCL_X396
RX CelloPub=CLPUB00149;
RX PubMed=6277475;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X402 ! COLO 508
OI CVCL_X395 ! COLO 509
OI CVCL_X401 ! COLO 510
SX Male
CA Cancer cell line
//
ID COLO 52
AC CVCL_X378
RX DOI=10.1093/jnci/59.2.301;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X379 ! COLO 53
OI CVCL_X380 ! COLO 55
SX Female
CA Cancer cell line
//
ID COLO 525
AC CVCL_X390
SY Colo 525
RX PubMed=6277475;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X391 ! COLO 527
CA Cancer cell line
//
ID COLO 526
AC CVCL_X400
SY Colo 526
RX PubMed=6277475;
RX PubMed=9213340;
CC Derived from metastatic site: Bone.
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 527
AC CVCL_X391
RX PubMed=6277475;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X390 ! COLO 525
CA Cancer cell line
//
ID COLO 53
AC CVCL_X379
RX DOI=10.1093/jnci/59.2.301;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X378 ! COLO 52
OI CVCL_X380 ! COLO 55
SX Female
CA Cancer cell line
//
ID COLO 534
AC CVCL_X393
RX PubMed=6277475;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 55
AC CVCL_X380
RX DOI=10.1093/jnci/59.2.301;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X378 ! COLO 52
OI CVCL_X379 ! COLO 53
SX Female
CA Cancer cell line
//
ID COLO 587
AC CVCL_F641
SY COLO-587; COLO587
DR ATCC; CRL-2000
DR BioSample; SAMN03151627
DR GEO; GSM784695
DR IZSLER; BS TCL 167
WW http://www.atcc.org/support/faqs/77d33/COLO%20587%20ATCC%20CRL2000-1058.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a COLO 320DM derivative.
CC Discontinued: ATCC; CRL-2000; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0219 ! COLO 320DM
SX Female
CA Cancer cell line
//
ID COLO 60H
AC CVCL_4572
SY COLO-60H; Colo-60H; COLO60H
DR CLS; 300456/p755_COLO-60H
DR GEO; GSM1448094
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 11,15
ST D13S317: 11
ST D16S539: 9,13
ST D18S51: 13,15
ST D21S11: 29,33.2
ST D3S1358: 15
ST D5S818: 9,16
ST D7S820: 7.3,10
ST D8S1179: 11
ST FGA: 21,24
ST Penta D: 14
ST Penta E: 11,13
ST TH01: 6,9.3
ST TPOX: 7,10
ST vWA: 15,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COLO 667
AC CVCL_A430
SY Colo 667; Colo-667; COLO667
DR Cosmic; 1070715
DR Cosmic; 1071884
RX PubMed=2823272;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 668
AC CVCL_1128
SY Colo 668; COLO-668; COLO668
DR CLO; CLO_0002549
DR EFO; EFO_0002138
DR CLDB; cl835
DR CCLE; COLO668_LUNG
DR ChEMBL-Cells; CHEMBL3308864
DR ChEMBL-Targets; CHEMBL2366215
DR Cosmic; 877393
DR Cosmic; 910692
DR Cosmic; 1152488
DR Cosmic; 1995370
DR Cosmic-CLP; 910692
DR ECACC; 87061209
DR GDSC; 910692
DR GEO; GSM17195
DR GEO; GSM886942
DR GEO; GSM888009
DR GEO; GSM1669686
RX PubMed=15016488;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Brain.
ST Source(s): Cosmic-CLP; ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,10 (Cosmic-CLP)
ST D7S820: 8.2,10 (ECACC)
ST TH01: 9
ST TPOX: 8,11 (Cosmic-CLP)
ST TPOX: 8 (ECACC)
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 677
AC CVCL_1862
SY COLO-677; COLO677
DR CLO; CLO_0002550
DR CLDB; cl837
DR CLDB; cl838
DR BioSample; SAMN03151910
DR CCLE; COLO677_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 753542
DR DSMZ; ACC-248
DR ECACC; 93072109
DR GEO; GSM784242
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a RPMI-8226 derivative (PubMed=20143388).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0014 ! RPMI-8226
SX Male
CA Cancer cell line
//
ID COLO 678
AC CVCL_1129
SY Colo-678; COLO-678; COLO678
DR BTO; BTO:0002200
DR CLO; CLO_0002572
DR EFO; EFO_0006371
DR CLDB; cl865
DR BioSample; SAMN03473135
DR CCLE; COLO678_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308349
DR ChEMBL-Targets; CHEMBL1075425
DR Cosmic; 910689
DR Cosmic; 948821
DR Cosmic; 995379
DR Cosmic; 1312299
DR Cosmic; 1995371
DR Cosmic; 2301970
DR Cosmic-CLP; 910689
DR DSMZ; ACC-194
DR GDSC; 910689
DR GEO; GSM206463
DR GEO; GSM513929
DR GEO; GSM514189
DR GEO; GSM784010
DR GEO; GSM886943
DR GEO; GSM888010
DR GEO; GSM1346868
DR GEO; GSM1374456
DR GEO; GSM1448174
DR GEO; GSM1669687
RX PubMed=10737795;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~60-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 9
ST D18S51: 11,14
ST D21S11: 27,29
ST D3S1358: 15,18
ST D5S818: 13,14
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 25,27
ST Penta D: 11,14
ST Penta E: 10,16
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COLO 679
AC CVCL_1130
SY COLO-679; COLO679
DR CLO; CLO_0050697
DR CLO; CLO_0002551
DR EFO; EFO_0006372
DR CLDB; cl840
DR CLDB; cl839
DR BioSample; SAMN03473118
DR CCLE; COLO679_SKIN
DR ChEMBL-Cells; CHEMBL3308723
DR ChEMBL-Targets; CHEMBL1075426
DR Cosmic; 687433
DR Cosmic; 906818
DR Cosmic; 1995372
DR Cosmic-CLP; 906818
DR DSMZ; ACC-264
DR ECACC; 87061210
DR GDSC; 906818
DR GEO; GSM886944
DR GEO; GSM888011
DR GEO; GSM1669688
DR LINCS; 50011
DR RCB; RCB0989
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~34 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=11416159; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 14,15
ST D19S433: 14
ST D21S11: 28
ST D2S1338: 24,25
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 19,25
ST Penta D: 7,11
ST Penta E: 5,13
ST TH01: 7,9
ST TPOX: 9,12
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 679-Luc
AC CVCL_J249
DR JCRB; JCRB1377
DR JCRB; NIHS0642
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0642; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 7,9
ST TPOX: 9,12
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1130 ! COLO 679
SX Female
CA Cancer cell line
//
ID COLO 680N
AC CVCL_1131
SY COLO-680N
DR CLO; CLO_0002573
DR EFO; EFO_0006373
DR CLDB; cl866
DR BioSample; SAMN03471044
DR BioSample; SAMN03473366
DR CCLE; COLO680N_OESOPHAGUS
DR ChEMBL-Cells; CHEMBL3308724
DR ChEMBL-Targets; CHEMBL1075427
DR CLS; 300464/p816_COLO-680N
DR Cosmic; 906817
DR Cosmic-CLP; 906817
DR DSMZ; ACC-182
DR GDSC; 906817
DR GEO; GSM827548
DR GEO; GSM886945
DR GEO; GSM888012
DR GEO; GSM1669689
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~60-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 11,12
ST D18S51: 19
ST D21S11: 27
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 14,15
ST FGA: 18.2
ST Penta D: 12
ST Penta E: 7,8
ST TH01: 8
ST TPOX: 6 (CLS; PubMed=25877200)
ST TPOX: 6,8 (Cosmic-CLP; DSMZ)
ST vWA: 17,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 684
AC CVCL_1132
SY COLO-684; COLO684; Colo684
DR CLO; CLO_0002552
DR CLDB; cl841
DR BioSample; SAMN03470977
DR CCLE; COLO684_ENDOMETRIUM
DR ChEMBL-Cells; CHEMBL3308284
DR ChEMBL-Targets; CHEMBL2366176
DR Cosmic; 910691
DR Cosmic-CLP; 910691
DR ECACC; 87061203
DR GDSC; 910691
DR GEO; GSM827423
DR GEO; GSM888013
DR GEO; GSM1669690
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D18S51: 13,15
ST D19S433: 14,15
ST D21S11: 27,31.2
ST D2S1338: 18,22
ST D3S1358: 14,17
ST D5S818: 12,13
ST D7S820: 11,13
ST D8S1179: 11,12
ST FGA: 19,20,23
ST Penta D: 11,12
ST Penta E: 11,12
ST TH01: 7,9.3
ST TPOX: 7,8
ST vWA: 14,15,16
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1991 ! COLO 685
SX Female
CA Cancer cell line
//
ID COLO 685
AC CVCL_1991
SY COLO-685; COLO685
DR CLO; CLO_0002553
DR CLDB; cl842
DR BioSample; SAMN03470978
DR ECACC; 87061206
DR GEO; GSM827424
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,12
ST D16S539: 12,13
ST D18S51: 13,15
ST D19S433: 14,15
ST D21S11: 27,31.2
ST D2S1338: 18,23
ST D3S1358: 14,17
ST D5S818: 12,13
ST D7S820: 11,13
ST D8S1179: 11,12
ST FGA: 20,23
ST Penta D: 11,12
ST Penta E: 11,12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1132 ! COLO 684
SX Female
CA Cancer cell line
//
ID COLO 699
AC CVCL_1992
SY COLO-699; Colo-699; Colo699; COLO699
DR BTO; BTO:0003017
DR CLO; CLO_0002574
DR EFO; EFO_0006374
DR CLDB; cl868
DR BioSample; SAMN03473074
DR CCLE; COLO699_LUNG
DR Cosmic; 844591
DR Cosmic; 877394
DR Cosmic; 1028946
DR Cosmic; 1146950
DR Cosmic; 1152489
DR DSMZ; ACC-196
DR GEO; GSM434300
DR GEO; GSM886946
DR GEO; GSM888014
DR IGRhCellID; COLO699GEO
DR PRIDE; PXD002556
RX PubMed=10908148;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~38 hours (DSMZ).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 11,12
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 10,13
ST FGA: 23
ST Penta D: 12,14
ST Penta E: 10,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1993 ! COLO 699N
SX Female
CA Cancer cell line
//
ID COLO 699N
AC CVCL_1993
SY COLO 699 N; COLO-699N
DR CLO; CLO_0002554
DR CLO; CLO_0002555
DR CLDB; cl843
DR CLDB; cl844
DR Cosmic; 687779
DR ECACC; 93052608
DR ICLC; HTL95009
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1992 ! COLO 699
SX Female
CA Cancer cell line
//
ID COLO 704
AC CVCL_1994
SY COLO-704; COLO704
DR CLO; CLO_0002575
DR EFO; EFO_0002139
DR CLDB; cl869
DR BioSample; SAMN03473293
DR BioSample; SAMN03473372
DR CCLE; COLO704_OVARY
DR Cosmic; 688095
DR Cosmic; 1707567
DR DSMZ; ACC-198
DR GEO; GSM659372
DR GEO; GSM886947
DR GEO; GSM888015
DR GEO; GSM1001490
DR IGRhCellID; COLO704
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25485619;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 26 hours (PubMed=25984343); ~30-40 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites from colon metastasis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12 (DSMZ)
ST CSF1PO: 11 (PubMed=25877200)
ST D13S317: 12
ST D16S539: 12
ST D18S51: 13,15
ST D21S11: 27,31.2
ST D3S1358: 14,17
ST D5S818: 12,13
ST D7S820: 11,13
ST D8S1179: 11,12
ST FGA: 20,23
ST Penta D: 11,12
ST Penta E: 11,12
ST TH01: 7,9.3
ST TPOX: 7,8
ST vWA: 15,16
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 720E
AC CVCL_1995
SY COLO 720 E; COLO-720E; COLO720E; Colo720E
DR CLO; CLO_0002556
DR CLDB; cl845
DR Cosmic; 688126
DR Cosmic; 1707568
RX PubMed=22710073;
RX PubMed=24023729;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Partially contaminated. Some stocks are contaminated by COLO 704 (CVCL_AV69).
ST Source(s): PubMed=22710073;
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 10,11
ST D19S433: 13,15.2
ST D21S11: 28,32.2
ST D2S1338: 18,24
ST D3S1358: 15,17
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 10,13
ST FGA: 21,25
ST TH01: 9
ST TPOX: 11
ST vWA: 14
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1863 ! COLO 720L
SX Female
CA Cancer cell line
//
ID COLO 720E contaminated
AC CVCL_AV69
DR BioSample; SAMN03473075
DR ECACC; 93072111
RX PubMed=25230021;
RX PubMed=25877200;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. The stock of COLO 720E distributed by ECACC was contaminated by COLO 704 (PubMed=25230021, PubMed=25877200).
CC Part of: OCCP ovarian cancer cell line panel.
CC Discontinued: ECACC; 93072111; true.
ST Source(s): PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 12,13,14
ST D18S51: 14
ST D21S11: 27,31.2
ST D3S1358: 17
ST D5S818: 12,15
ST D7S820: 11,13
ST D8S1179: 11,12
ST FGA: 20,23
ST Penta D: 10.4,12 (PubMed=25230021)
ST Penta D: 11,12 (PubMed=25877200)
ST Penta E: 11,12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1994 ! COLO 704
SX Female
CA Cancer cell line
//
ID COLO 720L
AC CVCL_1863
SY COLO 720 L; COLO-720L; Colo-720L
DR BTO; BTO:0002063
DR CLO; CLO_0002557
DR CLDB; cl846
DR CLDB; cl847
DR BioSample; SAMN03473376
DR DSMZ; ACC-206
DR ECACC; 93052623
CC Doubling time: ~20-30 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 10
ST TH01: 9
ST TPOX: 11
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1995 ! COLO 720E
SX Female
CA Transformed cell line
//
ID COLO 738
AC CVCL_2407
SY Colo 738; COLO-738; MFHL-2
DR ECACC; 94072238
CC Caution: Could be identical to RPMI-7932 (CVCL_2713).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COLO 741
AC CVCL_1133
SY COLO-741; Colo741; COLO741
DR CLO; CLO_0002558
DR EFO; EFO_0006375
DR CLDB; cl848
DR CLDB; cl849
DR BioSample; SAMN03472285
DR CCLE; COLO741_SKIN
DR ChEMBL-Cells; CHEMBL3308102
DR ChEMBL-Targets; CHEMBL1075428
DR Cosmic; 685866
DR Cosmic; 906815
DR Cosmic; 948864
DR Cosmic; 995383
DR Cosmic; 1043808
DR Cosmic; 1609496
DR Cosmic; 1805250
DR Cosmic; 1995373
DR Cosmic-CLP; 906815
DR ECACC; 93052621
DR GDSC; 906815
DR GEO; GSM206464
DR GEO; GSM741250
DR GEO; GSM827458
DR GEO; GSM886948
DR GEO; GSM888016
DR GEO; GSM1374457
DR GEO; GSM1448133
DR GEO; GSM1669691
DR ICLC; HTL95008
RX PubMed=10051639;
RX PubMed=10737795;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 30 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Indicated as a melanoma cell line at the Broad Institute (CCLE).
CC Derived from metastatic site: Pelvic wall.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 11,12 (Cosmic-CLP; ECACC)
ST D16S539: 12 (PubMed=25877200)
ST D18S51: 13
ST D21S11: 29,32.2
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 12
ST D8S1179: 16
ST FGA: 21
ST Penta D: 12,16
ST Penta E: 13,16
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 775
AC CVCL_1996
SY COLO-775
DR CLO; CLO_0002559
DR CLDB; cl850
DR CCLE; COLO775_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ECACC; 94072236
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 783
AC CVCL_1997
SY COLO-783; Colo783
DR CLO; CLO_0002576
DR EFO; EFO_0006376
DR BioSample; SAMN03473278
DR BioSample; SAMN03473334
DR CCLE; COLO783_SKIN
DR Cosmic-CLP; 1240125
DR DSMZ; ACC-257
DR GDSC; 1240125
DR GEO; GSM886949
DR GEO; GSM888017
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 48 hours (PubMed=25984343); ~5-7 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 13,14
ST D21S11: 30,33.2
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,11 (Cosmic-CLP; DSMZ)
ST D7S820: 8 (PubMed=25877200)
ST D8S1179: 13,15
ST FGA: 20,21
ST Penta D: 13,15
ST Penta E: 13
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 792
AC CVCL_1134
SY COLO-792
DR CLO; CLO_0002560
DR EFO; EFO_0006377
DR CLDB; cl851
DR BioSample; SAMN03472864
DR CCLE; COLO792_SKIN
DR ChEMBL-Cells; CHEMBL3308796
DR ChEMBL-Targets; CHEMBL1075429
DR Cosmic; 906814
DR Cosmic; 1995374
DR Cosmic-CLP; 906814
DR ECACC; 93052616
DR GDSC; 906814
DR GEO; GSM827459
DR GEO; GSM886950
DR GEO; GSM888018
DR GEO; GSM1669692
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Brain.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12 (Cosmic-CLP)
ST CSF1PO: 11 (ECACC; PubMed=25877200)
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 13,17
ST D21S11: 28,32.2
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 13,16
ST FGA: 18,21
ST Penta D: 8,13
ST Penta E: 10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COLO 794
AC CVCL_2408
SY Colo 794; COLO-794
DR BioSample; SAMN03472865
DR Cosmic; 972283
DR ECACC; 94072237
DR ESTDAB; ESTDAB-001
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): ECACC; ESTDAB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 13,14
ST D21S11: 29,30
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14,15
ST FGA: 23
ST Penta D: 11,13
ST Penta E: 7
ST TH01: 6
ST TPOX: 11
ST vWA: 16,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1135 ! COLO 800
SX Male
CA Cancer cell line
//
ID COLO 800
AC CVCL_1135
SY COLO-800
DR CLO; CLO_0002561
DR EFO; EFO_0006378
DR CLDB; cl852
DR CLDB; cl853
DR CLDB; cl854
DR CCLE; COLO800_SKIN
DR ChEMBL-Cells; CHEMBL3308285
DR ChEMBL-Targets; CHEMBL2366224
DR Cosmic; 687434
DR Cosmic; 906813
DR Cosmic; 1995375
DR Cosmic; 2163765
DR Cosmic-CLP; 906813
DR DSMZ; ACC-193
DR ECACC; 93051123
DR ESTDAB; ESTDAB-002
DR GDSC; 906813
DR GEO; GSM886951
DR GEO; GSM888019
DR GEO; GSM1669693
DR ICLC; HTL97005
DR LINCS; 50012
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; ESTDAB; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 13,14
ST D21S11: 29,30
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14,15
ST FGA: 23
ST TH01: 6
ST TPOX: 11
ST vWA: 16,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2408 ! COLO 794
SX Male
CA Cancer cell line
//
ID COLO 818
AC CVCL_1998
SY COLO-818; COLO818
DR CLO; CLO_0002562
DR CLDB; cl855
DR CLDB; cl169
DR BioSample; SAMN03151628
DR BioSample; SAMN03473279
DR CCLE; COLO818_SKIN
DR Cosmic; 972257
DR DSMZ; ACC-81
DR ECACC; 93052622
DR ESTDAB; ESTDAB-003
DR GEO; GSM886952
DR GEO; GSM888020
RX PubMed=10508494;
RX PubMed=20143388;
RX PubMed=22460905;
RX PubMed=25485619;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a COLO 800 derivative (PubMed=10508494, PubMed=20143388).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~60 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 93052622; true.
CC Derived from metastatic site: Subcutaneous.
ST Source(s): DSMZ; ESTDAB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 13,14
ST D21S11: 29,30
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14,15
ST FGA: 23
ST Penta D: 11,13
ST Penta E: 7
ST TH01: 6
ST TPOX: 11
ST vWA: 16,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1135 ! COLO 800
SX Male
CA Cancer cell line
//
ID COLO 824
AC CVCL_1136
SY Colo 824; COLO-824; Colo-824; COLO824; Colo824
DR CLO; CLO_0002577
DR CLDB; cl870
DR BioSample; SAMN03471347
DR BioSample; SAMN03473374
DR ChEMBL-Cells; CHEMBL3308725
DR ChEMBL-Targets; CHEMBL1075430
DR CLS; 300463/p815_Colo-824
DR Cosmic; 906812
DR Cosmic-CLP; 906812
DR DSMZ; ACC-200
DR GDSC; 906812
DR GEO; GSM718287
DR GEO; GSM783979
DR GEO; GSM847249
DR GEO; GSM847459
DR GEO; GSM843492
DR GEO; GSM843493
DR GEO; GSM1669694
RX PubMed=9892114;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~60-80 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Previously erroneously indicated as originating from a male patient, correct gender assignment from Moore G.E. in a personal communication to the authors of PubMed=9892114.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12,13
ST D16S539: 13 (CLS; Cosmic-CLP; PubMed=25877200)
ST D16S539: 12,13 (DSMZ)
ST D18S51: 15,19
ST D21S11: 28
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 8,11 (CLS; Cosmic-CLP; DSMZ)
ST D7S820: 7.9,8,11 (PubMed=25877200)
ST D8S1179: 12,14
ST FGA: 22
ST Penta D: 5,10
ST Penta E: 7
ST TH01: 7,9
ST TPOX: 6,11
ST vWA: 16
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COLO 829
AC CVCL_1137
SY Colo 829; COLO-829; Colo-829; COLO829; Colo829
DR CLO; CLO_0002563
DR EFO; EFO_0002140
DR CLDB; cl856
DR ATCC; CRL-1974
DR BioSample; SAMN03470888
DR CCLE; COLO829_SKIN
DR ChEMBL-Cells; CHEMBL3308286
DR ChEMBL-Targets; CHEMBL2366275
DR Cosmic; 687448
DR Cosmic; 965553
DR Cosmic; 1459644
DR Cosmic; 1477404
DR Cosmic; 1995376
DR Cosmic; 2159430
DR Cosmic-CLP; 687448
DR ECACC; 93052611
DR ENCODE; ENCBS172AAA
DR GDSC; 687448
DR GEO; GSM206465
DR GEO; GSM886953
DR GEO; GSM888021
DR GEO; GSM1008571
DR GEO; GSM1669695
DR IGRhCellID; COLO829
DR IZSLER; BS TCL 198
RX PubMed=14762065;
RX PubMed=18698037;
RX PubMed=20016485;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Colo829_Crawford_protocol.pdf
WW http://www.pawefish.path.cam.ac.uk/OtherCellLineDescriptions/COLO829.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 93052611; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 15
ST D21S11: 27,29
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 21,25
ST Penta D: 9,14
ST Penta E: 7,12
ST TH01: 10
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1999 ! COLO 829BL
SX Male
CA Cancer cell line
//
ID COLO 829BL
AC CVCL_1999
SY COLO-829BL; COLO 829 BL; COLO829BL
DR CLO; CLO_0002564
DR ATCC; CRL-1980
DR BioSample; SAMN03471268
RX PubMed=14762065;
RX PubMed=20016485;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Genome sequenced.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 10
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1137 ! COLO 829
SX Male
CA Transformed cell line
//
ID COLO 831
AC CVCL_L503
SY COLO-831; Colo 831
RX PubMed=8402545;
CC Derived from metastatic site: Umbilicus.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 832
AC CVCL_2000
SY COLO-832; Colo 832; COLO832
DR CLO; CLO_0002565
DR CLDB; cl857
DR ECACC; 93051124
CC Discontinued: ECACC; 93051124; probable.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 833
AC CVCL_L504
SY COLO-833; Colo 833
RX PubMed=8402545;
CC Derived from metastatic site: Skin.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 834
AC CVCL_L505
SY COLO-834; Colo 834
RX PubMed=8402545;
CC Derived from metastatic site: Skin.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 835
AC CVCL_L506
SY COLO-835; Colo 835
RX PubMed=8402545;
CC Derived from metastatic site: Left axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 838
AC CVCL_L507
SY COLO-838; Colo 838
RX PubMed=8402545;
CC Derived from metastatic site: Right axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 839
AC CVCL_2001
SY COLO-839; Colo 839; COLO839
DR CLO; CLO_0002566
DR CLDB; cl858
DR ECACC; 93051119
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 9.3,10
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Transformed cell line
//
ID COLO 845
AC CVCL_L508
SY COLO-845; Colo 845
RX PubMed=8402545;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 848
AC CVCL_L509
SY COLO-848; Colo 848
RX PubMed=8402545;
CC Derived from metastatic site: Right axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 849
AC CVCL_2002
SY COLO-849; Colo 849; COLO849
DR CLO; CLO_0002578
DR EFO; EFO_0006379
DR CLDB; cl872
DR BioSample; SAMN03473234
DR CCLE; COLO849_SKIN
DR Cosmic; 888062
DR DSMZ; ACC-216
DR GEO; GSM886954
DR GEO; GSM888022
RX PubMed=8402545;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-60 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 15
ST D21S11: 27,29
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 21,25
ST Penta D: 9,14
ST Penta E: 7,12
ST TH01: 10
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 853
AC CVCL_2003
SY COLO-853; Colo 853
DR CLO; CLO_0002567
DR EFO; EFO_0006380
DR CLDB; cl859
DR CLDB; cl860
DR ECACC; 93052606
DR GEO; GSM827310
DR ICLC; HTL96001
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 10
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2004 ! COLO 857
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 857
AC CVCL_2004
SY COLO-857; Colo 857; COLO857
DR CLO; CLO_0002568
DR EFO; EFO_0006381
DR CLDB; cl861
DR BioSample; SAMN03472866
DR Cosmic; 972258
DR ECACC; 93051120
DR GEO; GSM827425
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 25
ST Penta D: 9
ST Penta E: 7,12
ST TH01: 10
ST TPOX: 8,11
ST vWA: 17,19 (ECACC)
ST vWA: 17,18,19 (PubMed=25877200)
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2005 ! COLO 858
SX Male
CA Cancer cell line
//
ID COLO 858
AC CVCL_2005
SY COLO-858; Colo 858; COLO858
DR CLO; CLO_0002569
DR CLDB; cl862
DR CLDB; cl863
DR BioSample; SAMN03470979
DR ECACC; 93052613
DR GEO; GSM827426
DR ICLC; HTL97017
DR LINCS; 50149
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 15
ST D19S433: 14,15
ST D21S11: 29
ST D2S1338: 18,26
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 25
ST Penta D: 9
ST Penta E: 7,12
ST TH01: 10
ST TPOX: 8,11
ST vWA: 17,19 (ECACC)
ST vWA: 17 (PubMed=25877200)
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L503 ! COLO 831
OI CVCL_2000 ! COLO 832
OI CVCL_L504 ! COLO 833
OI CVCL_L505 ! COLO 834
OI CVCL_L506 ! COLO 835
OI CVCL_L507 ! COLO 838
OI CVCL_2001 ! COLO 839
OI CVCL_L508 ! COLO 845
OI CVCL_L509 ! COLO 848
OI CVCL_2002 ! COLO 849
OI CVCL_2003 ! COLO 853
OI CVCL_2004 ! COLO 857
SX Male
CA Cancer cell line
//
ID COLO 93
AC CVCL_X377
RX DOI=10.1093/jnci/59.2.301;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3934 ! COLO 38
SX Female
CA Cancer cell line
//
ID COLO 94H
AC CVCL_4573
SY COLO-94H; Colo-94H; COLO94H
DR CLS; 300161/p704_COLO-94H
DR GEO; GSM1448153
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 11,14
ST D13S317: 11
ST D16S539: 13
ST D18S51: 18
ST D21S11: 27,28
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 12
ST FGA: 21
ST Penta D: 12,13
ST Penta E: 17
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CoLo-TC
AC CVCL_8290
SY CoLoTC
DR BioSample; SAMN03151626
DR Cosmic; 1066208
DR RCB; RCB1984
DR TKG; TKG 0404
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a COLO 205 derivative (PubMed=20143388).
CC Discontinued: RCB; RCB1984; true.
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0218 ! COLO 205
SX Male
CA Cancer cell line
//
ID COLO/B
AC CVCL_U288
RX PubMed=2714338;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5451 ! COLO 316
SX Female
CA Cancer cell line
//
ID COLO/C
AC CVCL_U289
RX PubMed=2714338;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5451 ! COLO 316
SX Female
CA Cancer cell line
//
ID COLO/D
AC CVCL_U290
RX PubMed=2714338;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5451 ! COLO 316
SX Female
CA Cancer cell line
//
ID COLO/DDP50
AC CVCL_U291
RX PubMed=2714338;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5451 ! COLO 316
SX Female
CA Cancer cell line
//
ID COLO119
AC CVCL_F385
DR CLO; CLO_0051083
DR RCB; HSC0052
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO129
AC CVCL_F386
DR CLO; CLO_0051084
DR RCB; HSC0053
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO131
AC CVCL_F387
DR CLO; CLO_0051156
DR RCB; HSC0120
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia (Mestizo).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COLO133
AC CVCL_F388
DR CLO; CLO_0051174
DR RCB; HSC0140
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia (Mestizo).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO134
AC CVCL_F389
DR CLO; CLO_0051153
DR RCB; HSC0117
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia (Mestizo).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO142
AC CVCL_F390
DR CLO; CLO_0051155
DR RCB; HSC0119
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia (Mestizo).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COLO157
AC CVCL_F391
DR CLO; CLO_0051124
DR RCB; HSC0102
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO158
AC CVCL_F392
DR CLO; CLO_0051148
DR RCB; HSC0112
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO164
AC CVCL_F393
DR CLO; CLO_0051127
DR RCB; HSC0105
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO165
AC CVCL_F394
DR CLO; CLO_0051161
DR RCB; HSC0125
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO166
AC CVCL_F395
DR CLO; CLO_0051157
DR RCB; HSC0111
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO167
AC CVCL_F396
DR CLO; CLO_0051072
DR RCB; HSC0039
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO198
AC CVCL_F397
DR CLO; CLO_0051149
DR RCB; HSC0113
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO200
AC CVCL_F398
DR CLO; CLO_0051135
DR RCB; HSC0106
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COLO201
AC CVCL_F399
DR CLO; CLO_0051130
DR RCB; HSC0101
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COLO201-AR
AC CVCL_4V91
RX PubMed=21098728;
CC Selected for resistance to: ChEBI; CHEBI:90227; Selumetinib (AZD6244).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1987 ! COLO 201
CA Cancer cell line
//
ID COLO202
AC CVCL_F400
DR CLO; CLO_0051334
DR RCB; HSC0108
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO204
AC CVCL_F401
DR CLO; CLO_0051173
DR RCB; HSC0138
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID COLO205
AC CVCL_F402
DR CLO; CLO_0051333
DR RCB; HSC0107
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Colo205-luc2
AC CVCL_5J18
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124317.
CC Derived from metastatic site: Ascites.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0218 ! COLO 205
SX Male
CA Cancer cell line
//
ID Colo205-Red-FLuc
AC CVCL_5I92
SY Colo205 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124317
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Ascites.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0218 ! COLO 205
SX Male
CA Cancer cell line
//
ID COLO206F-AR
AC CVCL_4V92
RX PubMed=21098728;
CC Selected for resistance to: ChEBI; CHEBI:90227; Selumetinib (AZD6244).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1988 ! COLO 206F
SX Male
CA Cancer cell line
//
ID COLO209
AC CVCL_F403
DR CLO; CLO_0051154
DR RCB; HSC0118
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID COLO383
AC CVCL_F384
SY COL383
DR CLO; CLO_0051134
DR RCB; HSC0109
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Colo829/R
AC CVCL_IW11
RX PubMed=26365896;
CC Selected for resistance to: ChEBI; CHEBI:90295; PLX-4720.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1137 ! COLO 829
SX Male
CA Cancer cell line
//
ID Colon 26-L5
AC CVCL_3924
SY 26-L5; Colon26 clone 5
DR BTO; BTO:0000103
RX PubMed=19265263;
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0240 ! MC-26
SX Female
CA Cancer cell line
//
ID Colon C26-G
AC CVCL_3925
DR BTO; BTO:0003631
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0240 ! MC-26
SX Female
CA Cancer cell line
//
ID Colon26-Luc
AC CVCL_M253
DR JCRB; JCRB1496
DR JCRB; NIHS0704
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0240 ! MC-26
SX Female
CA Cancer cell line
//
ID COM-3
AC CVCL_3900
SY COM3
DR BTO; BTO:0004263
RX PubMed=9227903;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0188 ! C2C12
SX Female
CA Spontaneously immortalized cell line
//
ID COMA
AC CVCL_M813
RX PubMed=11063793;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COMMA-D
AC CVCL_5731
SY Comma-D; COMMA D; Comma 1D; COMMA-1D; COMMA1D; CD
RX PubMed=2423737;
RX PubMed=6587390;
RX PubMed=24259225;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID COMMA-D beta
AC CVCL_5732
SY Comma-Dbeta; CD-beta
RX PubMed=16545360;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Caution: Could be identical to COMMA-D beta-geo (CVCL_5733).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID COMMA-D beta-geo
AC CVCL_5733
SY COMMA-Dbeta-geo; CD-betageo; CDbetageo
RX PubMed=17227796;
RX PubMed=19913532;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Caution: Could be identical to COMMA-D beta (CVCL_5732).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5732 ! COMMA-D beta
SX Female
CA Spontaneously immortalized cell line
//
ID COMMA-F
AC CVCL_5G82
RX PubMed=2423737;
RX PubMed=24259225;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID COMMA-T
AC CVCL_5G83
RX PubMed=2423737;
RX PubMed=24259225;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID CoMS
AC CVCL_L345
RX PubMed=11642274;
CC Breed/subspecies: Mixed breed.
DI NCIt; C129077; Canine mastocytoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID CON.1
AC CVCL_G646
DR CLO; CLO_0002579
DR ATCC; CRL-2229
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID CON8
AC CVCL_9U76
RX PubMed=27345781;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ConA-B1-VICK
AC CVCL_5497
SY ConA-B1
DR CLO; CLO_0002580
DR ATCC; CRL-12357
RX Patent=US5691200;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID ConA-C1-VICK
AC CVCL_5498
SY ConA-C1
DR CLO; CLO_0002581
DR ATCC; CRL-12135
RX Patent=US5691200;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID Connor-HSA
AC CVCL_0D03
WW http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID COP,AH
AC CVCL_E533
SY COP, AH
DR dbMHC; 48732
DR ECACC; 94082212
DR IHW; IHW9113
DR IMGT/HLA; 11658
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl113.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94082212; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Cor Per
AC CVCL_4603
SY Cor Per II
DR CLO; CLO_0002582
DR CLDB; cl875
DR ATCC; CRL-1145
DR ATCC; CRL-1243
CC Discontinued: ATCC; CRL-1145; probable.
CC Discontinued: ATCC; CRL-1243; true.
DI NCIt; C125699; Ehlers-Danlos syndrome, type IV
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID COR-L103
AC CVCL_D744
SY COR L103; Cor L103; CORL103
DR ECACC; 96020735
RX PubMed=1327513;
RX PubMed=3034934;
CC Discontinued: ECACC; 96020735; probable.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2409 ! COR-L24
SX Male
CA Cancer cell line
//
ID COR-L105
AC CVCL_1138
SY CORL105; COR-L 105
DR CLO; CLO_0002584
DR EFO; EFO_0002141
DR CLDB; cl876
DR CCLE; CORL105_LUNG
DR ChEMBL-Cells; CHEMBL3308350
DR ChEMBL-Targets; CHEMBL1075431
DR Cosmic; 906805
DR Cosmic; 1995377
DR Cosmic-CLP; 906805
DR ECACC; 92031918
DR GDSC; 906805
DR GEO; GSM827563
DR GEO; GSM886955
DR GEO; GSM888023
DR GEO; GSM1669696
DR IGRhCellID; CORL105
DR NCBI_Iran; C113
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 10,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L23
AC CVCL_1139
SY CORL23; L23/P
DR CLO; CLO_0002585
DR EFO; EFO_0002142
DR CLDB; cl877
DR CLDB; cl878
DR CCLE; CORL23_LUNG
DR ChEMBL-Cells; CHEMBL3308073
DR ChEMBL-Targets; CHEMBL613854
DR Cosmic; 687780
DR Cosmic; 1995378
DR Cosmic-CLP; 687780
DR ECACC; 92031919
DR GDSC; 687780
DR GEO; GSM784278
DR GEO; GSM827427
DR GEO; GSM886956
DR GEO; GSM888024
DR GEO; GSM1669697
DR ICLC; HTL95012
DR IGRhCellID; CORL23
RX PubMed=2998422;
RX PubMed=3034934;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 35 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; ECACC
ST Amelogenin: X (Cosmic-CLP)
ST Amelogenin: X,Y (ECACC)
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 10,12
ST D7S820: 9
ST TH01: 9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L23/5010
AC CVCL_2006
DR CLO; CLO_0002586
DR CLDB; cl5054
DR ECACC; 96042338
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 10,12
ST D7S820: 9
ST TH01: 9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1139 ! COR-L23
SX Male
CA Cancer cell line
//
ID COR-L23/CPR
AC CVCL_2007
SY COR-L 23/CPR; L23/CPR
DR CLO; CLO_0002583
DR CLDB; cl5053
DR ECACC; 96042336
DR GEO; GSM827460
RX PubMed=1327513;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 10,12
ST D7S820: 9
ST TH01: 9
ST TPOX: 8
ST vWA: 19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1139 ! COR-L23
SX Male
CA Cancer cell line
//
ID COR-L23/R
AC CVCL_2008
DR CLO; CLO_0002587
DR CLDB; cl5055
DR ECACC; 96042339
RX PubMed=3011054;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1139 ! COR-L23
SX Male
CA Cancer cell line
//
ID COR-L23/R23-
AC CVCL_2009
SY COR-L23/Rev
DR ECACC; 96042337
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 10,12
ST D7S820: 9
ST TH01: 9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2008 ! COR-L23/R
SX Male
CA Cancer cell line
//
ID COR-L24
AC CVCL_2409
SY COR L24; Cor L24; CORL24
DR CLO; CLO_0002588
DR CLDB; cl879
DR CCLE; CORL24_LUNG
DR ECACC; 96020717
DR GEO; GSM886957
DR GEO; GSM888025
RX PubMed=2998422;
RX PubMed=3034934;
RX PubMed=12397641;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D5S818: 11
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D744 ! COR-L103
SX Male
CA Cancer cell line
//
ID COR-L26
AC CVCL_2410
SY CORL26
DR EFO; EFO_0006555
DR BioSample; SAMN03473034
DR ECACC; 96020740
RX PubMed=2998422;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 15
ST D21S11: 28,30
ST D3S1358: 18
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 11,14
ST FGA: 18,19
ST Penta D: 9,10
ST Penta E: 10,17
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COR-L266
AC CVCL_D745
RX PubMed=1327513;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L27
AC CVCL_D733
SY Cor L27
RX PubMed=2998422;
RX PubMed=3034934;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L279
AC CVCL_1140
SY CORL279
DR CLO; CLO_0002589
DR EFO; EFO_0002143
DR CLDB; cl880
DR BioSample; SAMN03473035
DR CCLE; CORL279_LUNG
DR ChEMBL-Cells; CHEMBL3308549
DR ChEMBL-Targets; CHEMBL2366352
DR Cosmic; 910937
DR Cosmic; 1524010
DR Cosmic-CLP; 910937
DR ECACC; 96020724
DR GDSC; 910937
DR GEO; GSM827428
DR GEO; GSM888026
DR GEO; GSM1669698
DR IGRhCellID; CORL279
RX PubMed=1327513;
RX PubMed=12397641;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 13,16
ST D21S11: 30,32.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 12
ST FGA: 22
ST Penta D: 14,15
ST Penta E: 7
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L283R
AC CVCL_7215
SY CORL283R
DR CLO; CLO_0002590
DR CLDB; cl5056
DR ECACC; 96020723
CC Discontinued: ECACC; 96020723; probable.
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L30
AC CVCL_D734
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L303
AC CVCL_2411
SY CORL303; COR L303
DR Cosmic-CLP; 1297438
DR ECACC; 96020722
DR GDSC; 1297438
DR GEO; GSM1669699
RX PubMed=27397505;
CC Doubling time: ~5 days (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,9
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COR-L31
AC CVCL_D735
SY Cor L31
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L311
AC CVCL_2412
SY CORL311
DR CLO; CLO_0002591
DR CLDB; cl881
DR CCLE; CORL311_LUNG
DR Cosmic; 687980
DR Cosmic; 1609513
DR Cosmic-CLP; 687980
DR ECACC; 96020721
DR GDSC; 687980
DR GEO; GSM886958
DR GEO; GSM888027
DR GEO; GSM1669700
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 14
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L32
AC CVCL_2413
SY Cor L32; CORL32
DR BioSample; SAMN03473036
DR Cosmic-CLP; 1322212
DR ECACC; 96020744
DR GDSC; 1322212
DR GEO; GSM1669701
RX PubMed=2998422;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11 (Cosmic-CLP)
ST D13S317: 8 (PubMed=25877200)
ST D16S539: 9,11
ST D18S51: 13
ST D21S11: 27,32.2
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 21
ST Penta D: 12,13
ST Penta E: 7,10
ST TH01: 7,9.3
ST TPOX: 10
ST vWA: 14
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L321
AC CVCL_2414
SY CORL321
DR Cosmic-CLP; 1322213
DR ECACC; 96020756
DR GDSC; 1322213
DR GEO; GSM1669702
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COR-L41
AC CVCL_D736
RX PubMed=2998422;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L42
AC CVCL_D737
SY Cor L42
RX PubMed=2998422;
RX PubMed=3034934;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L47
AC CVCL_2415
SY Cor L47; CORL47
DR CLO; CLO_0002592
DR EFO; EFO_0006556
DR CLDB; cl882
DR BioSample; SAMN03473037
DR CCLE; CORL47_LUNG
DR Cosmic; 753544
DR ECACC; 92031915
DR GEO; GSM886959
DR GEO; GSM888028
DR SKY/M-FISH/CGH; 1627
RX PubMed=2998422;
RX PubMed=3034934;
RX PubMed=12397641;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 13,15
ST D21S11: 30,31.2
ST D3S1358: 14
ST D5S818: 10,13
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 24
ST Penta D: 9,12
ST Penta E: 11,12
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L51
AC CVCL_2416
SY Cor L51; CORL51
DR CLO; CLO_0002593
DR CLDB; cl883
DR BioSample; SAMN03473038
DR CCLE; CORL51_LUNG
DR Cosmic; 687981
DR Cosmic; 910555
DR ECACC; 92031916
DR GEO; GSM17196
RX PubMed=2998422;
RX PubMed=3034934;
RX PubMed=12397641;
RX PubMed=15016488;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X (ECACC)
ST Amelogenin: X,Y (PubMed=25877200)
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 13,20
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 13
ST FGA: 21,23.2
ST Penta D: 10,11
ST Penta E: 11,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L54
AC CVCL_D738
RX PubMed=2998422;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L59
AC CVCL_D739
RX PubMed=2998422;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L64
AC CVCL_2417
SY CORL64
DR BioSample; SAMN03472983
DR ECACC; 96020749
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 12,19
ST D21S11: 30
ST D3S1358: 14,15
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 11,15
ST FGA: 22
ST Penta D: 12
ST Penta E: 7,12
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 18,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L65
AC CVCL_D740
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L71
AC CVCL_D741
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L80
AC CVCL_D742
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L84
AC CVCL_D743
RX PubMed=2998422;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID COR-L88
AC CVCL_1141
SY Cor L88; CORL88; CorL88
DR CLO; CLO_0002594
DR EFO; EFO_0002144
DR CLDB; cl884
DR BioSample; SAMN03473039
DR CCLE; CORL88_LUNG
DR ChEMBL-Cells; CHEMBL3308865
DR ChEMBL-Targets; CHEMBL2366329
DR Cosmic; 687982
DR Cosmic; 906808
DR Cosmic; 1609523
DR Cosmic; 1995379
DR Cosmic-CLP; 906808
DR ECACC; 92031917
DR GDSC; 906808
DR GEO; GSM17306
DR GEO; GSM827452
DR GEO; GSM886960
DR GEO; GSM888029
DR GEO; GSM1669703
DR IGRhCellID; CORL88
RX PubMed=2998422;
RX PubMed=3034934;
RX PubMed=12397641;
RX PubMed=15016488;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 16,17
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 9
ST D8S1179: 9,13
ST FGA: 19,20
ST Penta D: 9
ST Penta E: 14
ST TH01: 7
ST TPOX: 8,10
ST vWA: 14,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L95
AC CVCL_2418
SY CORL95
DR CLO; CLO_0002595
DR CCLE; CORL95_LUNG
DR Cosmic; 1297439
DR Cosmic; 2125174
DR Cosmic-CLP; 1297439
DR ECACC; 96020733
DR GDSC; 1297439
DR GEO; GSM827338
DR GEO; GSM886961
DR GEO; GSM888030
DR GEO; GSM1669704
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,13 (Cosmic-CLP)
ST D13S317: 8,11 (ECACC)
ST D16S539: 11,13
ST D5S818: 13
ST D7S820: 10
ST TH01: 6
ST TPOX: 9,10
ST vWA: 16,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID COR-L96-CAR
AC CVCL_1142
SY COR-L96CAR; CORL96CAR
DR Cosmic; 971776
RX PubMed=14762065;
CC Omics: CNV analysis.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V485 ! COR-L96-LCL
CA Cancer cell line
//
ID COR-L96-LCL
AC CVCL_V485
SY COR-L96LCL
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1142 ! COR-L96-CAR
CA Transformed cell line
//
ID Cor.4U
AC CVCL_Y550
SY Cor4U
WW http://axiogenesis.com/products/cardiac-cells/cor-4u-hipsc-cardiomyocytes.html
WW http://axiogenesis.com/images/pdf/flyers/Axiogenesis_Cor4U_hiPSC_Flyer.pdf
CC From: Axiogenesis AG; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID Cor.At
AC CVCL_Y551
SY Cor.At CL; Cor.At Colorless
RX PubMed=15659535;
WW http://axiogenesis.com/products/murine-cardiomyocytes/cells/cor-at-cl-es.html
CC From: Axiogenesis AG; Germany.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Finite cell line
//
ID Cor.At GFP
AC CVCL_Y552
RX PubMed=15659535;
WW http://axiogenesis.com/products/murine-cardiomyocytes/cells/cor-at-gfp-es.html
CC From: Axiogenesis AG; Germany.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Finite cell line
//
ID Cor.At-iPS-CL
AC CVCL_1E63
WW http://axiogenesis.com/products/murine-cardiomyocytes/cells/cor-at-cl-ips.html
CC From: Axiogenesis AG; Germany.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Finite cell line
//
ID COS-1
AC CVCL_0223
SY Cos-1; COS1; Cos1; CV-1 in Origin Simian-1
DR BTO; BTO:0001538
DR BTO; BTO:0004055
DR CLO; CLO_0002596
DR CLO; CLO_0050514
DR MCCL; MCC:0000111
DR CLDB; cl886
DR CLDB; cl887
DR CLDB; cl888
DR CLDB; cl889
DR CLDB; cl7122
DR ATCC; CRL-1650
DR BCRC; 60002
DR BCRJ; 0070
DR CCRID; 3111C0001CCC000157
DR CCRID; 3131C0001000400001
DR CCRID; 3153C0001000000088
DR ChEMBL-Cells; CHEMBL3308351
DR ChEMBL-Targets; CHEMBL614563
DR DSMZ; ACC-63
DR ECACC; 88031701
DR ICLC; ATL01002
DR IZSLER; BS CL 95
DR JCRB; JCRB9082
DR KCB; KCB 93018YJ
DR KCLB; 21650
DR Lonza; 722
DR MeSH; D019556
DR NCBI_Iran; C518
DR RCB; RCB0143
DR TOKU-E; 992
DR Wikidata; Q27556079
RX PubMed=6260373;
WW https://en.wikipedia.org/wiki/COS_cells
WW http://www.addexbio.com/productdetail?pid=34
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-13.html
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cos1/cos1cells.html
CC Group: Non-human primate cell line.
CC Doubling time: ~48 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0229 ! CV-1
SX Male
CA Transformed cell line
//
ID COS-1-InVitrus
AC CVCL_Z934
DR ECACC; 04092902
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0223 ! COS-1
SX Male
CA Transformed cell line
//
ID COS-1/B2T.cl.17
AC CVCL_FA30
RX PubMed=24709903;
CC Group: Non-human primate cell line.
CC Characteristics: Transfected with a TNFRSF13C-TNFRSF1A (BAFFR-TNFR1) hybrid receptor containing the extracellular BAFF-binding portion of the TNFRSF13C and the intracellular signaling portion of TNFRSF1A.
CC Transfected with: HGNC; 17755; TNFRSF13C (region 1-78).
CC Transfected with: HGNC; 11916; TNFRSF1A (region 204-443).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0223 ! COS-1
SX Male
CA Transformed cell line
//
ID COS-3
AC CVCL_HE48
SY Cos-3; COS3; Cos3; CV-1 in Origin Simian-3
RX PubMed=6260373;
WW https://en.wikipedia.org/wiki/COS_cells
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0229 ! CV-1
SX Male
CA Transformed cell line
//
ID COS-7
AC CVCL_0224
SY Cos-7; COS7; Cos7; CV-1 in Origin Simian-7
DR BTO; BTO:0000298
DR BTO; BTO:0004055
DR CLO; CLO_0002597
DR CLO; CLO_0050508
DR MCCL; MCC:0000112
DR CLDB; cl890
DR CLDB; cl891
DR CLDB; cl892
DR CLDB; cl893
DR ATCC; CRL-1651
DR BCRC; 60094
DR BCRJ; 0071
DR CCRID; 3111C0001CCC000033
DR CCRID; 3131C0001000400002
DR CCRID; 3142C0001000000088
DR CCRID; 3153C0001000000037
DR ChEMBL-Cells; CHEMBL3307648
DR ChEMBL-Targets; CHEMBL614564
DR CLS; 605470/p532_COS-7
DR DSMZ; ACC-60
DR ECACC; 87021302
DR ICLC; ATL96005
DR IFO; IFO50068
DR IZSLER; BS CL 103
DR JCRB; JCRB9127
DR KCB; KCB 93019YJ
DR KCLB; 21651
DR Lonza; 587
DR MeSH; D019556
DR NCBI_Iran; C143
DR RCB; RCB0539
DR TKG; TKG 0514
DR TOKU-E; 993
DR Wikidata; Q27556092
RX PubMed=6260373;
WW https://en.wikipedia.org/wiki/COS_cells
WW http://cos-7.com/
WW http://www.addexbio.com/productdetail?pid=35
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cos7/cos7cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-5.html
CC Group: Non-human primate cell line.
CC Doubling time: ~35-48 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0229 ! CV-1
SX Male
CA Transformed cell line
//
ID COS-7-InVitrus
AC CVCL_Z935
DR ECACC; 05063001
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0224 ! COS-7
SX Male
CA Transformed cell line
//
ID COS-7L
AC CVCL_0J76
SY COS7L
WW http://tools.thermofisher.com/content/sfs/manuals/3915.pdf
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
CC Discontinued: Thermofisher/Invitrogen; Catalog number 11622-016.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0224 ! COS-7
SX Male
CA Transformed cell line
//
ID COS-Fucci
AC CVCL_E071
DR CLO; CLO_0050516
DR RCB; RCB2814
RX PubMed=18267078;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0224 ! COS-7
SX Male
CA Transformed cell line
//
ID COS-M5
AC CVCL_C760
SY Cos-M5; COS M5; COS/M5; COSM5; CosM5; COS-7 subline M5
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0224 ! COS-7
SX Male
CA Transformed cell line
//
ID COS-M6
AC CVCL_8561
SY COS-m6; COS M6; COSM6; CosM6; COSm6; COS-7/M6; COS-7 subline M6
RX PubMed=6192195;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-196.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0224 ! COS-7
SX Male
CA Transformed cell line
//
ID COS_1186h
AC CVCL_FA21
RX DOI=10.3390/vetsci3020009;
CC Breed/subspecies: Dachshund.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_FA22 ! COS_1186w
SX Male
CA Cancer cell line
//
ID COS_1186w
AC CVCL_FA22
RX DOI=10.3390/vetsci3020009;
CC Breed/subspecies: Dachshund.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_FA21 ! COS_1186h
SX Male
CA Cancer cell line
//
ID COS_1189
AC CVCL_FA23
RX DOI=10.3390/vetsci3020009;
CC Breed/subspecies: Mixed breed.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID COS_1220
AC CVCL_FA24
RX DOI=10.3390/vetsci3020009;
CC Breed/subspecies: Boxer.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID COS_1033
AC CVCL_FA25
RX DOI=10.3390/vetsci3020009;
CC Derived from metastatic site: Lung.
CC Breed/subspecies: Boxer.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID COS1NR
AC CVCL_M797
RX PubMed=9619880;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===bone%20-%20COS1NR%20cells&-Find
CC Breed/subspecies: Fischer 344/Ns1c.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_M798 ! COS2NR
OI CVCL_M799 ! COS4NR
SX Male
CA Cancer cell line
//
ID COS2NR
AC CVCL_M798
RX PubMed=9619880;
CC Breed/subspecies: Fischer 344/Ns1c.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_M797 ! COS1NR
OI CVCL_M799 ! COS4NR
SX Male
CA Cancer cell line
//
ID COS31
AC CVCL_L346
SY COS 31; Canine osteosarcoma cells from passage 31
DR BTO; BTO:0005363
RX PubMed=9827352;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID COS31/rCDDP
AC CVCL_L347
RX PubMed=9827351;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L346 ! COS31
CA Cancer cell line
//
ID COS4NR
AC CVCL_M799
RX PubMed=9619880;
CC Breed/subspecies: Fischer 344/Ns1c.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_M797 ! COS1NR
OI CVCL_M798 ! COS2NR
SX Male
CA Cancer cell line
//
ID COSB
AC CVCL_5I33
RX PubMed=24582862;
CC Breed/subspecies: German Shepherd.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0C95 ! SB-HSA
SX Male
CA Cancer cell line
//
ID COSCA-Pr
AC CVCL_L349
SY COSCA-PR; COSCA-Princess
RX PubMed=9522958;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID COSCA-T
AC CVCL_L348
SY COSCA-Toby
RX PubMed=9522958;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID COST
AC CVCL_9491
RX PubMed=15356658;
RX PubMed=15356659;
RX PubMed=16596703;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Cou-L
AC CVCL_1K09
RX PubMed=11564178;
RX PubMed=14962098;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1K07 ! Cou-LS
SX Male
CA Cancer cell line
//
ID Cou-L3
AC CVCL_1K08
RX PubMed=12534590;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1K07 ! Cou-LS
SX Male
CA Cancer cell line
//
ID Cou-LS
AC CVCL_1K07
RX PubMed=9596682;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1K08 ! Cou-L3
SX Male
CA Cancer cell line
//
ID COV318
AC CVCL_2419
SY Cov318; COV-318
DR EFO; EFO_0006382
DR BioSample; SAMN03473267
DR CCLE; COV318_OVARY
DR ECACC; 07071903
DR GEO; GSM313686
DR GEO; GSM886962
DR GEO; GSM888031
RX PubMed=8436435;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 50 hours (PubMed=25984343).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Peritoneal ascites.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 14
ST D16S539: 9,12
ST D18S51: 12
ST D19S433: 13.2
ST D21S11: 30
ST D2S1338: 17,27
ST D3S1358: 14,16
ST D5S818: 11,13
ST D7S820: 9
ST D8S1179: 12,13
ST FGA: 20,23
ST Penta D: 10
ST Penta E: 7
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COV353
AC CVCL_4Y49
SY Cov353
RX PubMed=1958589;
RX PubMed=8436435;
CC Derived from metastatic site: Bladder dome.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2423 ! COV413B
SX Female
CA Cancer cell line
//
ID COV362
AC CVCL_2420
SY Cov362; COV-362
DR EFO; EFO_0006383
DR BioSample; SAMN03473268
DR CCLE; COV362_OVARY
DR ECACC; 07071910
DR GEO; GSM886963
DR GEO; GSM888032
RX PubMed=8436435;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 91 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 14
ST D16S539: 11
ST D18S51: 13
ST D19S433: 14
ST D21S11: 31,32.2
ST D2S1338: 24,25
ST D3S1358: 16,18
ST D5S818: 13
ST D7S820: 10,14
ST D8S1179: 11
ST FGA: 23,24
ST Penta D: 9
ST Penta E: 7,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 15,18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COV362.4
AC CVCL_2421
SY COV-362.4
DR BioSample; SAMN03473272
DR ECACC; 07071904
DR GEO; GSM313709
RX PubMed=8436435;
RX PubMed=25230021;
CC Part of: OCCP ovarian cancer cell line panel.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 14
ST D16S539: 11
ST D18S51: 13
ST D19S433: 14
ST D21S11: 31,32.2
ST D2S1338: 24,25
ST D3S1358: 16,18
ST D5S818: 12,13 (PubMed=25877200)
ST D5S818: 13 (PubMed=25230021)
ST D7S820: 10,14
ST D8S1179: 11
ST FGA: 24
ST Penta D: 9,11
ST Penta E: 7,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 15,18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2420 ! COV362
SX Female
CA Cancer cell line
//
ID COV413A
AC CVCL_2422
DR EFO; EFO_0006557
DR BioSample; SAMN03472963
DR ECACC; 07071905
RX PubMed=8436435;
RX PubMed=25230021;
RX PubMed=25485619;
CC Part of: OCCP ovarian cancer cell line panel.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Sigmoid colon.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 18
ST D19S433: 14,15
ST D21S11: 31.2
ST D2S1338: 17
ST D3S1358: 14
ST D5S818: 9,12
ST D7S820: 8,13
ST D8S1179: 13,14
ST FGA: 19
ST Penta D: 14
ST Penta E: 12,14
ST TH01: 6
ST TPOX: 9
ST vWA: 17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2423 ! COV413B
SX Female
CA Cancer cell line
//
ID COV413B
AC CVCL_2423
DR EFO; EFO_0006558
DR BioSample; SAMN03472965
DR ECACC; 07071906
RX PubMed=8436435;
RX PubMed=25230021;
RX PubMed=25485619;
CC Part of: OCCP ovarian cancer cell line panel.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Bladder dome.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 16
ST D19S433: 14,15
ST D21S11: 31.2
ST D2S1338: 17
ST D3S1358: 14
ST D5S818: 9,12
ST D7S820: 8,13
ST D8S1179: 13,14
ST FGA: 19
ST Penta D: 14
ST Penta E: 12,14
ST TH01: 6
ST TPOX: 9
ST vWA: 17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2422 ! COV413A
SX Female
CA Cancer cell line
//
ID COV434
AC CVCL_2010
SY COV-434
DR EFO; EFO_0006384
DR BioSample; SAMN03473273
DR CCLE; COV434_OVARY
DR Cosmic; 1149408
DR Cosmic; 1213590
DR Cosmic; 1429992
DR Cosmic; 2368539
DR Cosmic; 2391829
DR ECACC; 07071909
DR GEO; GSM313704
DR GEO; GSM886964
DR GEO; GSM888033
RX PubMed=8436435;
RX PubMed=15541573;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25485619;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 9,12
ST D18S51: 10,15
ST D21S11: 28
ST D3S1358: 15,19
ST D5S818: 10,11
ST D7S820: 8
ST D8S1179: 13,14
ST FGA: 24,25
ST Penta D: 10,12
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C6261; Ovarian granulosa cell tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COV504
AC CVCL_2424
SY Cov504; COV 504
DR EFO; EFO_0006385
DR BioSample; SAMN03473269
DR CCLE; COV504_OVARY
DR ECACC; 07071902
DR GEO; GSM886965
DR GEO; GSM888034
RX PubMed=8436435;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 50 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 13
ST D19S433: 15
ST D21S11: 29
ST D2S1338: 17,19
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 13
ST Penta E: 7,16
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COV644
AC CVCL_2425
SY COV-644
DR EFO; EFO_0006386
DR BioSample; SAMN03473270
DR CCLE; COV644_OVARY
DR ECACC; 07071908
DR GEO; GSM313681
DR GEO; GSM886966
DR GEO; GSM888035
RX PubMed=8436435;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 188 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 13,16.2
ST D21S11: 29
ST D2S1338: 17,18
ST D3S1358: 17,18
ST D5S818: 10,11
ST D7S820: 8,11
ST D8S1179: 12,14
ST FGA: 21,23
ST Penta D: 10
ST Penta E: 18
ST TH01: 8
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID COX
AC CVCL_E534
DR dbMHC; 48733
DR IHW; IHW9022
DR IMGT/HLA; 10429
RX PubMed=8307784;
RX PubMed=16702430;
WW http://bioinformatics.hsanmartino.it/ecbr/cl22.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID CP
AC CVCL_6F78
SY Climbing perch caudal Peduncle
RX PubMed=1717644;
CC Group: Fish cell line.
OX NCBI_TaxID=64144; ! Anabas testudineus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CP-1268
AC CVCL_Z342
RX PubMed=184032;
RX PubMed=5142331;
CC Group: Insect cell line.
OX NCBI_TaxID=82600; ! Cydia pomonella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CP-169
AC CVCL_Z343
SY Cp 169; Cp169
RX PubMed=5142331;
RX PubMed=8799737;
CC Group: Insect cell line.
OX NCBI_TaxID=82600; ! Cydia pomonella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID CP-81
AC CVCL_S374
SY CP81
DR ATCC; CRL-6302
RX PubMed=198878;
RX PubMed=208990;
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transformant: NCBI_TaxID; 159603; Pongine herpesvirus 2 (Herpesvirus pongo).
CC Discontinued: ATCC; CRL-6302; true.
OX NCBI_TaxID=9600; ! Pongo pygmaeus
OI CVCL_S375 ! CP81.Sk
SX Female
CA Transformed cell line
//
ID CP-A
AC CVCL_C451
SY KR-42421; QhTERT
DR ATCC; CRL-4027
DR BioSample; SAMN03471730
RX PubMed=12807723;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 7,8
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C2891; Barrett esophagus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID CP-B
AC CVCL_C452
SY CP-52731; ChTERT
DR ATCC; CRL-4028
DR BioSample; SAMN03471731
RX PubMed=12807723;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 8,12
ST D16S539: 10,13
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 18,20
DI NCIt; C2891; Barrett esophagus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID CP-C
AC CVCL_C453
SY CP-94251
DR ATCC; CRL-4029
RX PubMed=12807723;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 9,13
ST D13S317: 8,10
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C2891; Barrett esophagus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID CP-D
AC CVCL_C454
SY CP-18821
DR ATCC; CRL-4030
DR BioSample; SAMN03471733
RX PubMed=12807723;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C2891; Barrett esophagus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID CP132
AC CVCL_4148
DR CLO; CLO_0002598
DR CLDB; cl894
DR ATCC; CRL-6304
DR ECACC; 91012416
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6304; true.
CC Discontinued: ECACC; 91012416; probable.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Finite cell line
//
ID CP18.Sk
AC CVCL_S373
DR ATCC; CRL-6301
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6301; true.
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Male
CA Finite cell line
//
ID CP5
AC CVCL_X511
SY Carticular Progenitor 5
DR ECACC; 08052101
CC Characteristics: Able to re-differentiate into articular chondrocytes after extensive population doublings (>30 PD).
CC Breed/subspecies: Holstein Friesian.
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID CP50-MEL-B
AC CVCL_1143
SY CP50MELB
DR ChEMBL-Cells; CHEMBL3308325
DR ChEMBL-Targets; CHEMBL2366076
DR Cosmic; 753545
DR Cosmic-CLP; 753545
DR GDSC; 753545
DR GEO; GSM1669705
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 12,14
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID CP66-MEL
AC CVCL_1144
SY CP66MEL; CP66
DR ChEMBL-Cells; CHEMBL3308287
DR ChEMBL-Targets; CHEMBL2366363
DR Cosmic; 753546
DR Cosmic; 2230116
DR Cosmic-CLP; 753546
DR GDSC; 753546
DR GEO; GSM1669706
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 7,8
ST TPOX: 11,12
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
** -----------------------------------------------------------------------
** CALIPHO group at the SIB - Swiss Institute of Bioinformatics
** Geneva, Switzerland
** -----------------------------------------------------------------------
**
** Description: References file for the Cellosaurus
** Version: 24.0
** Last update: 15-November-2017
**
** -----------------------------------------------------------------------
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 10-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
免费订购电话: 400-800-2947